Sola JL. Bosque F. Arias MN. Facorro ME. Gomez MC. [Non-fulminating malignant hyperthermia during a thyroidectomy (letter)]. [Spanish] Revista Espanola de Anestesiologia y Reanimacion. 41(3):193, 1994 Francoise M. Francois C. Sandre D. Maingueneau C. Gouyon JB. [Hemorrhagic shock with encephalopathy syndrome or major hyperthermia syndrome?]. [French] Pediatrie. 48(11):792-5, 1993. Steinmann CM. A possible role for inositol 1,4,5-trisphosphate (IP3) in malignant hyperthermia. [Review] Medical Hypotheses. 42(3):190-2, 1994. Simon HB. Hyperthermia and heatstroke. Hospital Practice (Office Edition). 29(8):65-8, 73, 78-80, 1994 Ueda I. Shinoda F. Kamaya H. Krishna PR. Malignant hyperthermia and calcium-induced heat production. Canadian Journal of Anaesthesia-Journal Canadien d Anesthesie. 41(5 Pt 1):440-5, 1994 Treves S. Larini F. Menegazzi P. Steinberg TH. Koval M. Vilsen B. Andersen JP. Zorzato F. Alteration of intracellular Ca2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia. Biochemical Journal. 301 ( Pt 3):661-5, 1994 Mickelson JR. Ervasti JM. Litterer LA. Campbell KP. Louis CF. Skeletal muscle junctional membrane protein content in pigs with different ryanodine receptor genotypes. American Journal of Physiology. 267(1 Pt 1):C282-92, 1994 Byers DJ. Krishna G. Malignant hyperthermia. [Review] European Journal of Medicine. 1(1):88-95, 1992 Ambus T. Evans S. Smith NT. Thyrotoxicosis factitia in the anesthetized patient. Anesthesiology. 81(1):254-6, 1994 Book WJ. Abel M. Eisenkraft JB. Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management. [Review] Drug Safety. 10(5):331-49, 1994. Hopkins PM. Ellis FR. Halsall PJ. The effects of benzamil on in vitro contracture responses of human skeletal muscle to halothane. General Pharmacology. 25(1):23-9, 1994. Larach MG. Localio AR. Allen GC. Denborough MA. Ellis FR. Gronert GA. Kaplan RF. Muldoon SM. Nelson TE. Ording H. et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 80(4):771-9, 1994. Michel H. Larrey D. Blanc P. [Hepato-digestive disorders in athletic practice]. [Review] [French] Presse Medicale - Paris. 23(10):479-84, 1994. Figarella-Branger D. Kozak-Ribbens G. Rodet L. Aubert M. Borsarelli J. Cozzone PJ. Pellissier JF. Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscular Disorders. 3(5-6):553-6, 1993 Antognini JF. Anderson M. Cronan M. McGahan JP. Gronert GA. Ultrasonography: not useful in detecting susceptibility to malignant hyperthermia. Journal of Ultrasound in Medicine. 13(5):371-4, 1994 Sumpelmann R. Botel C. Zimmermann M. Krohn S. Strauss JM. [Malignant hyperthermia in swine during isoflurane anesthesia]. [German] DTW - Deutsche Tierarztliche Wochenschrift. 101(5):207-8, 1994 Quane KA. Keating KE. Manning BM. Healy JM. Monsieurs K. Heffron JJ. Lehane M. Heytens L. Krivosic-Horber R. Adnet P. et al. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Human Molecular Genetics. 3(3):471-6, 1994 Gronert GA. Should calcium be used to treat hyperkalemia after succinylcholine? [letter]. Anesthesiology. 80(6):1415, 1994 Urwyler A. Censier K. Kaufmann MA. Drewe J. Genetic effects on the variability of the halothane and caffeine muscle contracture tests. Anesthesiology. 80(6):1287-95, 1994 O'Flynn RP. Shutack JG. Rosenberg H. Fletcher JE. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. Anesthesiology. 80(6):1228-33, 1994 Iaizzo PA. Wedel DJ. Response to succinylcholine in porcine malignant hyperthermia. Anesthesia & Analgesia. 79(1):143-51, 1994 Chambers FA. Casey W. Dowling F. Moore KP. Malignant hyperthermia during isoflurane anaesthesia [letter]. Canadian Journal of Anaesthesia-Journal Canadien d Anesthesie. 41(4):355-6, 1994 Hopkins PM. Halsall PJ. Ellis FR. Diagnosing malignant hyperthermia susceptibility [editorial]. Anaesthesia. 49(5):373-5, 1994 Bichel T. Canivet JL. Damas P. Lamy M. Malignant hyperthermia and severe hypoglycemia after reexposure to halothane. Acta Anaesthesiologica Belgica. 45(1):23-7, 1994. Denborough M. Hopkinson KC. Death caused by overheating in piglets susceptible to malignant hyperthermia [letter]. Medical Journal of Australia. 160(11):731-2, 1994 Cooper PD. Spin label techniques for the detection of malignant hyperthermia [letter; comment]. British Journal of Anaesthesia. 71(6):921-2, 1993 Halsall PJ. Ellis FR. Knowles PF. Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility [see comments]. British Journal of Anaesthesia. 69(5):471-3, 1992 Brustia L. Adduci D. Fanzio M. Preseglio I. Cimino F. Piccolo G. Banfi P. Carnevale L. Imberti R. [TIVA inmitochondrial myopathy. A clinical case]. [Italian] Minerva Anestesiologica. 59(11):611-3, 1993 Nov. Hinkle AJ. Should malignant hyperthermia-susceptible patients undergo muscle biopsy? [letter; comment]. Anesthesiology. 80(3):708-9, 1994 Johnsen RD. Halothane concentrations for malignant hyperthermia testing [letter; comment]. Acta Anaesthesiologica Scandinavica. 38(1):89, 1994 Romero NB. Nivoche Y. Lunardi J. Bruneau B. Cheval MA. Hillaire D. Fardeau M. Malignant hyperthermia and central core disease: analysis of two families with heterogeneous clinical expression. Neuromuscular Disorders. 3(5-6):547-51, 1993 Larach MG. Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility? [editorial; comment] [see comments]. Anesthesiology. 79(1):1-4, 1993 Urwyler A. Funk B. Censier K. Drewe J. Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening [see comments]. Acta Anaesthesiologica Scandinavica. 36(2):115-8, 1992 de Araujo TL. Mancussi e Faro AC. Lagana MT. [Body temperature: the planning of nursing care in checking the temperature and in caring for fever and malignant hyperthermia]. [Portuguese] Temperatura corporal: planejamento da assistencia de enfermagemna verificacao da temperatura, no atendimento da febre e da hipertermia maligna. Revista Da Escola de Enfermagem Da USP. 26(3):315-24, 1992 Donnelly AJ. Malignant hyperthermia. Epidemiology, pathophysiology, treatment. [Review] AORN Journal. 59(2):393-5, 398-400, 403-5, 1994 Beck CF. Malignant hyperthermia. Are you prepared?. [Review] AORN Journal. 59(2):367, 370-84, 387-90, 1994 Feb. Otsu K. Nishida K. Kimura Y. Kuzuya T. Hori M. Kamada T. Tada M. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. Journal of Biological Chemistry. 269(13):9413-5, 1994 Williams C. Dozier S. Ilias W. Fulfer R. [Malignant hyperthermia in swine: a study of atracurium in MH-susceptible swine]. [German] Maligne Hyperthermie des Schweines: Untersuchung von Atracurium an MH-empfindlichen Schweinen. Anaesthesiologie und Reanimation. 19(1):23-5, 1994. Semmler A. Rieger C. Lesinski R. [A case report of malignant hyperthermia in a 14-month-old boy]. Kasuistik einer malignen Hyperthermie bei einem 14 Monate alten Knaben. Anaesthesiologie und Reanimation. 19(1):21-2, 1994. Hinkle AJ. Should malignant hyperthermia-susceptible patients undergo muscle biopsy? [letter]. Anesthesiology. 80(3):708-9, 1994 Mar. Louis CF. Roghair T. Mickelson JR. Volatile anesthetics inhibit dihydropyridine binding to malignant hyperthermia-susceptible and normal pig skeletal muscle membranes. Anesthesiology. 80(3):618-24, 1994 Johnsen RD. Halothane concentrations for malignant hyperthermia testing [letter]. Acta Anaesthesiologica Scandinavica. 38(1):89, 1994 Wedel DJ. Nelson TE. Malignant hyperthermia--diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone. Anesthesia & Analgesia. 78(4):787-92, 1994 Haynes GR. Gottesman J. Dorman BH. Brahen NH. Postoperative hyperthermia in a patient having cortical brain resection. Southern Medical Journal. 87(3):399-401, 1994 Gurtler H. Neubert E. [The effect of anesthesia, of an alpha or beta adrenergic blockade in conscious and of adrenaline in anesthetized halothane-positive swine on hematologic and metabolic parameters in the blood during the course of halothane exposure]. [German] Berliner und Munchener Tierarztliche Wochenschrift. 107(1):1-7, 1994 Lamb GD. Ca2+ inactivation, Mg2+ inhibition and malignant hyperthermia [news]. Journal of Muscle Research & Cell Motility. 14(6):554-6, 1993 Lenzen C. Roewer N. Wappler F. Scholz J. Kahl J. Blank M. Rumberger E. Schulte am Esch J. Accelerated contractures after administration of ryanodine to skele British Journal of Anaesthesia. 71(2):242-6, 1993 Mammar MS. Vignon X. Rock E. Mathieu F. Gandemer G. Analysis of lipid composition of sarcoplasmic reticulum membranes from normal and malignant hyperthermic pig skeletal muscle. Biochemistry & Cell Biology. 71(7-8):324-30, 1993 Ellis FR. Hassall PJ. Hopkins PM. Malignant hyperthermia [letter]. Anaesthesia & Intensive Care. 21(6):894-5, 1993 Allen GC. Malignant hyperthermia and associated disorders. [Review] Current Opinion in Rheumatology. 5(6):719-24, 1993 Zhang BX. [Malignant hyperthermia: preoperative prognosis, prevention and treatment]. [Chinese] Chung-Hua Wai Ko Tsa Chih. 31(5):298-300, 1993 Messing ML. Feinzimer ET. Brosnan JJ. Rochester D. CT of rhabdomyolysis associated with malignant hyperthermia and seizures. Clinical Imaging. 17(4):258-9, 1993 Olckers A. Jedlicka AE. Powers PA. Hogan K. Gregg RG. Levitt RC. G to A polymorphism in the CACNLG gene. Human Molecular Genetics. 2(12):2198, 1993 Wappler F. Roewer N. Lenzen C. Kochling A. Scholz J. Steinfath M. Schulte am Esch J. High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man. British Journal of Anaesthesia. 72(2):240-2, 1994 Adnet PJ. Krivosic-Horber RM. Krivosic I. Haudecoeur G. Reyford HG. Adamantidis MM. Medahoui H. Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases. British Journal of Anaesthesia. 72(1):93-7, 1994 Burns AP. Hopkins PM. Hall G. Pusey CD. Rhabdomyolysis and acute renal failure in unsuspected malignant hyperpyrexia [see comments]. Quarterly Journal of Medicine. 86(7):431-4, 1993 Karan SM. Crowl F. Muldoon SM. Malignant hyperthermia masked by capnographic monitoring. Anesthesia & Analgesia. 78(3):590-2, 1994 Larner AJ. Hyperthermia [letter]. Quarterly Journal of Medicine. 86(12):843-4, 1993 Williams JH. Holland M. Ward CW. Lee JC. Altered mechanical responses of malignant hyperthermic skeletal muscle during repetitive stimulation. Journal of Physiology, Paris. 86(4):159-65, 1992. Kitanaka C. Inoh Y. Toyoda T. Sasaki T. Eguchi T. Malignant brain stem hyperthermia caused by brain stem hemorrhage. Stroke. 25(2):518-20, 1994 Wappler F. Roewer N. Lenzen C. Scholz J. Steinfath M. Rumberger R. Schulte am Esch J. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia]. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 28(7):427-31, 1993 Kaus SJ. Rockoff MA. Malignant hyperthermia. [Review] Pediatric Clinics of North America. 41(1):221-37, 1994 van Laack RL. Faustman C. Sebranek JG. Pork quality and the expression of stress protein Hsp 70 in swine. Journal of Animal Science. 71(11):2958-64, 1993 Denborough MA. McLean A. Morgan G. Hopkinson KC. Fatal inherited rhabdomyolysis and malignant hyperthermia [letter]. Lancet. 343(8891):236-7, 1994 Leeb T. Schmolzl S. Brem G. Brenig B. Genomic organization of the porcine skeletal muscle ryanodine receptor (RYR1) gene coding region 4624 to 7929. Genomics. 18(2):349-54, 1993 Cooper PD. Spin label techniques for the detection of malignant hyperthermia [letter]. British Journal of Anaesthesia. 71(6):921-2, 1993 Kochs E. Hoffman WE. Schulte am Esch J. Improvement of brain electrical activity during treatment of porcine malignant hyperthermia with dantrolene. British Journal of Anaesthesia. 71(6):881-4, 1993 Claxton-Gill MS. Cornick-Seahorn JL. Gamboa JC. Boatright BS. Suspected malignant hyperthermia syndrome in a miniature pot-bellied pig anesthetized with isoflurane. Journal of the American Veterinary Medical Association. 203(10):1434-6, 1993 van Laack RL. Faustman C. Sebranek JG. Pork quality and the expression of stress protein Hsp 70 in swine. Journal of Animal Science. 71(11):2958-64, 1993 Caroff SN. Mann SC. Neuroleptic malignant syndrome and malignant hyperthermia [letter; comment]. Anaesthesia & Intensive Care. 21(4):477-8, 1993 Allen GC. Paramyotonia and MH [letter; comment]. Canadian Journal of Anaesthesia-Journal Canadien d Anesthesie. 40(6):580-1, 1993 Pollock N. Hodges M. Sendall J. Prolonged malignant hyperthermia in the absence of triggering agents [see comments]. Anaesthesia & Intensive Care. 20(4):520-3, 1992 Sessler DI. Hyperthermia [letter]. N Engl J Med. 330(3):218, 1994 Parness J. Hyperthermia [letter]. N Engl J Med. 330(3):218, 1994 Breucking E. Mortier W. Lampert R. Brandt L. Anesthesia and intensive therapy for a patient with mitochondrial myopathy. Anaesthesist. 42(10):719-23, 1993 Breucking E. Mortier W. Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results. [German] Anaesthesist. 42(10):684-90, 1993 Mortier W. Breucking E. Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests. [German] Anaesthesist. 42(10):675-83, 1993 MacLennan DH. Otsu K. Fujii J. Zorzato F. Phillips MS. O'Brien PJ. Archibald AL. Britt BA. Gillard EF. Worton RG. The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia. [Review] Symp Soc Exp Biol. 46:189-201, 1992. Reber A. Schumacher P. Urwyler A. Effects of three different types of management on the elimination kinetics of volatile anaesthetics. Implications for malignant hyperthermia treatment. Anaesthesia. 48(10):862-5, 1993 Bakshi KK. Rhabdomyolysis and acute renal failure following a single dose of succinylcholine [letter; comment]. J Assoc Physicians India. 40(8):549, 1992 Roberts MW. A protocol to manage malignant hyperthermia with general anesthesia. Pediatr Dent. 15(1):45-6, 1993 Freedman G. Sampson IH. Cagen S. Propofol use in malignant hyperthermia: a case report. Mt Sinai J Med. 60(4):333-5, 1993 Decanniere C. Van Hecke P. Vanstapel F. Ville H. Geers R. Metabolic response to halothane in piglets susceptible to malignant hyperthermia: an in vivo 31P-NMR study. J Appl Physiol. 75(2):955-62, 1993 O'Brien PJ. Shen H. Cory CR. Zhang X. Use of a DNA-based test for the mutation associated with porcine stress syndrome (malignant hyperthermia) in 10,000 breeding swine. J Am Vet Med Assoc. 203(6):842-51, 1993 Gareau PJ. Janzen EG. Towner RA. Stewart WA. In vivo 31P NMR spectroscopy studies of halothane induced porcine stress syndrome. No effect of C-phenyl N-tert-butyl nitrone (PBN). Free Radic Res Commun. 19(1):43-50, 1993. Quane KA. Healy JM. Keating KE. Manning BM. Couch FJ. Palmucci LM. Doriguzzi C. Fagerlund TH. Berg K. Ording H. et al.Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet. 5(1):51-5, 1993 Zhang Y. Chen HS. Khanna VK. De Leon S. Phillips MS. Schappert K. Britt BA. Browell AK. MacLennan DH. A mutation in the human ryanodine receptor gene associated with central core disease. Nat Genet. 5(1):46-50, 1993 Zuckerberg AL. A hot mnemonic for the treatment of malignant #5 hyperthermia [letter]. Anesth Analg. 77(5):1077, 1993 Caroff SN. Mann SC. Neuroleptic malignant syndrome and malignant #5 hyperthermia [letter]. Anaesth Intensive Care. 21(4):477-8, 1993 Scholz J. Steinfath M. Roewer N. Patten M. Troll U. Schmitz W. Scholz H. Schulte am Esch J. Biochemical changes in malignant hyperthermia susceptible swine: cyclic AMP, inositol phosphates, alpha 1, beta 1- and beta 2-adrenoceptors in skeletal and cardiac muscle. Acta Anaesthesiol Scand. 37(6):575-83, 1993 Hopkins D. Shipton EA. A hypermetabolic reaction during anaesthesia and surgery. A case report. S Afr J Surg. 31(2):85-8, 1993 Burns AP. Hopkins PM. Hall G. Pusey CD. Rhabdomyolysis and acute renal failure in unsuspected malignant hyperpyrexia. Q J Med. 86(7):431-4, 1993 Abballe C. Primieri P. De Cosmo G. The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report. [Italian] Minerva Anestesiol. 59(6):335-8, 1993 Foster PS. Gesini E. Denborough MA. Inositol 1,4,5-tris phosphate metabolism in red blood cells from individuals susceptible to malignant hyperpyrexia [letter]. Lancet. 342(8877):986-7, 1993 Rouquier S. Giorgi D. Trask B. Bergmann A. Phillips MS. MacLennan DH. de Jong P. A cosmid and yeast artificial chromosome contig containing the complete ryanodine receptor (RYR1) gene. Genomics. 17(2):330-40, 1993 Schwemmle S. Wolff K. Palmucci LM. Grimm T. Lehmann-Horn F. Hubner C. Hauser E. Iles DE. MacLennan DH. Muller CR. Multipoint mapping of the central core disease locus. Genomics. 17(1):205-7, 1993 Allen GC. Paramyotonia and MH [letter]. Can J Anaesth. 40(6):580-1, 1993 Hall-Curran JL. Stewart AD. Ball SP. Halsall JP. Hopkins PM. Ellis FR. No C1840 to T mutation in RYR1 in malignant hyperthermia [letter]. Hum Mutat. 2(4):330, 1993. Fletcher JE. Calvo PA. Rosenberg H. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation. Br J Anaesth. 71(3):410-7, 1993 Houde A. Pommier SA. Roy R. Detection of the ryanodine receptor mutation associated with malignant hyperthermia in purebred swine populations. J Anim Sci. 71(6):1414-8, 1993 Rempel WE. Lu M. el Kandelgy S. Kennedy CF. Irvin LR. Mickelson JR. Louis CF. Relative accuracy of the halothane challenge test and a molecular genetic test in detecting the gene for porcine stress syndrome. J Anim Sci. 71(6):1395-9, 1993 Buckmaster HA. Kerr KA. Kudynska J. Spin resonance spectroscopy to detect malignant hyperthermia susceptibility [letter; comment]. Br J Anaesth. 70(5):598-9, 1993 Ball SP. Johnson KJ. The genetics of malignant hyperthermia. [Review] J Med Genet. 30(2):89-93, 1993 Brem G. Brening B. Use of molecular genetic diagnosis of malignant hyperthermic syndrome (MHS) in selection of pigs. [RUSSIAN] Genetika. 29(6):1009-13, 1993 Stemp LI. Management of lethal catatonia with dantrolene sodium [letter]. Critical Care Medicine. 21(9):1403, 1993 Heinritzi K. Ehrenberg A. Berner H. Prevention of myopathies and cardiomyopathies in swine using magnesium aspartate hydrochloride. Berliner Und Munchener Tierarztliche Wochenschrift. 106(7):224-7, 1993 Bakshi KK. Rhabdomyolysis and acute renal failure following a single dose of #5 succinylcholine [letter]. Journal of the Association of Physicians of India. 40(8):549, 1992 Iles DE. Segers B. Sengers RC. Monsieurs K. Heytens L. Halsall PJ. Hopkins PM. Ellis FR. Hall-Curran JL. Stewart AD. et al. Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility. Human Molecular Genetics. [JC:brc] 2(7):863-8, 1993 Sudbrak R. Golla A. Hogan K. Powers P. Gregg R. Du Chesne I. Lehmann-Horn F. Deufel T. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect. Human Molecular Genetics. 2(7):857-62, 1993 Johnson K. Malignant hyperthermia hots up. Human Molecular Genetics. [JC:brc] 2(7):849, 1993 Rock E. Motta C. Vignon X. Kozak-Ribbens G. Fluidity state of lymphocyte plasma membrane in malignant hyperthermia susceptible pigs and humans. Acta Anaesthesiologica Scandinavica. 37(5):488-92, 1993 Komatsu H. Enzan K. Suzuki M. A case of abortive malignant hyperthermia during funnel chest surgery. [Japanese] Masui - Japanese Journal of Anesthesiology. 42(7):1053-5, 1993 Buchanec J. Javorka K. Disorders of thermoregulation in children and their therapy. [Slovak] Ceskoslovenska Pediatrie. 48(6):334-6, 1993 Bowie JR. Patients who are susceptible to malignant hyperthermia [letter]. Nurse Anesthetist. 4(2):99, 1993 Strazis KP. Fox AW. Malignant hyperthermia: a review of published cases. Anesthesia & Analgesia. 77(2):297-304, 1993 Isaacs H. Badenhorst M. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia [see comments]. Anesthesiology. 79(1):5-9, 1993 Larach MG. Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility? [editorial; comment]. Anesthesiology. 79(1):1-4, 1993 Buckmaster HA. Kerr KA. Kudynska J. Spin resonance spectroscopy to detect malignant hyperthermia susceptibility [letter; comment]. British Journal of Anaesthesia. 70(5):598-9, 1993 Nelson TE. Combined caffeine-halothane test for malignant hyperthermia [letter; comment]. British Journal of Anaesthesia. 70(5):597-8, 1993 Myles P. Thigh tourniquet a trigger for MH? [letter; comment]. Anaesthesia & Intensive Care. 21(2):255-6, 1993 Halsall PJ. Ellis FR. Knowles PF. Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility [see comments]. British Journal of Anaesthesia. 69(5):471-3, 1992 Ellis FR. Halsall PJ. Hopkins PM. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia? [see comments]. British Journal of Anaesthesia. 69(5):468-70, 1992 Pollock N. Hodges M. Sendall J. Prolonged malignant hyperthermia in the absence of triggering agents [see comments]. Anaesthesia & Intensive Care. 20(4):520-3, 1992 Geers R. Decanniere C. Ville H. Van Hecke P. Goedseels V. Bosschaerts L. Deley J. Janssens S. Nierynck W. Identification of halothane gene carriers by use of in vivo 31P nuclear magnetic resonance spectroscopy in pigs [see comments]. American Journal of Veterinary Research. 53(9):1711-4, 1992 Houde A. Pommier SA. Roy R. Detection of the ryanodine receptor mutation associated with malignant hyperthermia in purebred swine populations. Journal of Animal Science. 71(6):1414-8, 1993 Rempel WE. Lu M. el Kandelgy S. Kennedy CF. Irvin LR. Mickelson JR. Louis CF. Relative accuracy of the halothane challenge test and a molecular genetic test in detecting the gene for porcine stress syndrome. Journal of Animal Science. 71(6):1395-9, 1993 Thiel A. Wagner M. Behr R. Hempelmann G. Anesthesia in familial hyperkalemic periodic paralysis. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 28(2):125-7, 1993 Young MS. Kindred D. Malignant hyperthermia: not just an operating room emergency. MEDSURG Nursing. 2(1):41-3, 46, 1993 Buckmaster HA. Kerr KA. Kudynska J. Spin resonance spectroscopy to detect malignant hyperthermia susceptibility [letter]. British Journal of Anaesthesia. 70(5):598-9, 1993 Nelson TE. Combined caffeine-halothane test for malignant hyperthermia [letter]. British Journal of Anaesthesia. 70(5):597-8, 1993 Scholz J. Roewer N. Rum U. Schmitz W. Scholz H. Schulte am Esch J. Possible involvement of inositol-lipid metabolism in malignant hyperthermia.British Journal of Anaesthesia. 66(6):692-6, 1991 Khan KJ. Cooper GM. Propofol and malignant hyperthermia: a case for day-case anaesthesia? [letter]. Anaesthesia. 48(5):455-6, 1993 Myles P. Thigh tourniquet a trigger for MH? [letter]. Anaesthesia & Intensive Care. [JC:4m5] 21(2):255-6, 1993 Vladutiu GD. Hogan K. Saponara I. Tassini L. Conroy J. Carnitine palmitoyl transferase deficiency in malignant hyperthermia. Muscle & Nerve. 16(5):485-91, 1993 Wedel DJ. Gammel SA. Milde JH. Iaizzo PA. Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine. Anesthesiology. 78(6):1138-44, 1993 Hopkins PM. Ellis FR. Halsall PJ. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders. British Journal of Anaesthesia. 70(4):397-401, 1993 Mayhew JF. Anesthesia for children with Freeman-Sheldon syndrome [letter; comment]. Anesthesiology. 78(2):408, 1993 Jones R. Dolcourt JL. Muscle rigidity following halothane anesthesia in two patients with Freeman-Sheldon syndrome [see comments]. Anesthesiology. 77(3):599-600, 1992 Fletcher JE. Tripolitis L. Rosenberg H. Beech J. Malignant hyperthermia: halothane- and calcium-induced calcium release in skeletal muscle. Biochemistry & Molecular Biology International. 29(4):763-72, 1993 Payen JF. Bosson JL. Bourdon L. Jacquot C. Le Bas JF. Stieglitz P. Benabid AL. Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy. Anesthesiology. 78(5):848-55, 1993 Reiner G. Hecht W. Herzog A. Dzapo V. The reproductive performance of sows with different malignant hyperthermia syndrome status. [German] Dtw - Deutsche Tierarztliche Wochenschrift. 100(4):144-6, 1993 Kalow W. Sharer S. Britt B. Pharmacogenetics of caffeine and caffeine-halothane contractures in biopsies of human skeletal muscle. Pharmacogenetics. 1(3):126-35, 1991 Adeola O. Ball RO. House JD. O'Brien PJ. Regional brain neurotransmitter concentrations in stress-susceptible pigs. Journal of Animal Science. [JC:hc7] 71(4):968-74, 1993 Nathan MA. Malignant hyperthermia: perioperative considerations. Seminars in Perioperative Nursing. 2(1):38-44, 1993 Deufel T. Muller-Felber W. Pongratz DE. Hubner G. Johnson K. Iaizzo PA. Lehmann-Horn F. Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility (MHS) mutations. Neuromuscular Disorders. 2(5-6):389-96, 1992. Duthie GG. Arthur JR. Free radicals and calcium homeostasis: relevance to malignant hyperthermia?. Free Radical Biology & Medicine. 14(4):435-42, 1993 Foster PS. Denborough MA. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle. International Journal of Biochemistry. 25(4):495-504, 1993 Amore M. Montanari M. Neuroleptic malignant syndrome and related conditions. [Italian] Minerva Psichiatrica. 33(4):259-83, 1992 Yuge O. Maehara Y. Nakao M. Kubota M. Malignant hyperthermia. [Japanese] Nippon Rinsho - Japanese Journal of Clinical Medicine. 51 Suppl:1038-43, 1993 Ashcroft FM. Ca2+ channels and excitation-contraction coupling. Current Opinion in Cell Biology. 3(4):671-5, 1991 Stelzner J. Kretz FJ. Rieger A. Reinhart K. Anesthetic-induced heart arrest. A case report of 2 infants with previously unrecognized muscular dystrophy. [German] Anaesthesist. 42(1):44-6, 1993 Ball SP. Johnson KJ. The genetics of malignant hyperthermia. Journal of Medical Genetics. 30(2):89-93, 1993 Blanco D. Garcia M. Alloza P. Neuromuscular diseases and anesthesia. [Spanish] Neurologia. 8(1):13-27, 1993 Blank JW. Boggs SD. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene. Journal of Clinical Anesthesia. 5(1):69-72, 1993 Heiman-Patterson TD. Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant. Medical Clinics of North America. 77(2):477-92, 1993 Pommier SA. Houde A. Effect of the genotype for malignant hyperthermia as determined by a restriction endonuclease assay on the quality characteristics of #5 commercial pork loins. Journal of Animal Science. 71(2):420-5, 1993 Mayhew JF. Anesthesia for children with Freeman-Sheldon syndrome [letter]. Anesthesiology. [JC:4sg] 78(2):408, 1993 Feb. Goto S. Ogata K. Fujie T. Fujigaki T. Nakamura H. Yukinari T. Shibata O. Caesarean section in a patient with past history of fulminant malignant hyperthermia. [Japanese] Journal [24;1H Masui - Japanese Journal of Anesthesiology. [JC:khr] 42(2):271-5, 1993 Ecker-Schlipf B. Malignant hyperthermia. Physiologic and genetic principles. [German] Medizinische Monatsschrift Fur Pharmazeuten. [JC:m5g] 16(1):18-9, 1993 Urwyler A. Censier K. Seeberger MD. Rothenbuhler JM. Kaufmann MA. Drewe J. In vitro effect of ephedrine, adrenaline, noradrenaline and isoprenaline on halothane-induced contractures in skeletal muscle from patients potentially susceptible to malignant hyperthermia. British Journal of Anaesthesia. [JC:auo] 70(1):76-9, 1993 Ball SP. Dorkins HR. Ellis FR. Hall JL. Halsall PJ. Hopkins PM. Mueller RF. Stewart AD. Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia. British Journal of Anaesthesia. [JC:auo] 70(1):70-5, 1993 Shomer NH. Louis CF. Fill M. Litterer LA. Mickelson JR. Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor. American Journal of Physiology. [JC:3u8] 264(1 Pt 1):C125-35, 1993 Mulley JC. Kozman HM. Phillips HA. Gedeon AK. McCure JA. Iles DE. Gregg RG. Hogan K. Couch FJ. MacLennan DH. et al. Refined genetic localization for central core disease. American Journal of Human Genetics. [JC:3im] 52(2):398-405, 1993 Rosel U. Szentkuti L. In vitro caffeine test on skeletal muscle samples from swine. [German] Dtw - Deutsche Tierarztliche Wochenschrift. [JC:ect] 100(1):25-8, 1993 Allen GC. Byford LJ. Shamji FM. Anterior mediastinal mass in a patient susceptible to malignant hyperthermia. Canadian Journal of Anaesthesia. [JC:c8l] 40(1):46-9, 1993 Larner AJ. Neuroleptic malignant syndrome [letter; comment]. British Journal of Psychiatry. [JC:b1k] 160:868, 1992 Otsuka H. Kemmotsu O. Malignant hyperthermia during sevoflurane anesthesia [letter; comment]. Anesthesia & Analgesia. [JC:4r8] 75(5):867, 1992 Ochiai R. Toyoda Y. Nishio I. Takeda J. Sekiguchi H. Fukushima K. Kohda E. Possible association of malignant hyperthermia with sevoflurane anesthesia [see comments]. Anesthesia & Analgesia. [JC:4r8] 74(4):616-8, 1992 Adnet PJ. Bromberg NL. Haudecoeur G. Krivosic I. Adamantidis MM. Reyford H. Bello N. Krivosic Horber RM. Fiber-type caffeine sensitivities in skinned muscle fibers from humans susceptible to malignant hyperthermia. Anesthesiology. 78(1):168-77, 1993 Katz DN. Current understanding of malignant hyperthermia: genesis, prevention, and treatment. CRNA. 3(2):54-63, 1992 May. Wedel DJ. Malignant hyperthermia and neuromuscular disease. Neuromuscular Disorders. 2(3):157-64, 1992. Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Advances In Neurology. 60:140-7, 1993. Kenesi L. Gomard M. Rahmani J. A case of malignant hyperthermia induced by isoflurane. [French] Cahiers D Anesthesiologie. 40(6):430-2, 1992. Tatsukawa H. Okuda J. Kondoh M. Inoue M. Terashima S. Katoh S. Ida K. Malignant hyperthermia caused by intravenous lidocaine for ventricular arrhythmia. Internal Medicine. 31(8):1069-72, 1992 van der Spek AF. Triggering agents continued after masseter spasm: there is proof in this pudding: [letter; comment] [see comments]. Anesthesia & Analgesia. 73(3):364-5, 1991 Rosenberg H. Shutack JG. Masseter muscle spasm in children [letter; comment] [see comments]. Anesthesia & Analgesia. 73(3):361-3, 1991 Nelson TE. Butler IJ. Malignant hyperthermia: skeletal muscle defect(s) predisposing to labile Ca2+ regulation? [editorial]. Journal of Child Neurology. 7(4):329-31, 1992 Halsall PJ. Ellis FR. Knowles PF. Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility. British Journal of Anaesthesia. 69(5):471-3, 1992 Ellis FR. Halsall PJ. Hopkins PM. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?. British Journal of Anaesthesia. 69(5):468-70, 1992 Peluso A. Bianchini A. Malignant hyperthermia susceptibility in patients with Duchenne's muscular dystrophy [letter]. Canadian Journal of Anaesthesia. 39(10):1117-8, 1992 Dec. Pollock N. Hodges M. Sendall J. Prolonged malignant hyperthermia in the absence of triggering agents. Anaesthesia & Intensive Care. 20(4):520-3, 1992 Radeschi G. Bersano T. Guidelines for the treatment of the "hyperthermic" patient: the S.I.A.A.R.T.I. recommendations". [Italian] Minerva Anestesiologica. 58(10):1015-6, 1992 Oct. Barberis B. Marzano L. Death caused by malignant hyperthermia and approaches of the Italian judiciary. [Italian] Minerva Anestesiologica. 58(10):1013-4, 1992 Brancadoro V. Tufano R. Prevention of the clinical forms of malignant hyperthermia and safe anesthesia. [Italian] Minerva Anestesiologica. 58(10):1009-11, 1992 Tegazzin V. Susceptibility to malignant hyperthermia: diagnostic aspects and #5 practical implications. [Italian] Minerva Anestesiologica. 58(10):1005-8, 1992 Oct. Accorsi A. Etiopathogenic, physiopathologic, and clinical aspects of perianesthetic malignant hyperthermia and related forms. [Italian] Minerva Anestesiologica. 58(10):1001-4, 1992 Oct. Cosgrove SB. Eisele PH. Martucci RW. Gronert GA. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures. Laboratory Animal Science. 42(5):482-5, 1992 Oct. Fujii J. Otsu K. Mutations in the gene responsible for malignant hyperthermia. [Japanese] Seikagaku - Journal of Japanese Biochemical Society. 64(9):1129-33, 1992 Mickelson JR. Knudson CM. Kennedy CF. Yang DI. Litterer LA. Rempel WE. Campbell KP. Louis CF. Structural and functional correlates of a mutation in the malignant hyperthermia-susceptible pig ryanodine receptor. Febs Letters. 301(1):49-52, 1992 Saddler JM. Jaw stiffness--an ill understood condition [editorial] [see comments]. British Journal of Anaesthesia. 67(5):515-6, 1991 Otto K. Malignant hyperthermia as a complication of anesthesia in the dog. [German] Tierarztliche Praxis. [JC:vs4] 20(5):519-22, 1992 Williams JH. Lee JC. Holland M. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle. Research Communications In Chemical Pathology & Pharmacology. 77(2):253-6, 1992 Olckers A. Meyers DA. Meyers S. Taylor EW. Fletcher JE. Rosenberg H. Isaacs H. Levitt RC. Adult muscle sodium channel alpha-subunit is a gene candidate for malignant hyperthermia susceptibility. Genomics. 14(3):829-31, 1992 Iles DE. Segers B. Heytens L. Sengers RC. Wieringa B. High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families. Genomics. 14(3):749-54, 1992 Levitt RC. Olckers A. Meyers S. Fletcher JE. Rosenberg H. Isaacs H. Meyers DA. Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics. 14(3):562-6, 1992 Gerdes C. Richter A. Annies R. Loscher W. Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs. European Journal of Pharmacology. 220(1):91-4, 1992 Richter A. Gerdes C. Loscher W. Atypical reactions to halothane in a subgroup of homozygous malignant hyperthermia(MH)-susceptible pigs: indication of a heterogenous genetic basis for the porcine syndrome. Dtw - Deutsche Tierarztliche Wochenschrift. 99(10):401-6, 1992 Mathews EL. Dhamee MS. Propofol in patients susceptible to malignant hyperthermia: a case report and review of the literature. Journal of Clinical Anesthesia. [JC:an9] 4(4):331-2, 1992 Geers R. Decanniere C. Ville H. Van Hecke P. Goedseels V. Bosschaerts L. Deley J. Janssens S. Nierynck W. Identification of halothane gene carriers by use of in vivo 31P nuclear magnetic resonance spectroscopy in pigs. American Journal of Veterinary Research. 53(9):1711-4, 1992 Harbitz I. Kristensen T. Bosnes M. Kran S. Davies W. DNA sequence of the skeletal muscle calcium release channel cDNA and verification of the Arg615----Cys615 mutation, associated with porcine malignant hyperthermia, in Norwegian landrace pigs. Animal Genetics. 23(5):395-402, 1992 Kaplan RF. Rushing E. Isolated masseter muscle spasm and increased creatine kinase without malignant hyperthermia susceptibility or other myopathies. Anesthesiology. 77(4):820-2, 1992 Otsuka H. Kemmotsu O. Malignant hyperthermia during sevoflurane anesthesia [letter]. Anesthesia & Analgesia. 75(5):867, 1992 MacLennan DH. The genetic basis of malignant hyperthermia. Trends in Pharmacological Sciences. 13(8):330-4, 1992 Navas E. Sanchez-Pena J. Gutierrez-Crespo A. Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia. [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 39(5):309-11, 1992 Saleh KL. Practical points in the management of malignant hyperthermia. Journal of Post Anesthesia Nursing. 7(5):327-9, 1992 Chuong R. Postoperative variant of malignant hyperthermia: report of a case. Journal of Oral & Maxillofacial Surgery. 50(11):1235-7, 1992 Ording H. Bendixen D. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia. European Journal of Anaesthesiology. 9(5):367-76, 1992 Orimo S. Taniguchi A. Ichikawa T. Hiyamuta E. Tamaki M. Two familial cases with exertion-induced heat stroke--relationship to malignant hyperthermia. [Japanese] Rinsho Shinkeigaku - Clinical Neurology. 32(4):412-5, 1992 Ellis FR. Detecting susceptibility to malignant hyperthermia [editorial]. BMJ. 304(6830):791-2, 1992 el-Hayek R. Parness J. Valdivia HH. Coronado R. Hogan K. Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptors. Biochemical & Biophysical Research Communications. 187(2):894-900, 1992 Fletcher JE. Wieland SJ. Beech J. Heiman-Patterson TD. Rosenberg H. Modulation of Ca2+ release and Na+ channel function in skeletal muscle by fatty acids. Advances In Experimental Medicine & Biology. 311:329-31, 1992. Zhang W. Kuhlers DL. Rempel WE. Halothane gene and swine performance. Journal of Animal Science. 70(5):1307-13, 1992 May. Foster PS. Hopkinson KC. Denborough MA. Propofol anaesthesia in malignant hyperpyrexia susceptible swine. Clinical & Experimental Pharmacology & Physiology. 19(3):183 -6, 1992 Mar. Jones R. Dolcourt JL. Muscle rigidity following halothane anesthesia in two patients with Freeman-Sheldon syndrome. Anesthesiology. 77(3):599-600, 1992 Sep. Littleford JA. Patel LR. Bose D. Cameron CB. McKillop C. Masseter muscle spasm in children: implications of continuing the triggering anesthetic [see comments]. Anesthesia & Analgesia. 72(2):151-60, 1991 Feb. Ellis FR. Hopkins PM. Halsall PJ. Christian AS. Masseter muscle spasm and the diagnosis of malignant hyperthermia susceptibility [letter; comment]. Anesthesia & Analgesia. 75(1):143-6, 1992 Jul. Levitt RC. Prospects for the diagnosis of malignant hyperthermia susceptibility using molecular genetic approaches [published erratum appears in Anesthesiology 1992 Sep;77(3):614]. Anesthesiology. 76(6):1039-48, 1992 Jun. van der Spek AF. Triggering agents continued after masseter spasm: there is proof in this pudding: [letter; comment] [see comments]. Anesthesia & Analgesia. 73(3):364-5, 1991 Sep. Hogan K. Couch F. Powers PA. Gregg RG. A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia. Anesthesia & Analgesia. 75(3):441-8, 1992 Sep. Yentis SM. Levine MF. Hartley EJ. Should all children with suspected or confirmed malignant hyperthermia susceptibility be admitted after surgery? A 10-year review. Anesthesia & Analgesia. 75(3):345-50, 1992 Sep. Schneider V. Eyrich K. Stelzner J. Muscular dystrophy as a risk factor in anesthesia. [German] Versicherungsmedizin. 44(4):133-7, 1992 Aug 1. Grassano MT. Bersano T. Radeschi G. Gorgoni G. Torta M. Gorgerino F. Epidemiology of malignant hyperthermia in Piedmont and Valle d'Acosta. A study conducted with 2 different methods. [Italian] Minerva Anestesiologica. 58(7-8):453-7, 1992 Jul-Aug. Isaacs H. Badenhorst ME. Dominantly inherited malignant hyperthermia (MH) in the King-Denborough syndrome. Muscle & Nerve. 15(6):740-2, 1992 Jun. Gillard EF. Otsu K. Fujii J. Duff C. de Leon S. Khanna VK. Britt BA. Worton RG. MacLennan DH. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics. 13(4):1247-54, 1992 Aug. Mariani P. Johansson M. Ellegren H. Harbitz I. Juneja RK. Andersson L. Multiple restriction fragment length polymorphisms in the porcine calcium release channel gene (CRC): assignment to the halothane (HAL) linkage group. Animal Genetics. 23(3):257-62, 1992. Holland M. Williams JH. Lee JC. W-7, a calmodulin antagonist, and contracture of malignant hyperthermia susceptible skeletal muscle. Comparative Biochemistry & Physiology - C: Comparative Pharmacology & Toxicology. 101(2):383-8, 1992 Feb. Schwid HA. O'Donnell D. Educational computer simulation of malignant hyperthermia. Journal of Clinical Monitoring. 8(3):201-8, 1992 Jul. Meijer AE. Ziegan JB. Wirtz P. Dittrich H. Pitfalls in the histochemical demonstration of alpha-glucan phosphorylase activity in glycogen-depleted skeletal muscle fibres. Acta Histochemica. 92(2):207-15, 1992. Otsu K. Phillips MS. Khanna VK. de Leon S. MacLennan DH. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia. Genomics. 13(3):835-7, 1992 Heytens L. Martin JJ. Bossaert LL. In vitro diagnosis of malignant hyperthermia: influence of electrical stimulation on the contracture response to caffeine. British Journal of Anaesthesia. 69(1):87-91, 1992 Jul. Duthie GG. Wahle KW. Harris CI. Arthur JR. Morrice PC. Lipid peroxidation, antioxidant concentrations, and fatty acid contents of muscle tissue from malignant hyperthermia-susceptible swine. Archives of Biochemistry & Biophysics. 296(2):592-6, 1992 Aug 1. Eslambolchi S. Malignant hyperthermia: its importance with respect to dentistry. University of Toronto Dental Journal. 5(1):24-6, 29-30, 1991 Fall. McGirl BE. Malignant hyperthermia [letter]. Canadian Dental Association Journal - Journal De L Association Dentaire Canadienne. 58(5):351-2, 1992 May. Larach MG. Malignant hyperthermia [letter]. Science. 257(5066):11-2, 1992 Jul 3. Ellis FR. Malignant hyperthermia. Minerva Anestesiologica. 58(4 Suppl 1):3-4, 1992 Apr. Rivolta M. Riedo R. Ostaldo M. Fontana G. Motta F. The use of propofol in a female patient predisposed to malignant hyperthermia (central core disease). [Italian] Minerva Anestesiologica. 58(4):219-21, 1992 Apr. Pagani I. Ramaioli F. Belforti F. Parrini S. Raimondi M. Isolated postoperative myoglobinuria as the only sign of malignant hyperthermia. Value of spinal anesthesia with bupivacaine in a posterior surgical intervention. [Italian] Minerva Anestesiologica. 58(4):213-7, 1992 Apr. Larner AJ. Neuroleptic malignant syndrome [letter]. British Journal of Psychiatry. 160:868, 1992 Jun. Rosenberg M. Weaver J. General anesthesia. Anesthesia Progress. 38(4-5):172-86, 1991 Jul-Oct. Jantzen JP. Eberle B. Gaida BJ. Hennes HJ. Otto S. Schafer M. The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model. [German] Anaesthesist. 41(5):248-53, 1992. Christian AC. Ellis FR. Halsall PJ. Hopkins PM. A case of malignant hyperthermia? [letter]. Anaesthesia. 47(6):544-5, 1992 Jun. Murakami F. Harada K. Kaseno S. Yokota S. Kemmotsu O. A case report of a 63-year-old patient with malignant hyperthermia. [Japanese] Masui - Japanese Journal of Anesthesiology. 41(6):988-91, 1992 Jun. Ropers HH. Pericak-Vance MA. Carrano AV. Report of the Second International Workshop on Human Chromosome 19 mapping 1992. Cytogenetics & Cell Genetics. 60(2):87-95, 1992. Hachenberg T. Brussel T. Lawin P. Konertz W. Scheld HH. Heart transplantation in a patient with central core disease [letter]. Journal of Cardiothoracic & Vascular Anesthesia. 6(3):386-7, 1992 Jun. Cooper P. Kudynska J. Buckmaster HA. Kudynski R. An EPR investigation of spin-labelled erythrocytes as a diagnostic technique for malignant hyperthermia. Biochimica Et Biophysica Acta. 1139(1-2):70-6, 1992 Jun 9. Louis CF. Zualkernan K. Roghair T. Mickelson JR. The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum. Anesthesiology. 77(1):114-25, 1992 Jul. Kawana Y. Iino M. Oyamada H. Endo M. Effects of halothane, caffeine and ryanodine on the intracellular calcium store in blood mononuclear cells. [Japanese] Masui - Japanese Journal of Anesthesiology. 41(5):727-32, 1992 May. Fagerlund T. Islander G. Ranklev E. Harbitz I. Hauge JG. Mokleby E. Berg K. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clinical Genetics. 41(5):270-2, 1992 May. Hetherington N. Dantrolene. Australian Nurses Journal. 21(8):28-9, 1992 Mar. Amore M. Cerisoli M. Heatstroke and hyperthermias. Italian Journal of Neurological Sciences. 13(4):337-41, 1992 May. Deufel T. Golla A. Iles D. Meindl A. Meitinger T. Schindelhauer D. DeVries A. Pongratz D. MacLennan DH. Johnson KJ. et al. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. American Journal of Human Genetics. 50(6):1151-61, 1992 Ranklev-Twetman E. Isander G. Fletcher R. Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia. [Swedish] Lakartidningen. 89(21):1869, 1992 May 20. Quinn RD. Pae WE Jr. McGary SA. Wickey GS. Development of malignant hyperthermia during mitral valve replacement. Annals of Thoracic Surgery. 53(6):1114-6, 1992 Jun. McKenzie AJ. Couchman KG. Pollock N. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. Anaesthesia & Intensive Care. 20(2):165-8, 1992 May. Kosko JR. Brandom BW. Chan KH. Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice. International Journal of Pediatric Otorhinolaryngology. 23(1):45-50, 1992 Jan. Hopkins PM. Ellis FR. Halsall PJ. Inconsistency of data linking the ryanodine receptor and malignant hyperthermia genes [letter; comment]. Anesthesiology. 76(4):659-61, 1992 Apr. MacKenzie AE. Allen G. Lahey D. Crossan ML. Nolan K. Mettler G. Worton RG. MacLennan DH. Korneluk R. A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia [see comments]. Anesthesiology. 75(1):4-8, 1991 Haas DA. Young ER. Harper DG. Malignant hyperthermia and the general dentist: current recommendations [published erratum appears in J Can Dent Assoc 1992 Apr;58(4):256]. Canadian Dental Association Journal - Journal De L Association Dentaire Canadienne. 58(1):28-33, 1992 Jan. Joffe M. Savage N. Silove M. The biochemistry of malignant hyperthermia: recent concepts. International Journal of Biochemistry. 24(3):387-98, 1992 Mar. MacLennan DH. Phillips MS. Malignant hyperthermia. Science. 256(5058):789-94, 1992 May 8. Spirt MJ. Chan W. Thieberg M. Sachar DB. Neuroleptic malignant syndrome induced by domperidone. Digestive Diseases & Sciences. 37(6):946-8, 1992 Jun. Geers R. Decanniere C. Ville H. Van Hecke P. Goedseels V. Vanstapel F. Bosschaerts L. De Ley J. Zhang W. Janssens S. In vivo muscle 31P nuclear magnetic resonance spectroscopy during treatment of halothane-sensitive and halothane-nonsensitive pigs. American Journal of Veterinary Research. 53(4):613-6, 1992 Apr. Rosenberg MB. Propofol for anesthesia in a patient susceptible to malignant hyperthermia. Anesthesia Progress. 38(3):96-8, 1991 May-Jun. Gleed R. Precautions when using halothane. Veterinary Clinics of North America - Small Animal Practice. 22(2):323-5, 1992 Mar. Prescott RJ. Roberts SP. Williams G. Malignant hyperpyrexia: a rare cause of postoperative death. Journal of Clinical Pathology. 45(4):361-3, 1992 Apr. Fink HS. Maak S. von Lengerken G. Till U. Abnormalities in the regulation of blood platelet free cytosolic calcium in malignant hyperthermia. II. Pig platelets. Cell Calcium. 13(3):157-62, 1992 Mar. Fink HS. Hofmann JG. Hentschel H. Till U. Abnormalities in the regulation of blood platelet free cytosolic calcium in malignant hyperthermia. I. Human platelets. Cell Calcium. 13(3):149-55, 1992 Mar. Lopez JR. Gerardi A. Lopez MJ. Allen PD. Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology. 76(5):711-9, 1992 May. Moore JL. Rice EL. Malignant hyperthermia. American Family Physician. 45(5):2245-51, 1992 May. Lopez JR. Lopez M. Allen P. Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia. Acta Cientifica Venezolana. 41(2):135-7, 1990. Iannaccone ST. Myogenes and myotubes. Journal of Child Neurology. 7(2):180-7, 1992 Apr. Kumata DS. Propofol and malignant hyperthermia [letter; comment]. Anesthesia & Analgesia. 74(2):318, 1992 Feb. Gallen JS. Propofol does not trigger malignant hyperthermia [letter; comment] [see comments]. Anesthesia & Analgesia. 72(3):413-4, 1991 Mar. Thoren-Tolling K. Serum creatine kinase activity as a selection criterion for stress susceptibility after standardised stress in pigs. Annales De Recherches Veterinaires. 22(4):395-403, 1991. Deufel T. Malignant hyperthermia is genetically heterogenetic. Problems in search for molecular genetic markers. [German] Fortschritte Der Medizin. 110(1-2):49, 1992 Jan 20. Johnson C. Pregnancy and malignant hyperthermia [letter]. Journal of Clinical Anesthesia. 4(2):173, 1992 Mar-Apr. Johnson C. Edleman KJ. Malignant hyperthermia: a review. Journal of Perinatology. 12(1):61-71, 1992 Mar. Ochiai R. Toyoda Y. Nishio I. Takeda J. Sekiguchi H. Fukushima K. Kohda E. Possible association of malignant hyperthermia with sevoflurane anesthesia. Anesthesia & Analgesia. 74(4):616-8, 1992 Apr. Hawkes MJ. Nelson TE. Hamilton SL. [3H]ryanodine as a probe of changes in the functional state of the Ca(2+) -release channel in malignant hyperthermia. Journal of Biological Chemistry. 267(10):6702-9, 1992 Apr 5. Yavuz H. Ozel A. Kaynak A. Dilsiz A. Erkul I. Malignant hyperthermia and Hirschsprung's disease [letter; comment]. Lancet. 339(8787):256, 1992 Jan 25. Hopkins PM. Ellis FR. Halsall PJ. Evidence for related myopathies in exertional heat stroke and malignant hyperthermia [see comments]. Lancet. 338(8781):1491-2, 1991 Dec 14. Elechi EN. Dakaraju P. Malignant hyperthermia and Hirschsprung's disease [letter] [see comments]. Lancet. 338(8776):1206, 1991 Nov 9. Gaillard S. Rock E. Vignon X. Dufourc EJ. Renou JP. 31P NMR and freeze fracture studies of sarcoplasmic reticulum membranes from normal and malignant hyperthermic pigs: effect of halothane and dantrolene. Archives of Biochemistry & Biophysics. 294(1):154-9, 1992 Apr. Nelson TE. Halothane effects on human malignant hyperthermia skeletal muscle single calcium-release channels in planar lipid bilayers. Anesthesiology. 76(4):588-95, 1992 Apr. Adnet PJ. Krivosic-Horber RM. Adamantidis MM. Haudecoeur G. Reyford H. Imbenotte M. Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia. Anesthesiology. 76(4):544-9, 1992 Urwyler A. Funk B. Censier K. Drewe J. Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening. Acta Anaesthesiologica Scandinavica. 36(2):115-8, 1992 Feb. Everts ME. Ording H. Hansen O. Nielsen PA. Ca(2+)-ATPase and Na(+)-K(+)-ATPase content in skeletal muscle from malignant hyperthermia patients. Muscle & Nerve. 15(2):162-7, 1992 Feb. Boles JA. Parrish FC Jr. Huiatt TW. Robson RM. Effect of porcine stress syndrome on the solubility and degradation of myofibrillar/cytoskeletal proteins. Journal of Animal Science. 70(2):454-64, 1992 Feb. Hill MR. Porcine stress deaths [letter]. Veterinary Record. 130(3):59, 1992 Jan 18. Gifuni D. Costantino M. Chiacchio D. Ruggiero A. Cozzolino S. Mancini A. Bellezza G. Ambrosio A. Togo F. Malignant hyperthermia: 2 years of clinical experience at the center for the study of malignant hyperthermia of Naples. [Italian] Minerva Anestesiologica. 57(9):788-9, 1991 Sep. Rolle L. Belluomo-Anello C. Viglietto A. D'Ari G. Propofol in the anesthesia of patients at risk of malignant hyperthermia in pediatric ophthalmic surgery. [Italian] Minerva Anestesiologica. 57(9):602-3, 1991 Sep. Brenig B. Brem G. Genomic organization and analysis of the 5' end of the porcine ryanodine receptor gene (ryr1). Febs Letters. 298(2-3):277-9, 1992 Feb 24. Jantzen JP. Kaufmann-Stemp D. The history of malignant hyperthermia. [French] Cahiers D Anesthesiologie. 39(7):505-8, 1991. Sims C. Masseter spasm after suxamethonium in children. British Journal of Hospital Medicine. 47(2):139-43, 1992 Jan 23-Feb 4. Poels PJ. Joosten EM. Sengers RC. Stadhouders AM. Veerkamp JH. Benders AA. In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis. Journal of the Neurological Sciences. 105(1):67-72, 1991 Sep. Eldar I. Goldberg G. Glauber V. Perel A. In vitro diagnosis of malignant hyperpyrexia syndrome. [Hebrew] Harefuah. 121(12):499-502, 1991 Dec 15. French J. Heffron JJ. Kinetic analysis of halothane induced Ca2+ release from isolated heavy sarcoplasmic reticulum. Biochemical Society Transactions. 19(4):355S, 1991 Nov. Halsall PJ. Ellis FR. Does postoperative pyrexia indicate malignant hyperthermia susceptibility?. British Journal of Anaesthesia. 68(2):209-10, 1992 Feb. Gallant EM. Lentz LR. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia. American Journal of Physiology. 262(2 Pt 1):C422-6, 1992 Feb. Steelman R. Holmes D. Outpatient dental treatment of pediatric patients with malignant hyperthermia: report of three cases. Asdc Journal of Dentistry For Children. 59(1):62-5, 1992 Jan -Feb. Walther JU. Zafiriou D. Jensen M. Malignant hyperthermia and Marinesco-Sjogren syndrome [letter; comment]. Lancet. 338(8782-8783):1603, 1991 Dec 21-28. Lightstone H. Applications of molecular genetics to anesthesiology [letter; comment]. Anesthesiology. 75(6):1126-7, 1991 Dec. Levitt RC. Meyers D. Fletcher JE. Rosenberg H. Molecular genetics and malignant hyperthermia [editorial; comment] [see comments]. Anesthesiology. 75(1):1-3, 1991 Jul. Ezri T. Soroker D. Phaeochromocytoma presenting as MH [letter; comment]. Canadian Journal of Anaesthesia. 38(5):685, 1991 Jul. Allen GC. Rosenberg H. Phaeochromocytoma presenting as acute malignant hyperthermia--a diagnostic challenge [see comments]. Canadian Journal of Anaesthesia. 37(5):593-5, 1990 Jul. Harrison GG. Isaacs H. Malignant hyperthermia. An historical vignette. Anaesthesia. 47(1):54-6, 1992 Jan. Striebel HW. Lechner J. Wiegand C. Hartung E. Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):475-80, 1991 Dec. Hartung E. Preis I. Engelhardt W. Krauspe R. Diagnosis of malignant hyperthermia. The platelet test versus the in vitro contracture test. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):471-4, 1991 Dec. Schatke H. Schneider J. Abbushi W. Schneck HJ. The early diagnosis of malignant hyperthermia--the place of end -expiratory CO2 monitoring. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):468-70, 1991 Dec. Schulte-Sasse U. Eberlein HJ. An attempt to reconcile differences of opinion in the field of malignant hyperthermia. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):464-7, 1991 Dec. Lenzen C. Roewer N. Scholz J. Rumberger E. Schulte am Esch J. Ryanodine-induced contractures for the diagnosis of malignant hyperthermia susceptibility. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):459-63, 1991 Dec. Olthoff D. Meinecke CD. A new emphasis on the diagnosis of malignant hyperthermia using the in vitro contracture test?. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):454-8, 1991 Dec. Scholz J. Roewer N. Troll U. Patten M. Schmitz W. Scholz H. Schulte am Esch J. Malignant hyperthermia and inositol phosphate metabolism in the heart and skeletal musculature. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):450-3, 1991 Dec. Roewer N. Malignant hyperthermia today. [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):431-49, 1991 Dec. Schulte am Esch J. Malignant hyperthermia--a systemic disease? (editorial). [German] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 26(8):429-30, 1991 Dec. Heytens L. Martin JJ. Van de Kelft E. Bossaert LL. In vitro contracture tests in patients with various neuromuscular diseases. British Journal of Anaesthesia. 68(1):72-5, 1992 Jan. Kozak-Ribbens G. Yearly report of the European Group of Malignant Hyperthermia". [French] Annales Francaises D Anesthesie Et De Reanimation. 10(6):606 -7, 1991. Heytens LG. Even B. Martin JJ. Bossaert LL. Differential diagnosis of anesthesia induced rhabdomyolysis. A case report. Acta Neurologica Belgica. 91(5):303-7, 1991. Thomas MA. Rock E. Viret J. Membrane properties of the sarcolemma and sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. Action of halothane. Clinica Chimica Acta. 200(2-3):201-10, 1991 Aug 30. Adnet PJ. Krivosic-Horber RM. Adamantidis MM. Haudecoeur G. Reyford HG. Dupuis BA. Is resting membrane potential a possible indicator of viability of muscle bundles used in the in vitro caffeine contracture test?. Anesthesia & Analgesia. 74(1):105-11, 1992 Jan. Ording H. Bendixen D. Malignant hyperthermia. [Danish] Nordisk Medicin. 107(1):12-4, 1992. Gillard EF. Otsu K. Fujii J. Khanna VK. de Leon S. Derdemezi J. Britt BA. Duff CL. Worton RG. MacLennan DH. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics. 11(3):751-5, 1991 Nov. Otsu K. Khanna VK. Archibald AL. MacLennan DH. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families. Genomics. 11(3):744-50, 1991 Nov. Levitt RC. Nouri N. Jedlicka AE. McKusick VA. Marks AR. Shutack JG. Fletcher JE. Rosenberg H. Meyers DA. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics. 11(3):543-7, 1991 Nov. Mongan PD. Hosking MP. Hyperthermia after cardiopulmonary bypass in a child [letter]. Canadian Journal of Anaesthesia. 39(1):99-100, 1992 Jan. Ashcroft FM. Ca2+ channels and excitation-contraction coupling. Current Opinion in Cell Biology. 3(4):671-5, 1991 Aug. Gronert GA. Fowler W. Cardinet GH 3d. Grix A Jr. Ellis WG. Schwartz MZ. Absence of malignant hyperthermia contractures in Becker-Duchenne dystrophy at age 2. Muscle & Nerve. 15(1):52-6, 1992 Jan. Larach MG. Landis JR. Bunn JS. Diaz M. Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry. Anesthesiology. 76(1):16-27, 1992 Jan. Allen PD. Lopez JR. Sanchez V. Ryan JF. Sreter FA. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine. Anesthesiology. 76(1):132-8, 1992 Jan. Wieland SJ. Fletcher JE. Gong QH. Rosenberg H. Effects of lipid-soluble agents on sodium channel function in normal and MH-susceptible skeletal muscle cultures. Advances In Experimental Medicine & Biology. 301:9-19, 1991. Ohnishi ST. Katsuoka M. Why does halothane relax cardiac muscle but contract malignant hyperthermic skeletal muscle?. Advances In Experimental Medicine & Biology. 301:73-87, 1991. Fletcher JE. Rosenberg H. Beech J. Interactions of fatty acids with the calcium release channel in malignant hyperthermia. Advances In Experimental Medicine & Biology. 301:57-69, 1991. Sudo RT. Suarez-Kurtz G. Halothane-cooling contractures and regulation of the myoplasmic Ca2+ concentration in skeletal muscle. Advances In Experimental Medicine & Biology. 301:43-55, 1991. Ording H. Hedengran AM. Skovgaard LT. Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 35(8):711-6, 1991 Nov. Dulhunty AF. Junankar PR. Stanhope C. Calcium ATPase in the sarcoplasmic reticulum of muscle from normal and malignant hyperthermia susceptible pigs. Neuroscience Letters. 131(2):187-92, 1991 Oct 14. Gelling L. Uncommon disorders. Malignant hyperpyrexia. Nursing Standard. 6(12):35-7, 1991 Dec 11-17. Derkay CS. Grundfast KM. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene. Otolaryngology - Head & Neck Surgery. 105(5):680-6, 1991 Nov. Ayoub S. Berson G. Rock E. Younes A. Mitochondrial nucleotide translocase from skeletal muscle of halothane sensitive pigs: an electrophoretic study. Cell Biochemistry & Function. 9(3):193-9, 1991 Jul. Saddler JM. Jaw stiffness--an ill understood condition [editorial]. British Journal of Anaesthesia. 67(5):515-6, 1991 Nov. Hard C. Neuroleptic malignant syndrome versus malignant hyperthermia [letter; comment]. American Journal of Medicine. 91(3):322-3, 1991 Sep. Krivosic-Horber R. Adnet P. Reyford H. Relationship between exercise-induced myolysis and malignant hyperthermia [letter; comment]. British Journal of Anaesthesia. 67(2):221, 1991 Aug. Hackl W. Winkler M. Mauritz W. Sporn P. Steinbereithner K. Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis [see comments]. British Journal of Anaesthesia. 66(1):138-40, 1991 Jan. Broekema AA. Boersma GA. Hennis PJ. A case of malignant hyperthermia?. Anaesthesia. 46(11):942-5, 1991 Nov. Healy SJ. Heffron JJ. Lehane M. Bradley DG. Johnson K. McCarthy TV. Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers. BMJ. 303(6812):1225-8, 1991 Nov 16. Matsushima Y. Aoyagi M. Suzuki R. Tabata H. Ohno K. Perioperative complications of encephalo-duro-arterio-synangiosis: prevention and treatment. Surgical Neurology. 36(5):343-53, 1991 Nov. Iaizzo PA. Palahniuk RJ. Malignant hyperthermia. Diagnosis, treatment, genetics, and pathophysiology. Investigative Radiology. 26(11):1013-8, 1991 Nov. Kleinman B. Kalathiveetil J. Jain U. Blakeman B. Glisson S. D'Ambra MN. Donovan C. Harrell G. Kaplan DK. Akins CW. et al. Case conference 3--1990. Two patients develop some signs and symptoms of malignant hyperthermia during cardiac surgery with cardiopulmonary bypass --is it the real thing. Journal of Cardiothoracic Anesthesia. 4(3):385-99, 1990 Jun. Denborough M. Malignant hyperpyrexia and sudden infant death [letter; comment]. Australian & New Zealand Journal of Obstetrics & Gynaecology. 31(1):91, 1991 Feb. Rosenberg H. Shutack JG. Masseter muscle spasm in children [letter; comment]. Anesthesia & Analgesia. 73(3):361-3, 1991 Sep. Allen G. Propofol and malignant hyperthermia [letter; comment]. Anesthesia & Analgesia. 73(3):359, 1991 Sep. Mehler J. Bachour H. Simons F. Wolpers K. Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia. [German] Anaesthesist. 40(9):497-501, 1991 Sep. Entrup MH. Davis FG. Perioperative complications of anesthesia. Surgical Clinics of North America. 71(6):1151-73, 1991 Dec. Heiman-Patterson TD. Malignant hyperthermia. Seminars in Neurology. 11(3):220-7, 1991 Sep. Fletcher JE. Mayerberger S. Tripolitis L. Yudkowsky M. Rosenberg H. Fatty acids markedly lower the threshold for halothane-induced calcium release from the terminal cisternae in human and porcine normal and malignant hyperthermia susceptible skeletal muscle. Life Sciences. 49(22):1651-7, 1991. Akasaka T. Ogura Y. Anbe J. Nakajima H. Ozeki M. Mitsuishi T. Kato H. Yanagawa Y. Correction of tetralogy of Fallot accompanied by malignant hyperthermia. Case report. Journal of Cardiovascular Surgery. 32(5):581-4, 1991 Sep-Oct. Cooper P. Meddings JB. Erythrocyte membrane fluidity in malignant hyperthermia. Biochimica Et Biophysica Acta. 1069(2):151-6, 1991 Nov 4. Otsuka H. Komura Y. Mayumi T. Yamamura T. Kemmotsu O. Mukaida K. Malignant hyperthermia during sevoflurane anesthesia in a child with central core disease. Anesthesiology. 75(4):699-701, 1991 Oct. Kentsch M. Roewer N. Kunze KP. Kuck KH. Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humans. Anesthesiology. 75(4):583-7, 1991 Oct. Williams JH. Holland M. Lee JC. Ward CW. McGrath CJ. BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers. American Journal of Physiology. 261(4 Pt 2):R782-6, 1991 Oct. D'Honneur G. Bonnet F. Local, regional and general anesthesia. Evaluation of risk factors. [French] Revue Du Praticien. 41(19):1831-6, 1991 Sep 1. Iaizzo PA. Wedel DJ. Gallagher WJ. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update. Mayo Clinic Proceedings. 66(10):998-1004, 1991 Oct. Espinola TE. Miller RH. Remadhyani U. Malignant hyperthermia: case report and literature review. Journal of the Louisiana State Medical Society. 143(7):7-9, 1991 Jul. Foster PS. Hopkinson KC. Payne N. Denborough MA. The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle. Clinical & Experimental Pharmacology & Physiology. 18(7):489 -95, 1991 Jul. Larach DR. High KM. Larach MG. Hensley FA Jr. Martin DE. Williams DR. Cardiopulmonary bypass interference with dantrolene prophylaxis of malignant hyperthermia. Journal of Cardiothoracic Anesthesia. 1(5):448-53, 1987 Oct. Allsop P. Jorfeldt L. Rutberg H. Hall GM. Muscle pH recovery after high intensity cycle exercise in malignant hyperthermia susceptible subjects. Biochemical Society Transactions. 19(2):131S, 1991 Apr. Wedel DJ. Iaizzo PA. Milde JH. Desflurane is a trigger of malignant hyperthermia in susceptible swine. Anesthesiology. 74(3):508-12, 1991 Mar. Haggendal J. Jonsson L. Carlsten J. The role of sympathetic activity in initiating malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 34(8):677-82, 1990 Nov. Fletcher JE. Tripolitis L. Erwin K. Hanson S. Rosenberg H. Conti PA. Beech J. Fatty acids modulate calcium-induced calcium release from skeletal muscle heavy sarcoplasmic reticulum fractions: implications for malignant hyperthermia. Biochemistry & Cell Biology. 68(10):1195-201, 1990 Oct. Breuer EM. The adaptation of histometry and immunohistochemical detection of fetal myosin as diagnostic methods for stress myopathy in swine. [German] Zentralblatt Fur Veterinarmedizin - Reihe A. 37(5):356-71, 1990 Jun. Loscher W. Witte U. Fredow G. Ganter M. Bickhardt K. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia. Naunyn-Schmiedebergs Archives of Pharmacology. 341(6):483-93, 1990 Jun. Klip A. Mills GB. Britt BA. Elliott ME. Halothane-dependent release of intracellular Ca2+ in blood cells in malignant hyperthermia. American Journal of Physiology. 258(3 Pt 1):C495-503, 1990 Mar. Kollef MH. Sudden death in Air Force recruits [letter]. Military Medicine. 155(3):A7, 1990 Mar. Cornet C. Moeller R. Laxenaire MC. Clinical features of malignant hyperthermia crisis. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):435 -43, 1989. Meier-Hellmann A. Romer M. Hannemann L. Kersting T. Reinhart K. Early recognition of malignant hyperthermia using capnometry. [German] Anaesthesist. 39(1):41-3, 1990 Jan. Jonsson L. Haggendal J. Johansson G. Thoren-Tolling K. Bjurstrom S. Carlsten J. Cardiac manifestation and blood catecholamine levels during succinylcholine-induced stress of malignant hyperthermia sensitive pigs. Zentralblatt Fur Veterinarmedizin - Reihe A. 36(10):772-82, 1989 Dec. Krivosic-Horber R. Role of capnography in the monitoring of anesthesia. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(3):175 -81, 1989. Reiner G. Dzapo V. Erythrocyte osmotic fragility in porcine malignant hyperthermia and effects of halothane. Zentralblatt Fur Veterinarmedizin - Reihe A. 36(4):269-75, 1989 Apr. Isaacs H. Badenhorst ME. Du Sautoy C. Myophosphorylase B deficiency and malignant hyperthermia. Muscle & Nerve. 12(3):203-5, 1989 Mar. Murakawa M. Hatano Y. Mori K. Torizuka T. Tamaki N. Iwasaki R. Technetium-99m pyrophosphate scintigraphy in a patient with malignant hyperthermia [letter]. Journal of Nuclear Medicine. 30(5):718-9, 1989 May. Ervasti JM. Mickelson JR. Louis CF. Transverse tubule calcium regulation in malignant hyperthermia. Archives of Biochemistry & Biophysics. 269(2):497-506, 1989 Mar. Ervasti JM. Claessens MT. Mickelson JR. Louis CF. Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia. Journal of Biological Chemistry. 264(5):2711-7, 1989 Feb 15. Reiss GK. Desmoulin F. Martin CF. Monin G. Renou JP. Canioni P. Cozzone PJ. In vitro correlation between force and energy metabolism in porcine malignant hyperthermic muscle studied by 31P NMR. Archives of Biochemistry & Biophysics. 287(2):312-9, 1991 Jun. Heytens L. Heffron JJ. Camu F. The caffeine contracture test for malignant hyperthermia: caffeine citrate, caffeine benzoate or caffeine free base?. Acta Anaesthesiologica Scandinavica. 35(6):541-4, 1991 Aug. Fletcher JE. Conti PA. Rosenberg H. Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine. Acta Anaesthesiologica Scandinavica. 35(6):483-7, 1991 Aug. Solov'eva AD. Loseva MM. Posokhov SI. Vorob'eva OV. Topographic selective mapping in patients with disorders of thermoregulation of cerebral origin. [RUSSIAN] Zhurnal Nevropatologii I Psikhiatrii Imeni S - S - Korsakova. 91(5):19-22, 1991. Kausch K. Lehmann-Horn F. Janka M. Wieringa B. Grimm T. Muller CR. Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19. Genomics. 10(3):765-9, 1991 Jul. Schulte-Sasse U. Eberlein HJ. Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction. [German] Anaesthesiologie Und Reanimation. 16(3):202-7, 1991. Jaffe RS. Martucci RW. Gronert GA. Elliott TE. Cardinet GH 3d. Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures. Anesthesiology. 75(3):525-6, 1991 Sep. Adnet PJ. Krivosic-Horber RM. Adamantidis MM. Reyford H. Cordonnier C. Haudecoeur G. Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia. Anesthesiology. 75(3):413-9, 1991 Sep. Backman E. Henriksson KG. Rutberg H. Lennmarken C. Muscle relaxation rate in patients with malignant hyperthermia [letter]. Acta Anaesthesiologica Scandinavica. 35(5):463, 1991 Jul. Seewald MJ. Eichinger HM. Iaizzo PA. Malignant hyperthermia: an altered phospholipid and fatty acid composition in muscle membranes. Acta Anaesthesiologica Scandinavica. 35(5):380-6, 1991 Jul. Theunynck D. Imbenotte M. Guevart E. Haguenoer JM. Malignant hyperthermia: halothane kinetics in a study model of muscular contraction. Head space determination and comparison with a mathematical model. [French] Agressologie. 32(2):121-5, 1991. Vita GM. Fletcher JE. Tripolitis L. Rosenberg H. Conti PA. Altered [3H]ryanodine binding is not associated with malignant hyperthermia susceptibility in terminal cisternae preparations from swine. Biochemistry International. 23(3):563-70, 1991 Feb. Fujiwara K. Takenaka T. Okada S. Nomiyama S. Watanabe S. Tanaka R. The anesthetic management of a patient with the malignant hyperthermia trait diagnosed preoperatively. [Japanese] Masui - Japanese Journal of Anesthesiology. 40(6):978-81, 1991 Jun. Valdivia HH. Hogan K. Coronado R. Altered binding site for Ca2+ in the ryanodine receptor of human malignant hyperthermia. American Journal of Physiology. 261(2 Pt 1):C237-45, 1991 Aug. Fill M. Stefani E. Nelson TE. Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle. Biophysical Journal. 59(5):1085-90, 1991 May. Sailer R. Hinrichs B. Mantel K. Malignant hyperthermia in a child with acute lymphatic leukemia. [German] Anaesthesist. 40(5):298-301, 1991 May. Matsui K. Fujioka Y. Kikuchi H. Yuge O. Fujii K. Morio M. Endo M. Effects of several volatile anesthetics on the Ca(2+)-related functions of skinned skeletal muscle fibers from the guinea pig. Hiroshima Journal of Medical Sciences. 40(1):9-13, 1991 Mar. Comunale ME. DiNardo JA. Schwartz MJ. Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass. Journal of Cardiothoracic & Vascular Anesthesia. 5(2):153-5, 1991 Apr. Fujii J. Otsu K. Zorzato F. de Leon S. Khanna VK. Weiler JE. O'Brien PJ. MacLennan DH. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 253(5018):448-51, 1991 Jul 26. De Maio D. Laviani M. Lithium-TCA induced malignant syndrome. Case report. Progress In Neuro-Psychopharmacology & Biological Psychiatry. 15(3):427-31, 1991. Hackmann T. Sensitivity and specificity of tests of malignant hyperthermia susceptibility [letter]. Anesthesia & Analgesia. 73(2):233, 1991 Aug. Seewald MJ. Eichinger HM. Lehmann-Horn F. Iaizzo PA. Characterization of swine susceptible to malignant hyperthermia by in vivo, in vitro and post-mortem techniques. Acta Anaesthesiologica Scandinavica. 35(4):345-9, 1991 May. Scholz J. Roewer N. Rum U. Schmitz W. Scholz H. Schulte am Esch J. Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine. Acta Anaesthesiologica Scandinavica. 35(4):320-5, 1991 May. Scholz J. Roewer N. Rum U. Schmitz W. Scholz H. Schulte am Esch J. Possible involvement of inositol-lipid metabolism in malignant hyperthermia. British Journal of Anaesthesia. 66(6):692-6, 1991 Jun. Duthie GG. McPhail DB. Morrice PC. Arthur JR. Dietary vitamin E decreases ESR signal intensity in hepatic microsomal preparations from malignant hyperthermia susceptible pigs. Free Radical Research Communications. 14(2):133-7, 1991. Clausen T. Van Hardeveld C. Everts ME. Significance of cation transport in control of energy metabolism and thermogenesis. Physiological Reviews. 71(3):733-74, 1991 Jul. O'Brien PJ. Shen H. Weiler J. Ianuzzo CD. Wittnich C. Moe GW. Armstrong PW. Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failure. Canadian Journal of Physiology & Pharmacology. 69(2):262-8, 1991 Feb. Odom J. Lidocaine a safe agent to use for dysrhythmias during a malignant hyperthermia crisis [letter; comment]. Orthopaedic Nursing. 10(3):8, 1991 May-Jun. Payen JF. Bourdon L. Mezin P. Jacquot C. le Bas JF. Stieglitz P. Benabid AL. Susceptibility to malignant hyperthermia detected non-invasively [letter]. Lancet. 337(8756):1550-1, 1991 Jun 22. Wlody GS. Malignant hyperthermia. Critical Care Nursing Clinics of North America. 3(1):129-34, 1991 Mar. Urwyler A. Censier K. Seeberger MD. Drewe J. Rothenbuhler JM. Frei F. Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland. [German] Schweizerische Medizinische Wochenschrift - Journal Suisse De Medecine. 121(16):566-71, 1991 Apr 20. Joh S. Mietani W. Irifune M. Yokoyama K. Effects of halothane anesthesia on intracellular energy charge of rats' skeletal muscle. Anesthesia Progress. 36(4-5):171-2, 1989 Jul-Oct. Gillian CM. Heffron JJ. Lehane M. Marks A. McCarthy TV. Analysis of expression of the human ryanodine receptor gene in malignant hyperthermia skeletal muscle tissue. Biochemical Society Transactions. 19(1):46S, 1991 Feb. Carrier L. Villaz M. Dupont Y. Abnormal rapid Ca2+ release from sarcoplasmic reticulum of malignant hyperthermia susceptible pigs. Biochimica Et Biophysica Acta. 1064(2):175-83, 1991 May 7. Hopkins PM. Ellis FR. Halsall PJ. Hypermetabolism in arthrogryposis multiplex congenita. Anaesthesia. 46(5):374-5, 1991 May. Nelson TE. Malignant hyperthermia in dogs. Journal of the American Veterinary Medical Association. 198(6):989-94, 1991 Mar 15. Hopkins PM. Ellis FR. Halsall PJ. Ryanodine contracture: a potentially specific in vitro diagnostic test for malignant hyperthermia. British Journal of Anaesthesia. 66(5):611-3, 1991 May. Allsop P. Jorfeldt L. Rutberg H. Lennmarken C. Hall GM. Delayed recovery of muscle pH after short duration, high intensity exercise in malignant hyperthermia susceptible subjects [see comments]. British Journal of Anaesthesia. 66(5):541-5, 1991 May. Ellis FR. Green JH. Campbell IT. Muscle activity, pH and malignant hyperthermia [editorial; comment]. British Journal of Anaesthesia. 66(5):535-7, 1991 May. Scholz J. Troll U. Schulte am Esch J. Hartung E. Patten M. Sandig P. Schmitz W. Inositol-1,4,5-trisphosphate and malignant hyperthermia [letter]. Lancet. 337(8753):1361, 1991 Jun 1. Hosten K. Gaebel W. Atypical course of fever in treatment with clozapine. [German] Nervenarzt. 62(1):58-60, 1991 Jan. Vetter P. Proppe D. Hoppe-Seyler S. Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports. [German] Nervenarzt. 62(1):55-7, 1991 Jan. Gonzalez Montalvo JI. Elosua I. Perez del Molino J. Gomez Rodriguez A. Kessel H. Laguna B. Malignant hyperthermia during cataract extraction in an elderly patient. [Spanish] Revista Clinica Espanola. 187(6):290-1, 1990 Oct. Klotz RW. Propofol anesthesia in the malignant hyperthermia susceptible patient. Nurse Anesthetist. 2(1):33-5, 1991 Mar. Lingaraju N. Rosenberg H. Unexplained increases in serum creatine kinase levels: its relation to malignant hyperthermia susceptibility. Anesthesia & Analgesia. 72(5):702-5, 1991 May. Uhrin P. Postmortem metabolism of glycogen in the muscles of healthy pigs and in pigs with the malignant hyperthermia syndrome. [Slovak] Veterinarni Medicina. 35(7):403-9, 1990 Jul. Joffe M. Savage N. du Sautoy C. Mitchell G. Isaacs H. Kinase activity and protein phosphorylation in control and malignant hyperthermic skeletal muscle. International Journal of Biochemistry. 23(4):443-53, 1991. Pemberton DM. Muscle biopsy proven malignant hyperpyrexia and minimal symptoms under inhalational anaesthesia [letter]. Anaesthesia & Intensive Care. 19(1):133-4, 1991 Feb. Miller KE. Brooks RR. Bonk KR. Carpenter JF. Calcium handling by platelets from normal and malignant hyperthermia -susceptible pigs. Life Sciences. 48(15):1471-6, 1991. Lazarus A. Rosenberg H. Malignant hyperthermia during ECT [letter]. American Journal of Psychiatry. 148(4):541-2, 1991 Apr. Britt BA. Update on the therapy of malignant hyperthermia. [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 37(4):210-5, 1990 Jul-Aug. Iaizzo PA. Seewald MJ. Olsen R. Wedel DJ. Chapman DE. Berggren M. Eichinger HM. Powis G. Enhanced mobilization of intracellular Ca2+ induced by halothane in hepatocytes isolated from swine susceptible to malignant hyperthermia. Anesthesiology. 74(3):531-8, 1991 Mar. Sinkovich DD. Mitch-Resignalo AE. Malignant hyperthermia [see comments]. Orthopaedic Nursing. 10(1):39-43, 1991 Jan-Feb. Nelson TE. Lin M. Volpe P. Evidence for intraluminal Ca++ regulatory site defect in sarcoplasmic reticulum from malignant hyperthermia pig muscle. Journal of Pharmacology & Experimental Therapeutics. 256(2):645-9, 1991 Feb. Harrison GG. Propofol in malignant hyperthermia [letter]. Lancet. 337(8739):503, 1991 Feb 23. Guerreiro JF. Santos SE. Aguiar GF. Serum cholinesterase polymorphism (CHE1 and CHE2 loci) among several Indian groups from Amazon region of Brazil, and segregation of the C5 variant in families. Gene Geography. 3(1):11-20, 1989 Apr. Sinclair G. Masseter spasm following suxamethonium. British Journal of Hospital Medicine. 44(5):342, 1990 Nov. Bendixen D. Ording H. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 34(8):658-61, 1990 Nov. Fletcher JE. Conner GE. Allen GC. Huggins FJ. Rosenberg H. Importance of fasting in the lymphocyte calcium test for malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 34(8):636-9, 1990 Nov. Radeschi G. Grassano MT. Bersano T. Torta M. Gorgoni G. Gorgerino F. Malignant hyperthermia: a retrospective epidemiologic study in Piedmont and Valle d'Aosta. [Italian] Minerva Anestesiologica. 56(9):751-3, 1990 Sep. Ervasti JM. Strand MA. Hanson TP. Mickelson JR. Louis CF. Ryanodine receptor in different malignant hyperthermia-susceptible porcine muscles. American Journal of Physiology. 260(1 Pt 1):C58-66, 1991 Jan. Wajon P. Phaeochromocytoma in a malignant hyperthermia patient under anaesthesia. Anaesthesia & Intensive Care. 18(4):570-4, 1990 Nov. Sedgwick JV. Lewis IH. Linter SP. Anesthesia and mental illness. International Journal of Psychiatry In Medicine. 20(3):209-25, 1990. Adnet PJ. Krivosic-Horber RM. Haudecoeur G. Adamantidis MM. Reyford GH. Imbenotte M. Cordonnier C. Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia. British Journal of Anaesthesia. 65(6):791-5, 1990 Dec. Hon CA. Landers DF. Platts AA. Effects of neuroleptic agents on rat skeletal muscle contracture in vitro. Anesthesia & Analgesia. 72(2):194-202, 1991 Feb. Verkaaik AP. Erdmann W. Respiratory diagnostic possibilities during closed circuit anesthesia. Acta Anaesthesiologica Belgica. 41(3):177-88, 1990. Foster PS. Malignant hyperpyrexia. International Journal of Biochemistry. 22(11):1217-22, 1990. Olgin J. Rosenberg H. Allen G. Seestedt R. Chance B. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility. Anesthesia & Analgesia. 72(1):36-47, 1991 Jan. Artigas i Pallares J. Argemi i Renom J. Miro i Bedos X. Sancho i Oliver S. Navarro Fernandez-Balbuena C. Lechuga Campoy JL. King's syndrome. Malignant hyperthermia. [Spanish] Anales Espanoles De Pediatria. 33(1):66-8, 1990 Jul. Kochs E. Nollen H. Schulte am Esch J. Characteristics of cerebral blood flow and the electroencephalogram during experimental malignant hyperthermia. [German] Anasthesie, Intensivtherapie, Notfallmedizin. 25(5):348-53, 1990 Oct. Harbitz I. Chowdhary B. Thomsen PD. Davies W. Kaufmann U. Kran S. Gustavsson I. Christensen K. Hauge JG. Assignment of the porcine calcium release channel gene, a candidate for the malignant hyperthermia locus, to the 6p11----q21 segment of chromosome 6. Genomics. 8(2):243-8, 1990 Oct. Doize F. Roux I. Martineau-Doize B. DeRoth L. Prediction of the halothane (Hal) genotypes by means of linked marker loci (Phi, Po2, Pgd) in Quebec Landrace pigs. Canadian Journal of Veterinary Research. 54(4):397-9, 1990 Oct. Lehmann-Horn F. Iaizzo PA. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?. British Journal of Anaesthesia. 65(5):692-7, 1990 Nov. Kochs E. Hoffman WE. Roewer N. Schulte am Esch J. Alterations in brain electrical activity may indicate the onset of malignant hyperthermia in swine. Anesthesiology. 73(6):1236-42, 1990 Dec. Hagley MT. Sorrell JH. Asymptomatic rhabdomyolysis of unknown etiology. Journal of the American Board of Family Practice. 3(4):265-9, 1990 Oct-Dec. Tweed WA. Neuroleptic malignant syndrome and malignant hyperthermia susceptibility [letter; comment]. Acta Anaesthesiologica Scandinavica. 34(7):605, 1990 Oct. Hackl W. Mauritz W. Winkler M. Sporn P. Steinbereithner K. Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases. Acta Anaesthesiologica Scandinavica. 34(7):534-7, 1990 Oct. Valverde A. Boyd CJ. Dyson DH. Pascoe PJ. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse. Journal of the American Veterinary Medical Association. 197(8):1051-3, 1990 Oct 15. Saissy JM. Gohard R. Raux O. Kempf J. Diatta B. Hyperkinetic shock and cerebral malaria. [French] Annales Francaises D Anesthesie Et De Reanimation. 9(5):456-9, 1990. Ellis FR. Halsall PJ. Christian AS. Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands. Anaesthesia. 45(10):838-41, 1990 Oct. Gurgey A. Altay C. Ozgen S. Malignant hyperthermia in a patient with sickle cell anemia. Turkish Journal of Pediatrics. 31(3):245-7, 1989 Jul-Sep. Adnet P. Krivosic-Horber R. Reyford H. Leys D. Adamantidis M. Dupuis B. Do neuroleptic malignant syndrome and malignant hyperthermia of anesthesia share a common mechanism? (letter). [French] Presse Medicale - Paris. 19(31):1460, 1990 Sep 29. Isaacs H. Gericke G. Concurrence of malignant hyperthermia and congenital abnormalities. Muscle & Nerve. 13(10):915-7, 1990 Oct. Quinlan JG. Wedel DJ. Iaizzo PA. Multiple-pulse stimulation and dantrolene in malignant hyperthermia. Muscle & Nerve. 13(10):904-8, 1990 Oct. Urwyler A. Ellis FR. Halsall PJ. Hopkins PM. Muscle relaxation rates in individuals susceptible to malignant hyperthermia. British Journal of Anaesthesia. 65(3):421-3, 1990 Sep. Grillo PP. Malignant hyperthermia crisis. Planning a mock demonstration. Aorn Journal. 52(3):585, 587, 589-91, 1990 Sep. Stratton M. Inappropriate use of the t-test [letter; comment]. Anesthesiology. 73(4):790-1, 1990 Oct. Philpott I. Malignant hyperpyrexia and oxygen consumption [letter]. Anaesthesia & Intensive Care. 18(3):422-3, 1990 Aug. Kuan JC. Huang TT. Chang HJ. Wang CM. A suspicious malignant hyperthermia--report of one case. Ma Tsui Hsueh Tsa Chi. 28(2):235-40, 1990 Jun. Hu LH. Sit KF. Cheng CR. Lai KB. Wei TT. Intraoperative malignant hyperthermia--report of one case. Ma Tsui Hsueh Tsa Chi. 28(2):229-33, 1990 Jun. Fletcher JE. Huggins FJ. Rosenberg H. The importance of calcium ions for in vitro malignant hyperthermia testing. Canadian Journal of Anaesthesia. 37(6):695-8, 1990 Sep. Jantzen JP. Kleemann PP. Dick W. Differential clinical diagnosis of malignant hyperthermia. [French] Cahiers D Anesthesiologie. 38(3):179-81, 1990 May-Jun. Krivosic-Horber R. Malignant hyperthermia. Treatment of the acute episode. Acta Anaesthesiologica Belgica. 41(2):83-6, 1990. Heffron JJ. McCarthy TV. Current views of the molecular basis of the malignant hyperthermia syndrome. Acta Anaesthesiologica Belgica. 41(2):73-8, 1990. Breucking E. Mortier W. Anesthesia in neuromuscular diseases. Acta Anaesthesiologica Belgica. 41(2):127-32, 1990. Mortier W. Malignant hyperthermia: relation to other diseases. Acta Anaesthesiologica Belgica. 41(2):119-26, 1990. McCarthy TV. Healy JM. Lehane M. Heffron JJ. Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level. Acta Anaesthesiologica Belgica. 41(2):107-12, 1990. Davies K. Malignant hyperthermia may be due to a defect in a large Ca2+ release channel protein. Trends in Genetics. 6(6):171-2, 1990 Jun. Newberry JE. Malignant hyperthermia in the postanesthesia care unit: a review of current etiology, diagnosis, and treatment. Journal of Post Anesthesia Nursing. 5(1):25-8, 1990 Feb. von Rohden L. Steinbicker V. Krebs P. Wiemann D. Koditz H. The value of ultrasound for the diagnosis of malignant hyperthermia. Journal of Ultrasound In Medicine. 9(5):291-5, 1990 May. Gillis JM. Control and kinetics of intracellular calcium movement in striated muscle. [French] Bulletin Et Memoires De L Academie Royale De Medecine De Belgique. 144(8-9):398-405; discussion 405-6, 1989. Lienhart A. Anesthesia in myotonia. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):469 -84, 1989. Saint-Maurice C. Egu JF. Gaudiche O. Loose JP. Murat I. Anesthesia in patients with Duchenne muscular dystrophy. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):457 -68, 1989. Krivosic-Horber R. Adnet P. Screening tests for malignant hyperthermia susceptibility. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):444 -56, 1989. Amiel I. Nivoche Y. Treatment of malignant hyperthermia crisis during anesthesia. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):427 -34, 1989. Jacquot C. Stieglitz P. Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):417 -26, 1989. Ording H. Pathophysiology of malignant hyperthermia. Annales Francaises D Anesthesie Et De Reanimation. 8(5):411-6, 1989. O'Brien PJ. Klip A. Britt BA. Kalow BI. Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis. Canadian Journal of Veterinary Research. 54(1):83-92, 1990 Jan. Vassallo SU. Delaney KA. Pharmacologic effects on thermoregulation: mechanisms of drug-related heatstroke. Journal of Toxicology - Clinical Toxicology. 27(4-5):199-224, 1989. Campos Suarez JM. Malignant hyperthermia. [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 36(4):232-9, 1989 Jul-Aug. Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesthesia & Analgesia. 69(4):511-5, 1989 Oct. Wlody GS. Malignant hyperthermia. Potential crisis in patient care. Aorn Journal. 50(2):286-7, 289-93, 295 passim, 1989 Aug. Uldry PA. Regli F. Muscular diseases in relation to drug consumption. [French] Schweizerische Rundschau Fur Medizin Praxis. 78(23):671-3, 1989 Jun 6. Westlund UJ. Fridrich KL. Warner DS. Sokoll MD. An unusual anesthetic course in a patient susceptible to malignant hyperthermia. Journal of Oral & Maxillofacial Surgery. 47(8):860-4, 1989 Aug. Landers DF. Becker GL. Wong KC. Calcium, calmodulin, and anesthesiology. Anesthesia & Analgesia. 69(1):100-12, 1989 Jul. Longstaff F. Eltringham R. Malignant hyperpyrexia. British Journal of Hospital Medicine. 41(2):181, 1989 Feb. Dershwitz M. Ryan JF. Guralnick W. Safety of amide local anesthetics in patients susceptible to malignant hyperthermia. Journal of the American Dental Association. 118(3):276, 278, 280, 1989 Mar. Krivosic-Horber R. Adnet P. Krivosic I. Reyford H. Diagnosis of susceptibility to malignant hyperthermia in children. [French] Archives Francaises De Pediatrie. 47(6):421-4, 1990 Jun-Jul. Corrigan JJ Jr. The 'H' in hemorrhagic shock and encephalopathy syndrome should be 'hyperpyrexia' [editorial; comment] [see comments]. American Journal of Diseases of Children. 144(10):1077, 1990 Oct. Takagi A. Kojima S. Advances in research of malignant hyperthermia. [Japanese] Nippon Rinsho - Japanese Journal of Clinical Medicine. 48(7):1557-62, 1990 Jul. Haag GP. Are you prepared for a malignant hyperpyrexia crisis? [editorial]. Aana Journal. 58(4):250-1, 1990 Aug. Lee TL. Kumar A. Ng KS. Foo KL. Malignant hyperthermia. Annals of the Academy of Medicine, Singapore. 19(3):416-20, 1990 May. Ghouri A. Feinstein R. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility [letter] [published erratum appears in Anesthesiology 1990 Dec;73(6):1299] [comment]. Anesthesiology. 73(3):581-2, 1990 Sep. Nelson TE. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology. 73(3):449-54, 1990 Sep. Sufit RL. Kreul JF. Bellay YM. Helmer P. Brunson DB. Will J. Doxacurium and mivacurium do not trigger malignant hyperthermia in susceptible swine. Anesthesia & Analgesia. 71(3):285-7, 1990 Sep. O'Brien PJ. Kalow BI. Ali N. Lassaline LA. Lumsden JH. Compensatory increase in calcium extrusion activity of untreated lymphocytes from swine susceptible to malignant hyperthermia. American Journal of Veterinary Research. 51(7):1038-43, 1990 Jul. Ashby D. Malignant hyperthermia: a potential crisis in the postanesthesia care unit. Journal of Post Anesthesia Nursing. 5(4):279-81, 1990 Aug. Williams JH. Holland M. Lee JC. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle. Research Communications In Chemical Pathology & Pharmacology. 68(3):387-90, 1990 Jun. van Arendonk JA. Kennedy BW. Efficiency of selection strategies for halothane-negative gene. Journal of Animal Science. 68(6):1569-76, 1990 Jun. Rock E. Mammar MS. Vignon X. Thomas MA. Viret J. Abnormal fluidity state in membranes of malignant hyperthermia pig skeletal muscle. Archives of Biochemistry & Biophysics. 281(1):36-40, 1990 Aug 15. Healy JM. Lehane M. Heffron JJ. Farrell M. Johnson K. McCarthy TV. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-q13.2. Biochemical Society Transactions. 18(2):326, 1990 Apr. Fay RS. Gallant EM. Halothane sensitivity of young pigs in vivo and in vitro. American Journal of Physiology. 259(1 Pt 2):R133-8, 1990 Jul. Webster DW. Thompson RT. Gravelle DR. Laschuk MJ. Driedger AA. Metabolic response to exercise in malignant hyperthermia-sensitive patients measured by 31P magnetic resonance spectroscopy. Magnetic Resonance In Medicine. 15(1):81-9, 1990 Jul. Adnet PJ. Krivosic-Horber RM. Haudecoeur G. Reyford HG. Adamantidis MM. Dupuis BA. Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle. Canadian Journal of Anaesthesia. 37(5):556-9, 1990 Jul. Heytens L. Differential diagnosis of MH. Acta Anaesthesiologica Belgica. 41(2):95-102, 1990. Mauritz W. Hackl W. Winkler M. Sporn P. Steinbereithner K. Anesthesia in malignant hyperthermia susceptible patients. Acta Anaesthesiologica Belgica. 41(2):87-94, 1990. Ranklev-Twetman E. Malignant hyperthermia: the clinical syndrome. Acta Anaesthesiologica Belgica. 41(2):79-82, 1990. Ellis FR. Malignant hyperthermia: how important after 30 years. Acta Anaesthesiologica Belgica. 41(2):61-3, 1990. Anonymous. Malignant hyperthermia. A symposium. Antwerp, May 5, 1990. Proceedings. Acta Anaesthesiologica Belgica. 41(2):61-132, 1990. Ording H. Current diagnostic methods of malignant hyperthermia: an evaluation. Acta Anaesthesiologica Belgica. 41(2):103-6, 1990. Doize F. Roux I. DeRoth L. Erythrocyte osmotic fragility, serum creatine kinase and its isoenzymes related to body weight in porcine malignant hyperthermia. Journal of Comparative Pathology. 102(4):467-73, 1990 May. Gericke GS. Isaacs H. Genetically determined hyperthermic reactivity associated with certain congenital abnormalities [letter]. South African Medical Journal. 78(1):43, 1990 Jul 7. Norris MK. Malignant hyperthermia. Nursing. 20(6):33, 1990 Jun. Lopez JR. Sanchez V. Lopez I. Ryan JF. Mendoza M. Sreter FA. Allen PD. The effects of extracellular magnesium on myoplasmic [Ca2+] in malignant hyperthermia susceptible swine. Anesthesiology. 73(1):109-17, 1990 Jul. Wolcott K. McDonnell A. Malignant hyperthermia: nursing implications. Critical Care Nurse. 10(3):78-85, 1990 Mar. Girard JF. Funel MT. Vincent G. The treatment of malignant hyperthermia. [French] Cahiers D Anesthesiologie. 38(1):55-6, 1990 Jan. Frederick C. Rosemann D. Austin MJ. Malignant hyperthermia: nursing diagnosis and care. Journal of Post Anesthesia Nursing. 5(1):29-32, 1990 Feb. Vitkun SA. Boccio RV. Poppers PJ. Anesthetic management of a patient with neuroleptic malignant syndrome. Journal of Clinical Anesthesia. 2(3):188-91, 1990 May-Jun. Tytz-Lemieszek E. Malignant hyperthermia. [Polish] Pielegniarka I Polozna. (10-12):6-7, 1989. Gericke GS. Isaacs H. An association between certain congenital abnormalities and the malignant hyperthermia trait. South African Medical Journal. 77(11):570-4, 1990 Jun 2. Levitt RC. McKusick VA. Fletcher JE. Rosenberg H. Gene candidate [letter]. Nature. 345(6273):297-8, 1990 May 24. Jantzen JP. Eck J. Kleemann PP. An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia. [German] Anaesthesist. 38(11):639-41, 1989 Nov. McSweeney DM. Heffron JJ. Uptake and release of calcium ions by heavy sarcoplasmic reticulum fraction of normal and malignant hyperthermia-susceptible human skeletal muscle. International Journal of Biochemistry. 22(4):329-33, 1990. Hodges M. Pollock NA. Couchman K. Hall KH. Spiers AD. Improving management following a malignant hyperthermia crisis. Anaesthesia & Intensive Care. 18(1):116-9, 1990 Feb. Hackl W. Mauritz W. Schemper M. Winkler M. Sporn P. Steinbereithner K. Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs [see comments]. British Journal of Anaesthesia. 64(4):425-9, 1990 Apr. Ellis FR. Predicting malignant hyperthermia [editorial; comment]. British Journal of Anaesthesia. 64(4):411-2, 1990 Apr. Wilhoit RD. Brown RE Jr. Bauman LA. Possible malignant hyperthermia in a 7-week-old infant [see comments]. Anesthesia & Analgesia. 68(5):688-91, 1989 May. O'Brien PJ. Microassay for malignant hyperthermia susceptibility: hypersensitive ligand-gating of the Ca channel in muscle sarcoplasmic reticulum causes increased amounts and rates of Ca-release. Molecular & Cellular Biochemistry. 93(1):53-9, 1990 Mar 5. Ording H. Foder B. Scharff O. Cytosolic free calcium concentrations in lymphocytes from malignant hyperthermia susceptible patients. British Journal of Anaesthesia. 64(3):341-5, 1990 Mar. Kaukonen L. Hoffman RS. Cocaine [letter; comment]. New York State Journal of Medicine. 90(1):39, 1990 Jan. Dudley JP. Reynolds R. Dubrow TJ. Malignant hyperthermia in the otolaryngologic patient: prospective anesthetic and surgical management of eight children. Annals of Otology, Rhinology & Laryngology. 99(4 Pt 1):297-9, 1990 Apr. Brenig B. Jurs S. Brem G. The porcine PHIcDNA linked to the halothane gene detects a NotI RFLP in normal and malignant hyperthermia susceptible pigs. Nucleic Acids Research. 18(2):388, 1990 Jan 25. Brenig B. Jurs S. Brem G. The porcine PHIcDNA linked to the halothane gene detects a HindIII and XbaI RFLP in normal and malignant hyperthermia susceptible pigs. Nucleic Acids Research. 18(2):388, 1990 Jan 25. Lauri A. Corbari M. Galli C. Marri M. Use of neuroleptoanesthesia for carrying out a Harrington intervention in a patient probably susceptible to malignant hyperthermia. [Italian] Minerva Anestesiologica. 55(9):331-5, 1989 Sep. Bender K. Senff H. Wienker TF. Spiess-Kiefer C. Lehmann-Horn F. A linkage study of malignant hyperthermia (MH). Clinical Genetics. 37(3):221-5, 1990 Mar. Mickelson JR. Litterer LA. Jacobson BA. Louis CF. Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs. Archives of Biochemistry & Biophysics. 278(1):251-7, 1990 Apr. Allen GC. Rosenberg H. Fletcher JE. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility [see comments]. Anesthesiology. 72(4):619-22, 1990 Apr. McGuire N. Easy WR. Malignant hyperthermia during isoflurane anaesthesia. Anaesthesia. 45(2):124-7, 1990 Feb. Lehmann-Horn F. Iaizzo PA. Resealed fiber segments for the study of the pathophysiology of human skeletal muscle. Muscle & Nerve. 13(3):222-31, 1990 Mar. Duthie GG. McPhail DB. Arthur JR. Goodman BA. Morrice PC. Spin trapping of free radicals and lipid peroxidation in microsomal preparations from malignant hyperthermia susceptible pigs. Free Radical Research Communications. 8(2):93-9, 1990. Duthie GG. Arthur JR. The antioxidant abnormality in the stress-susceptible pig. Effect of vitamin E supplementation. Annals of the New York Academy of Sciences. 570:322-34, 1989. Aitken HA. Howie JC. Possible malignant hyperpyrexia [letter]. Anaesthesia. 45(1):60-1, 1990 Jan. Little S. Fatal reaction. Nursing Times. 86(9):20-1, 1990 Feb 28-Mar 6. Kozak-Reiss G. New research on muscular function: NMR spectroscopy. Application to malignant hyperthermia. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):400-5, 1989. Ellis FR. Introduction. Implications of the inheritance of MHS. Annales Francaises D Anesthesie Et De Reanimation. 8(5):390-1, 1989. Anonymous. Anesthesia-resuscitation in muscle pathology. Meeting of the French Society of Anesthesia and Resuscitation. Grenoble, 27-28 January 1989. Proceedings. [French] Annales Francaises D Anesthesie Et De Reanimation. 8(5):389 -468, 1989. Szilagyi M. Laky G. Suri A. Guba F. Activities of some serum enzymes in halothane reacted and non-reacted pigs. Acta Veterinaria Hungarica. 37(1-2):117-21, 1989. Fill M. Coronado R. Mickelson JR. Vilven J. Ma JJ. Jacobson BA. Louis CF. Abnormal ryanodine receptor channels in malignant hyperthermia. Biophysical Journal. 57(3):471-5, 1990 Mar. Dershwitz M. Sreter FA. Azumolene reverses episodes of malignant hyperthermia in susceptible swine. Anesthesia & Analgesia. 70(3):253-5, 1990 Mar. Cheah KS. Cheah AM. Fletcher JE. Rosenberg H. Calcium accumulation by sarcoplasmic reticulum in whole muscle homogenate preparations of malignant hyperthermia diagnostic patients and pigs. Acta Anaesthesiologica Scandinavica. 34(2):114-9, 1990 Feb. Knudson CM. Mickelson JR. Louis CF. Campbell KP. Distinct immunopeptide maps of the sarcoplasmic reticulum Ca2+ release channel in malignant hyperthermia. Journal of Biological Chemistry. 265(5):2421-4, 1990 Feb 15. Adnet PJ. Krivosic-Horber RM. Adamantidis MM. Haudecoeur G. Reyfort GH. Dupuis BA. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia. British Journal of Anaesthesia. 64(1):64-6, 1990 Jan. Hackl W. Winkler M. Mauritz W. Steinbereithner K. The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia. [German] Anaesthesist. 38(12):681-5, 1989 Dec. O'Brien PJ. Pook HA. Klip A. Britt BA. Kalow BI. McLaughlin RN. Scott E. Elliott ME. Canine stress syndrome/malignant hyperthermia susceptibility: calcium -homeostasis defect in muscle and lymphocytes. Research In Veterinary Science. 48(1):124-8, 1990 Jan. Benedetti A. Bresadola F. Welber D. Malignant hyperthermia. A case with minimal manifestations. [Italian] Minerva Anestesiologica. 55(6):287-8, 1989 Jun. McCarthy TV. Healy JM. Heffron JJ. Lehane M. Deufel T. Lehmann-Horn F. Farrall M. Johnson K. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature. 343(6258):562-4, 1990 Feb 8. MacLennan DH. Duff C. Zorzato F. Fujii J. Phillips M. Korneluk RG. Frodis W. Britt BA. Worton RG. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 343(6258):559-61, 1990 Feb 8. Foster PS. Hopkinson KC. Denborough MA. Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle. Clinical & Experimental Pharmacology & Physiology. 16(10):799 -805, 1989 Oct. Allen GC. Fletcher JE. Huggins FJ. Conti PA. Rosenberg H. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group [see comments]. Anesthesiology. 72(1):71-6, 1990 Jan. Mitsumoto H. DeBoer GE. Bunge G. Andrish JT. Tetzlaff JE. Cruse RP. Fiber-type specific caffeine sensitivities in normal human skinned muscle fibers. Anesthesiology. 72(1):50-4, 1990 Jan. Allen G. Rosenberg H. Diagnosis of malignant hyperthermia in infants [letter; comment]. Anesthesia & Analgesia. 70(1):115-6, 1990 Jan. Allen GC. Rosenberg H. Malignant hyperthermia susceptibility in adult patients with masseter muscle rigidity. Canadian Journal of Anaesthesia. 37(1):31-5, 1990 Jan. Adnet P. Haudecoeur G. Adamantidis M. Krivosic-Horber R. Effects of BAY K 8644, a slow calcium channel agonist, on muscle contraction induced by halothane in sensitive subjects with malignant hyperthermia. [French] Annales Francaises D Anesthesie Et De Reanimation. 8 Suppl:R145, 1989. Bellah JR. Robertson SA. Buergelt CD. McGavin AD. Suspected malignant hyperthermia after halothane anesthesia in a cat. Veterinary Surgery. 18(6):483-8, 1989 Nov-Dec. Klein L. Ailes N. Fackelman GE. Kellon E. Rosenberg H. Postanesthetic equine myopathy suggestive of malignant hyperthermia. A case report. Veterinary Surgery. 18(6):479-82, 1989 Nov-Dec. Meluch AM. Sibert KS. Bloch EC. Malignant hyperthermia following isoflurane anesthesia in an American Lumbee Indian. North Carolina Medical Journal. 50(9):485-7, 1989 Sep. McKenzie A. Pollock N. Preparation of theatres for malignant hyperpyrexia patients [letter] [published erratum appears in Anaesth Intensive Care 1990 Feb;18(1):144]. Anaesthesia & Intensive Care. 17(4):510-1, 1989 Nov. Cain AG. Bell AD. How much dantrolene? A case of fulminant malignant hyperthermia. Anaesthesia & Intensive Care. 17(4):500-2, 1989 Nov. Staufenberg EF. Tantam D. Malignant hyperpyrexia syndrome in combined treatment [letter]. British Journal of Psychiatry. 154:577-8, 1989 Apr. Birmingham PK. Stevenson GW. Uejima T. Hall SC. Isolated postoperative myoglobinuria in a pediatric outpatient. A case report of malignant hyperthermia. Anesthesia & Analgesia. 69(6):846-9, 1989 Dec. Adnet PJ. Krivosic-Horber RM. Adamantidis MM. Haudecoeur G. Adnet-Bonte CA. Saulnier F. Dupuis BA. The association between the neuroleptic malignant syndrome and malignant hyperthermia [see comments]. Acta Anaesthesiologica Scandinavica. 33(8):676-80, 1989 Nov. Cheah KS. Cheah AM. Fletcher JE. Rosenberg H. Skeletal muscle mitochondrial respiration of malignant hyperthermia -susceptible patients. Ca2+-induced uncoupling and free fatty acids. International Journal of Biochemistry. 21(8):913-20, 1989. Foster PS. White MD. Denborough MA. Characterization of the terminal cisternae and longitudinal tubules of sarcoplasmic reticulum from malignant hyperpyrexia susceptible porcine skeletal muscle. International Journal of Biochemistry. 21(10):1119-26, 1989. Ervasti JM. Mickelson JR. Lewis SM. Thomas DD. Louis CF. An electron paramagnetic resonance study of skeletal muscle membrane fluidity in malignant hyperthermia. Biochimica Et Biophysica Acta. 986(1):70-4, 1989 Nov 17. Wiswell TE. Bent RC. Solenberger R. Malignant hyperthermia in infancy. Southern Medical Journal. 82(11):1451-2, 1989 Nov. Thomas SD. Malignant hyperthermia. Critical Care Nurse. 9(6):58-70, 1989 Jun. Mickelson JR. Gallant EM. Rempel WE. Johnson KM. Litterer LA. Jacobson BA. Louis CF. Effects of the halothane-sensitivity gene on sarcoplasmic reticulum function. American Journal of Physiology. 257(4 Pt 1):C787-94, 1989 Oct. Gallant EM. Mickelson JR. Roggow BD. Donaldson SK. Louis CF. Rempel WE. Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia. American Journal of Physiology. 257(4 Pt 1):C781-6, 1989 Oct. Wieland SJ. Fletcher JE. Rosenberg H. Gong QH. Malignant hyperthermia: slow sodium current in cultured human muscle cells. American Journal of Physiology. 257(4 Pt 1):C759-65, 1989 Oct. Ording H. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle. Acta Anaesthesiologica Scandinavica. 33(5):405-8, 1989 Jul. Pasch T. Applied pharmacology of anesthetics. [German] Schweizerische Rundschau Fur Medizin Praxis. 78(35):925-7, 1989 Aug 29. Trillo Urrutia L. Hansen Ferrer ES. Campos Suarez JM. Villar Landeira JM. Malignant hyperthermia. Apropos of a case. [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 36(4):229 -31, 1989 Jul-Aug. Fletcher JE. Rosenberg H. Michaux K. Tripolitis L. Lizzo FH. Triglycerides, not phospholipids, are the source of elevated free fatty acids in muscle from patients susceptible to malignant hyperthermia. European Journal of Anaesthesiology. 6(5):355-62, 1989 Sep. Nowak R. Ellendorff F. Halothane anesthesia of several hours' duration in swine of the German Landrace breed, selected for resistance to malignant hyperthermia. [German] Dtw - Deutsche Tierarztliche Wochenschrift. 96(8):423-4, 1989 Sep. McGraw TT. Keon TP. Malignant hyperthermia and the clean machine. Canadian Journal of Anaesthesia. 36(5):530-2, 1989 Sep. Vanek T. Valenta J. Malignant hyperthermia associated with epidural conduction anesthesia. [Czech] Casopis Lekaru Ceskych. 128(28):889-91, 1989 Jul 7. Levenson JL. Tricyclic antidepressants and malignant hyperthermia [letter; comment]. American Journal of Psychiatry. 146(10):1359-60, 1989 Oct. Krivosic-Horber R. Reyfort H. Becq MC. Adnet P. Effect of propofol on the malignant hyperthermia susceptible pig model. British Journal of Anaesthesia. 62(6):691-3, 1989 Jun. Foster PS. Gesini E. Claudianos C. Hopkinson KC. Denborough MA. Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine. Lancet. 2(8655):124-7, 1989 Jul 15. Raff M. Harrison GG. The screening of propofol in MHS swine [see comments]. Anesthesia & Analgesia. 68(6):750-1, 1989 Jun. Burket RC. Hodgin JD. Fluoxetine treatment of a depressed patient susceptible to malignant hyperthermia [letter] [see comments]. American Journal of Psychiatry. 146(5):680, 1989 May. Cartwright DP. Propofol in patients susceptible to malignant hyperpyrexia [letter]. Anaesthesia. 44(2):173, 1989 Feb. Dershwitz M. Sreter FA. Ryan JF. Ketamine does not trigger malignant hyperthermia in susceptible swine. Anesthesia & Analgesia. 69(4):501-3, 1989 Oct. Melton AT. Martucci RW. Kien ND. Gronert GA. Malignant hyperthermia in humans--standardization of contracture testing protocol. Anesthesia & Analgesia. 69(4):437-43, 1989 Oct. Rosenberg H. Standards for halothane/caffeine contracture test [editorial]. Anesthesia & Analgesia. 69(4):429-30, 1989 Oct. Nelson TE. Diagnosing malignant hyperthermia [letter; comment]. Plastic & Reconstructive Surgery. 84(4):699-700, 1989 Oct. Hermesh H. Aizenberg D. Lapidot M. Munitz H. Neuroleptic malignans [letter; comment]. Neurology. 39(9):1273, 1989 Sep. Bercault N. Martin P. Hatahet Z. Gueveler C. Malignant hyperthermia during alcohol withdrawal. [French] Revue De Medecine Interne. 10(3):203-5, 1989 May-Jun. Ellis FR. Halsall PJ. Malignant hyperthermia in the Wolf-Hirschhorn syndrome [letter; comment]. Anaesthesia. 44(6):519, 1989 Jun. Takagi A. Kojima S. Araki M. Clinical implications of enhanced caffeine contracture in malignant hyperthermia (MH) and Duchenne muscular dystrophy (DMD). [Japanese] Rinsho Shinkeigaku - Clinical Neurology. 29(3):301-5, 1989 Mar. Hofmann JG. Buttner C. Till U. Sensitivity of the adenine nucleotide metabolism of platelets from malignant hyperthermia patients to halothane. Biomedica Biochimica Acta. 48(4):343-50, 1989. Allen G. Rosenberg H. Muscle biopsy testing for malignant hyperthermia [letter; comment]. Plastic & Reconstructive Surgery. 84(2):373-4, 1989 Aug. Gallant EM. Goettl VM. Porcine malignant hyperthermia: halothane effects on force generation in skeletal muscles. Muscle & Nerve. 12(1):56-63, 1989 Jan. Schwartz N. Eisenkraft JB. Malignant hyperthermia in a child with sleep apnea. Mount Sinai Journal of Medicine. 56(2):123-5, 1989 Mar. Harioka T. Sone T. Toda H. Miyake C. Malignant hyperthermia in a hemodialysis patient. Anesthesia & Analgesia. 69(1):119-21, 1989 Jul. Turpin IM. Manino J. Malignant hyperthermia in an office surgery suite: a case report. Aesthetic Plastic Surgery. 13(2):121-3, 1989 Spring. Ong RO. Rosenberg H. Malignant hyperthermia-like syndrome associated with metrizamide myelography. Anesthesia & Analgesia. 68(6):795-7, 1989 Jun. Shah A. Sahgal V. Subramani V. Membrane abnormality in malignant hyperthermia. Acta Neuropathologica. 78(1):86-9, 1989. Matsui K. Fujioka Y. Mukaida K. Takahashi M. Kikuchi H. Fujii K. Morio M. Comparative study of in vitro diagnosis by the skinned fiber test and clinical diagnosis of malignant hyperthermia. [Japanese] Masui - Japanese Journal of Anesthesiology. 38(2):195-201, 1989 Feb. Foster PS. Denborough MA. Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle. British Journal of Anaesthesia. 62(5):566-72, 1989 May. Foster PS. Hopkinson KC. Denborough MA. Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane. British Journal of Anaesthesia. 62(5):560-5, 1989 May. Christian AS. Ellis FR. Halsall PJ. Is there a relationship between masseteric muscle spasm and malignant hyperpyrexia?. British Journal of Anaesthesia. 62(5):540-4, 1989 May. Allen G. A circle system is best when anesthetizing malignant hyperthermia susceptible patients [letter]. Anesthesiology. 70(6):1025-6, 1989 Jun. Mitterschiffthaler G. Hackl JM. Neumann R. The malignant neuroleptic syndrome and malignant hyperthermia. [German] Anaesthesist. 38(4):210-3, 1989 Apr. Fletcher JE. Rosenberg H. Lizzo FH. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 33(3):187-92, 1989 Apr. Krivosic-Horber R. Krivosic I. Central core disease associated with malignant hyperthermia sensitivity. [French] Presse Medicale - Paris. 18(16):828-31, 1989 Apr 22. Larew RE. Malignant hyperthermia. Quick recognition and treatment to avoid death. Postgraduate Medicine. 85(8):117-8, 128-9, 1989 Jun. Gallant EM. Donaldson SK. Skeletal muscle excitation-contraction coupling. II. Plasmalemma voltage control of intact bundle contractile properties in normal and malignant hyperthermic muscles. Pflugers Archiv - European Journal of Physiology. 414(1):24 -30, 1989 May. Donaldson SK. Gallant EM. Huetteman DA. Skeletal muscle excitation-contraction coupling. I. Transverse tubule control of peeled fiber Ca2+-induced Ca2+ release in normal and malignant hyperthermic muscles. Pflugers Archiv - European Journal of Physiology. 414(1):15 -23, 1989 May. Foster PS. Hopkinson K. Denborough MA. 31P-NMR spectroscopy: the metabolic profile of malignant hyperpyrexic porcine skeletal muscle. Muscle & Nerve. 12(5):390-6, 1989 May. Salviati G. Betto R. Ceoldo S. Tegazzin V. Della Puppa A. Caffeine sensitivity of sarcoplasmic reticulum of fast and slow fibers from normal and malignant hyperthermia human muscle. Muscle & Nerve. 12(5):365-70, 1989 May. Iaizzo PA. Lehmann-Horn F. The in vitro determination of susceptibility to malignant hyperthermia. Muscle & Nerve. 12(3):184-90, 1989 Mar. Iaizzo PA. Lehmann-Horn F. Taylor SR. Gallant EM. Malignant hyperthermia: effects of halothane on the surface membrane. Muscle & Nerve. 12(3):178-83, 1989 Mar. Tateishi M. Sumita S. Watanabe H. Kumeta H. Narimatsu E. Namiki A. Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test. [Japanese] Masui - Japanese Journal of Anesthesiology. 38(4):546-51, 1989 Apr. Dubrow TJ. Wackym PA. Abdul-Rasool IH. Moore TC. Malignant hyperthermia: experience in the prospective management of eight children. Journal of Pediatric Surgery. 24(2):163-6, 1989 Feb. Carroll JE. Makari GS. Update on neuromuscular diseases of childhood. Current Problems In Pediatrics. 19(3):113-66, 1989 Mar. Bacon AK. Pulse oximetry in malignant hyperthermia. Anaesthesia & Intensive Care. 17(2):208-10, 1989 May. Denborough M. Fatal thermal injury [letter]. Medical Journal of Australia. 150(10):608, 1989 May 15. Lamb GD. Hopkinson KC. Denborough MA. Calcium currents and asymmetric charge movement in malignant hyperpyrexia. Muscle & Nerve. 12(2):135-40, 1989 Feb. Quinlan JG. Iaizzo PA. Lambert EH. Gronert GA. Ankle dorsiflexor twitch properties in malignant hyperthermia. Muscle & Nerve. 12(2):119-25, 1989 Feb. Fletcher JE. Lizzo FH. Rosenberg H. Suxamethonium and malignant hyperthermia [letter]. British Journal of Anaesthesia. 62(4):468-9, 1989 Apr. Lerman J. McLeod ME. Strong HA. Pharmacokinetics of intravenous dantrolene in children. Anesthesiology. 70(4):625-9, 1989 Apr. Schnorr C. Muller H. Menges T. Bachmann-Mennenga B. Hempelmann G. Hyperthermic reaction in the perioperative phase in 2 children with acute lymphoblastic leukemia of B-cell type. [German] Anaesthesist. 38(2):85-8, 1989 Feb. Puschel K. Koops E. Schulz-Baldes JG. Postoperative malignant hyperthermia in a 7-day-old infant?. [German] Anaesthesist. 38(2):81-4, 1989 Feb. Haberer JP. Fabre F. Rose E. Malignant hyperthermia and myotonia congenita (Thomsen's disease) [letter]. Anaesthesia. 44(2):166, 1989 Feb. Lloyd EL. Multiple anaesthetics for a malignant hyperthermia susceptible patient [letter]. Anaesthesia. 44(1):76-7, 1989 Jan. Bennett MH. Wainwright AP. Acute thyroid crisis on induction of anaesthesia. Anaesthesia. 44(1):28-30, 1989 Jan. Dickinson JG. Heat-exercise hyperpyrexia. Journal of the Royal Army Medical Corps. 135(1):27-9, 1989 Feb. Erbstoesser M. Care of the patient with malignant hyperthermia. Journal of Post Anesthesia Nursing. 4(2):71-4, 1989 Apr. Cooper JB. Philip JH. More on anesthesia machines and malignant hyperpyrexia [letter]. Anesthesiology. 70(3):561-2, 1989 Mar. Duthie GG. Arthur JR. Bremner P. Kikuchi Y. Nicol F. Increased peroxidation of erythrocytes of stress-susceptible pigs: an improved diagnostic test for porcine stress syndrome. American Journal of Veterinary Research. 50(1):84-7, 1989 Jan. O'Brien PJ. Kalow BI. Brown BD. Lumsden JH. Jacobs RM. Porcine malignant hyperthermia susceptibility: halothane-induced increase in cytoplasmic free calcium in lymphocytes. American Journal of Veterinary Research. 50(1):131-5, 1989 Jan. Ohta T. Endo M. Nakano T. Morohoshi Y. Wanikawa K. Ohga A. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle. American Journal of Physiology. 256(2 Pt 1):C358-67, 1989 Feb. Fairbrass MJ. Coe P. Ellis FR. Adrenal cortical reserve in patients undergoing muscle biopsy for malignant hyperthermia screening. British Journal of Anaesthesia. 62(1):66-9, 1989 Jan. Allen GC. Cattran CB. Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management. Canadian Journal of Anaesthesia. 36(1):81-5, 1989 Jan. Hermesh H. Aizenberg D. Lapidot M. Munitz H. The relationship between malignant hyperthermia and neuroleptic malignant syndrome [letter]. Anesthesiology. 70(1):171-3, 1989 Jan. Brooks JH. Midazolam in a malignant hyperthermia-susceptible patient [letter]. Anesthesiology. 70(1):167-8, 1989 Jan. Cirillo DP. Parker M. Malignant hyperthermia crisis. Plastic & Reconstructive Surgery. 83(2):332-6, 1989 Feb. Sorosky JI. Ingardia CJ. Botti JJ. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy. American Journal of Perinatology. 6(1):46-8, 1989 Jan. Materson BJ. Preston RA. Myoglobinuria versus hemoglobinuria. Hospital Practice (office Edition). 23(10A):29-38, 1988 Oct 30. Nadeau S. DeRoth L. Contractile responses of the renal and iliac arteries to catecholamines in the presence of halothane in swine susceptible to malignant hyperthermia. [French] Zentralblatt Fur Veterinarmedizin - Reihe A. 35(6):461-6, 1988 Jul. Denborough MA. Hopkinson KC. Banney DG. Firefighting and malignant hyperthermia. British Medical Journal - Clinical Research. 296(6634):1442-3, 1988 May 21. Daugschies A. Rommel M. Schnieder T. Henning M. Kallweit E. Effects of Sarcocystis miescheriana infection on carcass quality and on the water-binding capacity of the meat of halothane-tested fattening pigs. Veterinary Parasitology. 27(3-4):231-7, 1988 Mar. Daugschies A. Schnieder T. Rommel M. Bickhardt K. The effects of Sarcocystis miescheriana infections on blood enzymes and weight gain of stress-sensitive and stress-insensitive pigs. Veterinary Parasitology. 27(3-4):221-9, 1988 Mar. Ording H. Fonsmark L. Use of vecuronium and doxapram in patients susceptible to malignant hyperthermia. British Journal of Anaesthesia. 60(4):445-9, 1988 Mar. D'Ambrosio J. Adragna MG. Guidelines for the use of local anesthetics in the dental treatment of patients who are susceptible to malignant hyperthermia. Special Care In Dentistry. 8(2):61-3, 1988 Mar-Apr. Hartshorne JE. Carstens IL. Muller GJ. Malignant hyperthermia in the dental practice and survey of the literature. [Afrikaans] Tydskrif Van Die Tandheelkundige Vereniging Van Suid Afrika. 43(6):271-3, 1988 Jun. Negre F. Caujolle JP. Ghenassia C. Dupont D. Lods F. Malignant hyperthermia in ophthalmologic surgery. [French] Journal Francais D Ophtalmologie. 11(11):753-7, 1988. Kuska J. Kokot F. Acute non-traumatic rhabdomyolysis. [Polish] Polski Tygodnik Lekarski. 43(31-32):1031-3, 1988 Aug 1-8. Nelson TE. SR function in malignant hyperthermia. Cell Calcium. 9(5-6):257-65, 1988 Dec. Hayakawa A. Shimonaka H. Uematsu H. Yamamoto M. Non-rigid type malignant hyperthermia and dantrolene sodium. [Japanese] Masui - Japanese Journal of Anesthesiology. 37(10):1243-8, 1988 Oct. Allen GC. Cattran CB. Peterson RG. Lalande M. Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients. Anesthesiology. 69(6):900-4, 1988 Dec. Minasian A. Yagiela JA. The use of amide local anesthetics in patients susceptible to malignant hyperthermia. Oral Surgery, Oral Medicine, Oral Pathology. 66(4):405-15, 1988 Oct. Glisson SN. Malignant hyperthermia. Comprehensive Therapy. 14(10):33-41, 1988 Oct. Escolano Villen F. Lopez Bosque R. Malignant hyperpyrexia caused by neuroleptics. [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 35(4):214-7, 1988 Jul-Aug. Simon D. The influence of breeding precautions on the meat quality in swine. [German] Dtw - Deutsche Tierarztliche Wochenschrift. 95(6):231-4, 1988 Jun. Simons ML. Goldman E. Atypical malignant hyperthermia with persistent hyperkalaemia during renal transplantation. Canadian Journal of Anaesthesia. 35(4):409-12, 1988 Jul. Lerman J. Controversies in paediatric anaesthesia. Canadian Journal of Anaesthesia. 35(3 ( Pt 2)):S18-22, 1988 May. Danzl DF. Hyperthermic syndromes. American Family Physician. 37(6):157-62, 1988 Jun. Smidt D. Kallweit E. Ladewig J. Stress, health and production in swine. [German] Tierarztliche Praxis - Supplement. 3:1-10, 1988. Smith RJ. Malignant hyperthermia. Preoperative assessment of risk factors. British Journal of Anaesthesia. 60(3):317-9, 1988 Feb. Harriman DG. Malignant hyperthermia myopathy--a critical review. British Journal of Anaesthesia. 60(3):309-16, 1988 Feb. Brownell AK. Malignant hyperthermia: relationship to other diseases. British Journal of Anaesthesia. 60(3):303-8, 1988 Feb. Ording H. Diagnosis of susceptibility to malignant hyperthermia in man. British Journal of Anaesthesia. 60(3):287-302, 1988 Feb. Harrison GG. Malignant hyperthermia. Dantrolene--dynamics and kinetics. British Journal of Anaesthesia. 60(3):279-86, 1988 Feb. Heffron JJ. Malignant hyperthermia: biochemical aspects of the acute episode. British Journal of Anaesthesia. 60(3):274-8, 1988 Feb. Rosenberg H. Clinical presentation of malignant hyperthermia. British Journal of Anaesthesia. 60(3):268-73, 1988 Feb. Gronert GA. Mott J. Lee J. Aetiology of malignant hyperthermia. British Journal of Anaesthesia. 60(3):253-67, 1988 Feb. Collins SP. White MD. Denborough MA. Calmodulin-antagonist drugs and porcine malignant hyperpyrexia. Clinical & Experimental Pharmacology & Physiology. 15(6):473 -7, 1988 Jun. Eichhorn JH. Malignant hyperthermia revisited [editorial] [see comments]. Plastic & Reconstructive Surgery. 82(5):883-5, 1988 Nov. Jelic JS. Moore PA. Malignant hyperthermia and amide local anesthetics. Pennsylvania Dental Journal. 55(4):35-6, 1988 Jul-Aug. Carey CM. Malignant hyperthermia and the dental practitioner. Tydskrif Van Die Tandheelkundige Vereniging Van Suid Afrika. 43(1):14-5, 1988 Jan. Marks LF. Edwards JC. Linter SP. Propofol during cardiopulmonary bypass in a patient susceptible to malignant hyperpyrexia. Anaesthesia & Intensive Care. 16(4):482-5, 1988 Nov. Denborough M. Hopkinson KC. Propofol and malignant hyperpyrexia [letter]. Lancet. 1(8578):191, 1988 Jan 23. Kanoza R. Weinberg S. Lai J. Malignant hyperthermia. Ontario Dentist. 65(9):21, 23-5, 1988 Nov. Eriksson E. Heden P. Method for skin blood flow studies in the pig. Scandinavian Journal of Plastic & Reconstructive Surgery & Hand Surgery. 22(3):229-32, 1988. Duthie G. Arthur J. Hoppe P. Porcine stress syndrome, free radicals and vitamin E. Basic Life Sciences. 49:605-9, 1988. Parris WC. Kambam J. Adkins B. Typical and atypical presentation of malignant hyperpyrexia in nonwhite patients. Anesthesia Progress. 35(5):208-11, 1988 Sep-Oct. Stewart CR. Kahler SG. Gilchrist JM. Congenital myopathy with cleft palate and increased susceptibility to malignant hyperthermia: King syndrome?. Pediatric Neurology. 4(6):371-4, 1988 Nov-Dec. Radeschi G. Bersano T. Gorgoni G. Morra A. Gorgerino F. Malignant hyperthermia: 2 cases in a family. [Italian] Minerva Anestesiologica. 54(7-8):333-6, 1988 Jul-Aug. Amores Lloret A. Martinez Hernandez A. Malignant hyperthermia or myotonia congenita (letter). [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 35(6):346, 1988 Nov-Dec. Crowley KJ. Cunningham AJ. Conroy B. O'Connell PR. Collins PG. Phaeochromocytoma--a presentation mimicking malignant hyperthermia. Anaesthesia. 43(12):1031-2, 1988 Dec. Shindoh M. Enomoto K. Tatekawa S. Yukioka H. Yoshimoto N. Fujimori M. Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia. [Japanese] Masui - Japanese Journal of Anesthesiology. 37(7):861-7, 1988 Jul. Jacquot C. Stieglitz P. Kozak-Reiss G. Krivosic-Horber R. Laxenaire MC. Lienhart A. Nivoche Y. Registration of peranesthetic cases of malignant hyperthermia in France. An update. [French] Annales Francaises D Anesthesie Et De Reanimation. 7(6):524 -34, 1988. Marsepoil T. Ho P. Levesque P. Letessier G. Sebbah JL. Blin F. Malignant hyperthermia electrocardiographic and hemodynamic study. [French] Revue De Medecine Interne. 9(4):417-9, 1988 Sep-Oct. Adam H. Olthoff D. Rustow B. von Lengerken G. Changes in phospholipid metabolism in the skeletal muscle cell in induced malignant hyperthermia in the domestic pig. [German] Anaesthesiologie Und Reanimation. 13(3):149-55, 1988. Bouges M. Faggianelli M. Brunel MP. Senesse J. Bugat JJ. Gely D. Penta-chlorophenol (Xylophene) poisoning. [French] Agressologie. 29(3):199-201, 1988 Mar. DeRoth L. Nadeau S. Effects of halothane on the mechanical responses in vitro of coronary arterial rings of malignant hyperthermia susceptible swine. Journal of Veterinary Pharmacology & Therapeutics. 11(4):402 -4, 1988 Dec. Rozsival P. Sedy J. Malignant hyperthermia--an unusual complication of eye surgery. [Czech] Ceskoslovenska Oftalmologie. 44(6):435-8, 1988 Nov. Ohnishi ST. Katagi H. Ohnishi T. Brownell AK. Detection of malignant hyperthermia susceptibility using a spin label technique on red blood cells. British Journal of Anaesthesia. 61(5):565-8, 1988 Nov. Welfringer P. Cornet C. Is the prevention of peranesthetic malignant hyperthermia with dantrolene justified? (letter). [French] Annales Francaises D Anesthesie Et De Reanimation. 7(5):437-8, 1988. Houvenaeghel M. Achilli-Cornesse E. Jullian-Papouin H. Martin-Meyssonier A. Manelli JC. Oral dantrolene in a parturient with myotonic dystrophy and susceptibility to malignant hyperthermia. [French] Annales Francaises D Anesthesie Et De Reanimation. 7(5):408 -11, 1988. Davies W. Harbitz I. Fries R. Stranzinger G. Hauge JG. Porcine malignant hyperthermia carrier detection and chromosomal assignment using a linked probe. Animal Genetics. 19(3):203-12, 1988. Anghelu:ta F. Nichiteanu C. Bacalba:sa N. Zaharia ME. Fulminant form of intra-anesthetic malignant hyperthermia. [Rumanian] Revista De Chirurgie, Oncologie Radiologie Orl Oftalmologie Stomatologie - Chirurgie. 37(4):311-5, 1988 Jul-Aug. Stieglitz P. Peranesthetic malignant hyperthermia (editorial). [French] Annales Francaises D Anesthesie Et De Reanimation. 7(4):275, 1988. DeRoth L. Nadeau S. Heon H. Halothane induced vasomotion of coronary, renal and iliac arterial rings in malignant hyperthermia susceptible swine. Canadian Journal of Veterinary Research. 52(4):407-10, 1988 Oct. Fletcher JE. Rosenberg H. Michaux K. Cheah KS. Cheah AM. Lipid analysis of skeletal muscle from pigs susceptible to malignant hyperthermia. Biochemistry & Cell Biology. 66(8):917-21, 1988 Aug. Haggendal J. Jonsson L. Johansson G. Bjurstrom S. Carlsten J. Disordered catecholamine release in pigs susceptible to malignant hyperthermia. Pharmacology & Toxicology. 63(4):257-61, 1988 Oct. Shimonaka H. Yamamoto M. Enzyme-linked immunoglobulins in the serum in malignant hyperthermia. [Japanese] Masui - Japanese Journal of Anesthesiology. 37(9):1034-43, 1988 Sep. Ohnishi ST. Ohnishi T. Halothane induced disorder of red cell membranes of subjects susceptible to malignant hyperthermia. Cell Biochemistry & Function. 6(4):257-61, 1988 Oct. Kim DH. Sreter FA. Ikemoto N. Involvement of the 60 kDa phosphoprotein in the regulation of Ca2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles. Biochimica Et Biophysica Acta. 945(2):246-52, 1988 Nov 22. Allen G. Atracurium or vecuronium for MHS patients? [letter]. British Journal of Anaesthesia. 61(4):513, 1988 Oct. Hermesh H. Aizenberg D. Lapidot M. Munitz H. Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families. American Journal of Psychiatry. 145(11):1431-4, 1988 Nov. Thomas A. Leopold U. Winkler H. Malignant hyperthermia in paramyotonia congenita. [German] Anaesthesiologie Und Reanimation. 13(5):295-300, 1988. Kemp DR. Choong LS. Malignant hyperthermia and the conscious patient. Australian & New Zealand Journal of Surgery. 58(5):423-7, 1988 May. Mauritz W. Hackl W. Sporn P. Steinbereithner K. Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients. [German] Anaesthesist. 37(8):522-8, 1988 Aug. Mulrooney L. Counselling on malignant hyperpyrexia [editorial]. Anaesthesia. 43(9):727-8, 1988 Sep. Merlin SI. Brissie RM. Kapila A. Hauser MT. Hyperpyrexia, seizures, and hypotension in a 31-year-old man [clinical conference]. Alabama Journal of Medical Sciences. 25(3):274-9, 1988 Jul. Shime J. Gare D. Andrews J. Britt B. Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant. American Journal of Obstetrics & Gynecology. 159(4):831-4, 1988 Oct. Krivosic-Horber R. Optimal treatment for malignant hyperthermia today. Acta Anaesthesiologica Belgica. 39(3 Suppl 2):255-9, 1988. Ellis FR. Ambulatory laboratory investigations for malignant hyperthermia susceptible patients. Acta Anaesthesiologica Belgica. 39(3 Suppl 2):253-4, 1988. Wackym PA. Dubrow TJ. Abdul-Rasool IH. Lesavoy MA. Malignant hyperthermia in plastic surgery. Plastic & Reconstructive Surgery. 82(5):878-82, 1988 Nov. Ruppersberg JP. Rudel R. Differential effects of halothane on adult and juvenile sodium channels in human muscle. Pflugers Archiv - European Journal of Physiology. 412(1-2):17 -21, 1988 Jul. Basrur PK. Bouvet A. McDonell WN. Open canalicular system of platelets in porcine stress syndrome. Canadian Journal of Veterinary Research. 52(3):380-5, 1988 Jul. Beebe JJ. Sessler DI. Preparation of anesthesia machines for patients susceptible to malignant hyperthermia. Anesthesiology. 69(3):395-400, 1988 Sep. Bickhardt K. Fenger R. Wilms-Schulze-Kump A. Stress reactions in clinically healthy sows at the time of birth and their relationship to the CK test. [German] Tierarztliche Praxis - Supplement. 3:72-6, 1988. Hogan KJ. Gregg RG. Malignant hyperthermia, congenital anomalies, and DNA linkage analysis [letter]. Anesthesiology. 68(4):649, 1988 Apr. Hall DB. Mahla ME. Muldoon SM. Factitious malignant hyperthermia. Anesthesia & Analgesia. 67(10):1005-7, 1988 Oct. Emmanuel ER. Multiple anaesthetics for a malignant hyperthermia susceptible patient. Anaesthesia. 43(8):666-70, 1988 Aug. Hanichen T. Heinritzi K. Bollwahn W. Blendl HM. The advantages of the use of vitamin E and selenium for the prevention and therapy of porcine stress syndrome. [German] Tierarztliche Praxis. 16(2):147-51, 1988. Wackym PA. Dubrow TJ. Abdul-Rasool IH. Peacock WJ. Neurosurgery in the malignant hyperthermia-susceptible patient. Neurosurgery. 22(6 Pt 1):1032-6, 1988 Jun. Schwartz N. Eisenkraft JB. Malignant hyperthermia and sleep apnea [letter]. Anesthesiology. 69(3):433, 1988 Sep. Mauritz W. Hackl W. Sporn P. Graf M. Sluga E. Steinbereithner K. Malignant hyperthermia in Austria. II. A comparison of the results of diagnostic test procedures. [German] Anaesthesist. 37(7):425-31, 1988 Jul. Grigg JR. Neuroleptic malignant syndrome and malignant hyperthermia [letter]. American Journal of Psychiatry. 145(9):1175, 1988 Sep. Pippin LK. Armstrong J. Schreiber T. Malignant hyperthermia in a patient with King syndrome. Aana Journal. 56(3):234-7, 1988 Jun. Iaizzo PA. Klein W. Lehmann-Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflugers Archiv - European Journal of Physiology. 411(6):648 -53, 1988 Jun. Helms U. Kahle M. Fink KW. Heilmann K. Malignant hyperthermia. An unusual course of a rare disease. [German] Anaesthesist. 37(4):277-81, 1988 Apr. Moncada G. Malignant hyperthermia: an update for the office-based practice. Plastic Surgical Nursing. 8(2):48-52, 1988 Summer. Gallant EM. Porcine malignant hyperthermia: no role for plasmalemmal depolarization [letter]. Muscle & Nerve. 11(7):785-6, 1988 Jul. Ginsburg R. Purcell-Jones G. Malignant hyperthermia in the Wolf-Hirschhorn syndrome [see comments]. Anaesthesia. 43(5):386-8, 1988 May. Brajsa P. Snur I. Strinovic D. Malignant hyperthermia during anesthesia. [SerboCroation (Roman)] Lijecnicki Vjesnik. 110(3-4):100-3, 1988 Mar-Apr. Hara Y. Kato A. Horikawa H. Kato Y. Ichiyanagi K. Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient. [Japanese] Masui - Japanese Journal of Anesthesiology. 37(4):483-7, 1988 Apr. Wackym PA. Abdul-Rasool IH. Prospective management of malignant hyperthermia in the otolaryngological patient. Journal of Laryngology & Otology. 102(6):513-6, 1988 Jun. San Juan AC Jr. Wong KC. Port JD. Hyperkalemia after dantrolene and verapamil-dantrolene administration in dogs. Anesthesia & Analgesia. 67(8):759-62, 1988 Aug. Sainsbury DA. Osborne GA. A case of malignant hyperthermia. Anaesthesia & Intensive Care. 16(2):218-21, 1988 May. Harrison GG. Wright IG. Morrell DF. The effects of calcium channel blocking drugs on halothane initiation of malignant hyperthermia in MHS swine and on the established syndrome. Anaesthesia & Intensive Care. 16(2):197-201, 1988 May. Merry SN. Merry AF. Neuroleptic malignant syndrome and malignant hyperthermia [letter]. New Zealand Medical Journal. 101(848):431, 1988 Jun 22. Backman E. Lennmarken C. Rutberg H. Henriksson KG. Skeletal muscle contraction characteristics in vivo in malignant hyperthermia susceptible subjects. Acta Neurologica Scandinavica. 77(4):278-82, 1988 Apr. Campos Suarez JM. Cabrera Ruiz-Lopera JC. Catala Puigbo E. Villar Landeira JM. Calcium blockers and malignant hyperthermia (letter). [Spanish] Revista Espanola De Anestesiologia Y Reanimacion. 35(2):108 -10, 1988 Mar-Apr. Scott SL. Malignant hyperthermia--a review. Canadian Bulletin of Cardiovascular Nursing. 12(2):9-11, 10-3, 1988 May. Pamukcoglu T. Sudden death due to malignant hyperthermia. American Journal of Forensic Medicine & Pathology. 9(2):161-2, 1988 Jun. Lombard TP. Couper JL. Malignant hyperthermia in a black adolescent. A case report. South African Medical Journal. 73(12):726-9, 1988 Jun 18. Mickelson JR. Gallant EM. Litterer LA. Johnson KM. Rempel WE. Louis CF. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. Journal of Biological Chemistry. 263(19):9310-5, 1988 Jul 5. Nelson TE. Suxamethonium and MHS muscle [letter]. British Journal of Anaesthesia. 60(5):596-7, 1988 Apr. Duthie GG. Arthur JR. Simpson SP. Nicol F. Plasma pyruvate kinase activity vs creatine kinase activity as an indicator of the porcine stress syndrome. American Journal of Veterinary Research. 49(4):508-10, 1988 Apr. Murakawa M. Hatano Y. Magaribuchi T. Mori K. Should calcium administration be avoided in treatment of hyperkalemia in malignant hyperthermia? [letter]. Anesthesia & Analgesia. 67(6):604-5, 1988 Jun. Heiman-Patterson TD. Rosenberg H. Fletcher JE. Tahmoush AJ. Halothane-caffeine contracture testing in neuromuscular diseases. Muscle & Nerve. 11(5):453-7, 1988 May. Hargrove JC. Are we really prepared for malignant hyperthermia: Part II [letter]. Anesthesiology. 68(5):815, 1988 May. Wendt M. Bickhardt K. Stress reactions in sows during difficult births and after transport. [German] Tierarztliche Praxis - Supplement. 3:77-83, 1988. Brasdefer D. Cantineau D. Tassin M. Krivosic-Horber R. Scherpereel P. Peroperative disclosure of a case of malignant hyperthermia. Elements of suspicion of the diagnosis, in vitro study of the sensitivity of muscle fibers. [French] Cahiers D Anesthesiologie. 36(2):149-51, 1988 Mar-Apr. Krivosic-Horber R. Adnet P. Krivosic I. Theunynck D. Guevart E. Adamantidis M. Tests of contracture and sensitivity to malignant hyperthermia in 27 patients. [French] Annales Francaises D Anesthesie Et De Reanimation. 7(2):132-8, 1988. Heiman-Patterson T. Martino C. Rosenberg H. Fletcher J. Tahmoush A. Malignant hyperthermia in myotonia congenita. Neurology. 38(5):810-2, 1988 May. Schroder J. Linge C. Wahner A. Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison. [German] Fortschritte Der Neurologie-Psychiatrie. 56(3):97-101, 1988 Mar. Gronert GA. White DA. Failure of norepinephrine to initiate porcine malignant hyperthermia. Pflugers Archiv - European Journal of Physiology. 411(2):226 -8, 1988 Feb. Olgin J. Argov Z. Rosenberg H. Tuchler M. Chance B. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. Anesthesiology. 68(4):507-13, 1988 Apr. Tuman KJ. Spiess BD. Wong CA. Ivankovich AD. Sufentanil-midazolam anesthesia in malignant hyperthermia. Anesthesia & Analgesia. 67(4):405-8, 1988 Apr. Britt BA. Combined anesthetic- and stress-induced malignant hyperthermia in two offspring of malignant hyperthermic-susceptible parents. Anesthesia & Analgesia. 67(4):393-9, 1988 Apr. Anonymous. Central core disease [editorial]. Lancet. 1(8590):866, 1988 Apr 16. Ellis FR. The diagnosis of MH: its social implications [editorial]. British Journal of Anaesthesia. 60(3):251-2, 1988 Feb. Taskalos I. A faster way to reconstitute dantrolene sodium for malignant hyperthermia. Aorn Journal. 47(2):600, 602-3, 1988 Feb. Ording H. Hansen U. Skovgaard LT. Age, fiber type composition and in vitro contracture responses in human malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 32(2):121-4, 1988 Feb. Froster-Iskenius UG. Waterson JR. Hall JG. A recessive form of congenital contractures and torticollis associated with malignant hyperthermia. Journal of Medical Genetics. 25(2):104-12, 1988 Feb. Mauritz W. Sporn P. Steinbereithner K. Malignant hyperthermia susceptibility confirmed in both parents of probands. A report of three Austrian families. Acta Anaesthesiologica Scandinavica. 32(1):24-6, 1988 Jan. Lopez JR. Allen PD. Alamo L. Jones D. Sreter FA. Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine. Muscle & Nerve. 11(1):82-8, 1988 Jan. Feuerman T. Gade GF. Reynolds R. Stress-induced malignant hyperthermia in a head-injured patient. Case report. Journal of Neurosurgery. 68(2):297-9, 1988 Feb. Johnson SB. Alvarez WA. Nonneuroleptic malignant syndrome [letter]. Journal of Clinical Psychiatry. 49(2):79-80, 1988 Feb. Ellis FR. Halsall PJ. Harriman DG. Malignant hyperpyrexia and sudden infant death syndrome. British Journal of Anaesthesia. 60(1):28-30, 1988 Jan. Bohm M. Roewer N. Schmitz W. Scholz H. Schulte am Esch J. Effects of beta- and alpha-adrenergic agonists, adenosine, and carbachol in heart muscle isolated from malignant hyperthermia susceptible swine. Anesthesiology. 68(1):38-43, 1988 Jan. Geiduschek J. Cohen SA. Khan A. Cullen BF. Repeated anesthesia for a patient with neuroleptic malignant syndrome. Anesthesiology. 68(1):134-7, 1988 Jan. Nossaman BD. Mata JA. Re: Anesthetic induction trismus, more than a closed mouth problem [letter]. Journal of Urology. 139(1):146, 1988 Rock E. Kozak-Reiss G. Effect of halothane on the Ca2+-transport system of surface membranes isolated from normal and malignant hyperthermia pig skeletal muscle. Archives of Biochemistry & Biophysics. 256(2):703-7, 1987 Mickelson JR. Ross JA. Hyslop RJ. Gallant EM. Louis CF. Skeletal muscle sarcolemma in malignant hyperthermia: evidence for a defect in calcium regulation. Biochimica Et Biophysica Acta. 897(3):364-76, 1987 Mar 12. Gronert GA. Ahern CP. Milde JH. Treatment of porcine malignant hyperthermia: lactate gradient from muscle to blood. Canadian Anaesthetists Society Journal. 33(6):729-36, 1986 Nov. Ording H. Nielsen VG. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia. British Journal of Anaesthesia. 58(9):1001-4, 1986 Sep. Moeller R. Kozak-Reiss G. Gascard JP. Laxenaire MC. Contracture test with ionophore A 23187 for the diagnosis of malignant hyperthermia [Fre] Annales Francaises D Anesthesie Et De Reanimation. 5(2):177 -81, 1986. Reiss G. Monin G. Lauer C. Comparative effects of the ionophore A23187 on the mechanical responses of muscle in normal Pietrain pigs and pigs with malignant hyperthermia. Canadian Journal of Physiology & Pharmacology. 64(3):248-53, 1986 Mar. Ording H. Hald A. Sj:ntoft E. Ketanserin and malignant hyperthermia in pigs. Acta Anaesthesiologica Scandinavica. 30(1):7-9, 1986 Jan. Gronert GA. Ahern CP. Milde JH. White RD. Effect of CO2, calcium, digoxin, and potassium on cardiac and skeletal muscle metabolism in malignant hyperthermia susceptible swine. Anesthesiology. 64(1):24-8, 1986 Jan. Heiman-Patterson TD. Rosenberg HR. Binning CP. Tahmoush AJ. King-Denborough syndrome: contracture testing and literature review. Pediatric Neurology. 2(3):175-7, 1986 May-Jun. O'Brien PJ. Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium -release channel of skeletal muscle sarcoplasmic reticulum. Veterinary Research Communications. 11(6):527-59, 1987. Wergowske GL. Carmody TJ. Neuroleptic malignant syndrome. Ohio Medicine. 83(5):347, 350, 353 passim, 1987 May. Endo M. Malignant hyperthermia [Jpn] Masui - Japanese Journal of Anesthesiology. 36(12):1882-9, 1987 Dec. Byers DJ. Merin RG. Malignant hyperthermia in a renal transplant recipient. Anesthesiology. 67(6):979-81, 1987 Dec. McGrath CJ. Malignant hyperthermia. Seminars in Veterinary Medicine & Surgery. 1(3):238-44, 1986 Aug. Yeragani VK. Chaitin P. A prostaglandin theory of neuroleptic malignant syndrome. Medical Hypotheses. 24(2):143-9, 1987 Oct. Tomarken JL. Britt BA. Malignant hyperthermia. Annals of Emergency Medicine. 16(11):1253-65, 1987 Nov. Bidzi:nska E. Malignant neuroleptic syndrome [Pol] Psychiatria Polska. 20(6):483-8, 1986 Nov-Dec. McLeod ME. Creighton RE. Anesthesia for pediatric neurological and neuromuscular diseases. Journal of Child Neurology. 1(3):189-97, 1986 Jul. Galanter-Mosielski MM. Hardie J. Cattran CB. Malignant hyperthermia and the dental practitioner. Canadian Dental Association Journal - Journal De L Association Dentaire Canadienne. 53(4):295-6, 1987 Apr. Robertson GR. Malignant hyperthermia. Canadian Dental Association Journal - Journal De L Association Dentaire Canadienne. 53(1):33-5, 1987 Jan. Mauritz W. Sporn P. Steinbereithner K. Malignant hyperthermia in Austria. I. Epidemiology and clinical aspects [Ger] Anaesthesist. 35(11):639-50, 1986 Nov. Krivosic-Horber R. Gu:evart E. Adnet P. Theunynck D. Morelle G. Anesthesia in subjects sensitive to malignant hyperthermia [Fre] Cahiers D Anesthesiologie. 34(6):505-11, 1986 Oct. Haddad FS. Malignant hyperthermia--a clinical review. Middle East Journal of Anesthesiology. 8(6):469-85, 1986 Oct. Ward A. Chaffman MO. Sorkin EM. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs. 32(2):130-68, 1986 Aug. Arias P:erez J. Aller Reyero MA. Lorente Ruig:omez L. Dur:an Sacrist:an H. Malignant hyperthermia during heterotopic orthotopic liver transplantation (letter) [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 33(3):199 -200, 1986 May-Jun. Yacoub OF. Morrow DH. Malignant hyperthermia and ECT. American Journal of Psychiatry. 143(8):1027-9, 1986 Aug. Sessler DI. Malignant hyperthermia. Journal of Pediatrics. 109(1):9-14, 1986 Jul. Schulte-Sasse U. Eberlein HJ. New findings and experiences in the field of malignant hyperthermia [Ger] Anaesthesist. 35(1):1-9, 1986 Jan. Rampertaap MP. Neuroleptic malignant syndrome. Southern Medical Journal. 79(3):331-6, 1986 Mar. Richardson J. Propofol infusion for coronary artery bypass surgery in a patient with suspected malignant hyperpyrexia [letter] Anaesthesia. 42(10):1125, 1987 Oct. Landymore RW. Allen C. Johnstone D. Wood J. Malignant hyperthermia: a dilemma for the cardiac surgeon. Canadian Journal of Surgery. 30(3):209-11, 1987 May. Spiess-Kiefer C. Hippius H. Malignant neuroleptic syndrome and malignant hyperthermia--a comparison [Ger] Fortschritte Der Neurologie-Psychiatrie. 54(5):158-70, 1986 May. Warrington RD. Kochansky CY. Bach DE. Treatment of a patient susceptible to malignant hyperthermia. Clinical Preventive Dentistry. 8(1):27-9, 1986 Jan-Feb. Koransky JS. Creatine phosphokinase levels and isotretinoin therapy [letter] of the American Academy of Dermatology. 17(5 Pt 1):851 -2, 1987 Nov. Leung AK. Malignant hyperthermia in Chinese children [letter] Oral Surgery, Oral Medicine, Oral Pathology. 63(3):317, 1987 Mar. Jones JE. Dierdorf SF. Clapp DW. General anesthesia in a malignant hyperthermia susceptible patient. Journal of Oral Medicine. 42(1):22-4, 66, 1987 Jan-Mar. Milam SB. Intraoperative anesthetic complications. Dental Clinics of North America. 31(1):97-115, 1987 Jan. Cantin RY. Poole A. Ryan JF. Malignant hyperthermia. Oral Surgery, Oral Medicine, Oral Pathology. 62(4):389-92, 1986 Oct. Cherny I. Lopez JI. Schuman NJ. Dental treatment for a patient with Duchenne muscular dystrophy and malignant hyperthermia. General Dentistry. 34(4):299-300, 1986 Jul-Aug. Lauri A. Galli C. Palombaro G. Glorialanza E. Corbari M. Vincenti C. Marri M. Spinal anesthesia with hyperbaric bupivacaine in a patient known to be susceptible to malignant hyperthermia [Ita] Minerva Anestesiologica. 53(9):543-5, 1987 Sep. Klein W. Spiess-Kiefer C. K:uther G. Pongratz D. Lehmann-Horn F. Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test [Ger] Anaesthesist. 36(12):685-91, 1987 Dec. Sim AT. White MD. Denborough MA. Thiophosphorylation of skeletal muscle sarcoplasmic reticulum in porcine malignant hyperpyrexia. International Journal of Biochemistry. 19(12):1217-24, 1987. Sim AT. White MD. Denborough MA. The effect of oxytocin on porcine malignant hyperpyrexia susceptible skeletal muscle. Clinical & Experimental Pharmacology & Physiology. 14(7):605 -10, 1987 Jul. Thatte HS. Addis PB. Thomas DD. Bigelow DJ. Mickelson JR. Louis CF. Temperature-dependent abnormalities of the erythrocyte membrane in porcine malignant hyperthermia. Biochemical Medicine & Metabolic Biology. 38(3):366-77, 1987 Dec. Thatte HS. Mickelson JR. Addis PB. Louis CF. Erythrocyte membrane ATPase and calcium pumping activities in porcine malignant hyperthermia. Biochemical Medicine & Metabolic Biology. 38(3):355-65, 1987 Dec. Adityanjee. Role of electroconvulsive therapy in neuroleptic malignant syndrome (NMS) [letter] Acta Psychiatrica Scandinavica. 76(5):603-4, 1987 Nov. Lopez JR. Allen P. Alamo L. Ryan JF. Jones DE. Sreter F. Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine. Cell Calcium. 8(5):385-96, 1987 Oct. Sim AT. White MD. Denborough MA. Effects of adenylate cyclase activators on porcine skeletal muscle in malignant hyperpyrexia. British Journal of Anaesthesia. 59(12):1557-62, 1987 Dec. Krivosic-Horber R. Adnet P. Guevart E. Theunynck D. Lestavel P. Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests. British Journal of Anaesthesia. 59(12):1554-6, 1987 Dec. Schulte-Sasse U. A round-the-clock information service for malignant hyperthermia emergencies: regional exchange of central information (letter) [Ger] Anaesthesist. 36(11):668, 1987 Nov. Sim AT. White MD. Denborough MA. The effects of chlorbutol on skeletal muscle sarcoplasmic reticulum function in porcine malignant hyperpyrexia. International Journal of Biochemistry. 19(9):827-30, 1987. Collins SP. White MD. Denborough MA. The effects of calmodulin antagonist drugs on isolated sarcoplasmic reticulum from malignant hyperpyrexia susceptible swine. International Journal of Biochemistry. 19(9):819-26, 1987. Schulte-Sasse U. Eberlein HJ. "Round the clock"--an information service for malignant hyperthermia emergencies [Ger] Anasthesie, Intensivtherapie, Notfallmedizin. 22(5):249, 1987 Oct. Friedman AH. Succinylcholine: a depolarizing relaxant [letter] American Journal of Diseases of Children. 141(12):1254, 1987 Dec. Mickelson JR. Thatte HS. Beaudry TM. Gallant EM. Louis CF. Increased skeletal muscle acetylcholinesterase activity in porcine malignant hyperthermia. Muscle & Nerve. 10(8):723-7, 1987 Oct. Rogers KH. Rose DK. Byrick RJ. Severe hypercarbia with a Bain breathing circuit during malignant hyperthermia reaction [letter] Canadian Journal of Anaesthesia. 34(6):652-3, 1987 Nov. Frappat P. Pincemaille O. Plantaz D. Severe hyperthermia syndrome in the infant. Apropos of 11 cases [Fre] Pediatrie. 42(4):303-7, 1987. Thomas DW. Dev VJ. Whitehead MJ. Malignant hyperpyrexia and isoflurane. A case report. British Journal of Anaesthesia. 59(9):1196-8, 1987 Sep. Rosenberg H. Trismus is not trivial. Anesthesiology. 67(4):453-5, 1987 Oct. Adam H. Olthoff D. Adam H. R:ustow B. Kunze D. von Lengerken G. Schwalbe M. Changes in the content of membrane phospholipids of subcellular structures of skeletal muscle in halothane-induced malignant hyperthermia of the domestic pig [Ger] Anaesthesiologie Und Reanimation. 12(4):201-6, 1987. Jordan LM. Malignant hyperthermia. Todays Or-Nurse. 9(4):12-8, 1987 Apr. Klip A. Britt BA. Elliott ME. Pegg W. Frodis W. Scott E. Anaesthetic-induced increase in ionised calcium in blood mononuclear cells from malignant hyperthermia patients. Lancet. 1(8531):463-6, 1987 Feb 28. Seidman CB. Action stat: Malignant hyperthermia. Nursing. 16(9):33, 1986 Sep. Burden N. Emergency preparedness in the ambulatory setting: medical emergencies. Journal of Post Anesthesia Nursing. 1(2):132-6, 1986 May. Caine R. Molla K. Reynolds R. Malignant hyperthermia: a critical care challenge. Dimensions of Critical Care Nursing. 5(3):144-54, 1986 May -Jun. Greany D. Brown MM. Malignant hyperthermia--a concern for critical care nurses. Focus On Critical Care. 13(2):52-7, 1986 Apr. Parks Y. Sunderland R. Sudden febrile infant death [letter] Lancet. 1(8483):744-5, 1986 Mar 29. Rutberg H. H:akanson E. Hall GM. Jorfeldt L. Effects of graded exercise on leg exchange of energy substrates in malignant hyperthermia susceptible subjects. Anesthesiology. 67(3):308-13, 1987 Sep. Bailey AG. Bloch EC. Malignant hyperthermia in a three-month-old American Indian infant. Anesthesia & Analgesia. 66(10):1043-5, 1987 Oct. Kistler P. Fletcher JE. Rosenberg H. Erythrocyte fragility screening is not a tool for diagnosis of human malignant hyperthermia. Anesthesia & Analgesia. 66(10):1004-7, 1987 Oct. Ording H. Skovgaard LT. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium. Acta Anaesthesiologica Scandinavica. 31(5):462-5, 1987 Jul. Ording H. Skovgaard LT. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests. Acta Anaesthesiologica Scandinavica. 31(5):458-61, 1987 Jul. Urwyler A. Gerber H. Malignant hyperthermia: clinical aspects, diagnosis and practical procedures [Ger] Therapeutische Umschau. 44(7):559-63, 1987 Jul. Keilani MR. Hijazi HK. Malignant hyperthermia in Jordan. Middle East Journal of Anesthesiology. 9(2):169-83, 1987 Jun. Shuaib A. Paasuke RT. Brownell KW. Central core disease. Clinical features in 13 patients. Medicine. 66(5):389-96, 1987 Sep. Bo:icheva A. Mincheva-Saeva M. Velinov P. Gavrilova N. A rare case of malignant hyperthermia in infancy [Bul] Khirurgiia - Sofia. 40(3):88-9, 1987. Robinson LK. O'Brien NC. Puckett MC. Cox MA. Multiple pterygium syndrome: a case complicated by malignant hyperthermia. Clinical Genetics. 32(1):5-9, 1987 Jul. Schulte-Sasse U. Eberlein HJ. An "around-the-clock" information service for malignant hyperthermia emergencies [Ger] Chirurg. 58(5):365, 1987 May. Harrison GG. Morrell DF. Brain V. Jaros GG. Acute calcium homeostasis in MHS swine. Canadian Journal of Anaesthesia. 34(4):377-9, 1987 Jul. Tolpin EI. Fletcher JE. Rosenberg H. Michaux K. Effects of anaesthetic agents on erythrocyte fragility: comparison of normal and malignant hyperthermia susceptible patients. Canadian Journal of Anaesthesia. 34(4):366-72, 1987 Jul. Bamforth S. Hall JG. Neuroleptic malignant syndrome (NMS): what are the genetic factors? [letter] Canadian Journal of Psychiatry - Revue Canadienne De Psychiatrie. 32(4):331-2, 1987 May. Nelson TE. Flewellen EH. Belt MW. Kennamer DL. Winsett OE. Bee DE. Calcium and magnesium content of skeletal muscle. Studies in subjects undergoing diagnostic testing for malignant hyperthermia. British Journal of Anaesthesia. 59(6):730-4, 1987 Jun. Heiman-Patterson T. Fletcher JE. Rosenberg H. Tahmoush AJ. No relationship between fiber type and halothane contracture test results in malignant hyperthermia. Anesthesiology. 67(1):82-4, 1987 Jul. Caroff SN. Rosenberg H. Fletcher JE. Heiman-Patterson TD. Mann SC. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Anesthesiology. 67(1):20-5, 1987 Jul. Kalinowsky LB. Lethal catatonia and neuroleptic malignant syndrome [letter] American Journal of Psychiatry. 144(8):1106-7, 1987 Aug. Jantzen JP. Erdmann K. Kleemann PP. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique. Acta Anaesthesiologica Belgica. 38(1):107-13, 1987. Oikkonen M. Rosenberg PH. Bj:orkenheim JM. Paetau A. Huopaniemi T. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man. Acta Anaesthesiologica Scandinavica. 31(4):309-11, 1987 May. Merigian KS. Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. Journal of Toxicology - Clinical Toxicology. 25(1-2):135-48, 1987. Mora CT. Eisenkraft JB. Dantrolene prophylaxis and neuromuscular disorders [letter] Anesthesiology. 66(5):702-3, 1987 May. Nagarajan K. Fishbein WN. Muldoon SM. Pezeshkpour G. Calcium uptake in frozen muscle biopsy sections compared with other predictors of malignant hyperthermia susceptibility. Anesthesiology. 66(5):680-5, 1987 May. Klip A. Ramlal T. Walker D. Britt BA. Elliott ME. Selective increase in cytoplasmic calcium by anesthetic in lymphocytes from malignant hyperthermia-susceptible pigs. Anesthesia & Analgesia. 66(5):381-5, 1987 May. Lennmarken C. Rutberg H. Henriksson KG. Abnormal relaxation rates in subjects susceptible to malignant hyperthermia. Acta Neurologica Scandinavica. 75(2):81-3, 1987 Feb. Johannesson G. Veel T. Rogstadius J. Malignant hyperthermia during isoflurane anaesthesia. A case report. Acta Anaesthesiologica Scandinavica. 31(3):231-2, 1987 Apr. Collins SP. White MD. Denborough MA. Calmodulin in porcine malignant hyperpyrexia. International Journal of Biochemistry. 19(1):63-70, 1987. O'Brien PJ. Fletcher TF. Metz AL. Kurtz HJ. Reed BK. Rempel WE. Clark EG. Louis CF. Malignant hyperthermia susceptibility: cardiac histomorphometry of dogs and young and market-weight swine. Canadian Journal of Veterinary Research. 51(1):50-5, 1987 Jan. Gallant EM. Rempel WE. Porcine malignant hyperthermia: false negatives in the halothane test. American Journal of Veterinary Research. 48(3):488-91, 1987 Mar. Larach MG. Rosenberg H. Larach DR. Broennle AM. Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology. 66(4):547-50, 1987 Apr. Baines DB. Douglas ID. Overton JH. Anaesthesia for patients with arthrogryposis multiplex congenita: what is the risk of malignant hyperthermia?. Anaesthesia & Intensive Care. 14(4):370-2, 1986 Nov. Richter MA. Joffe RT. Use of tricyclic antidepressants in a patient with malignant hyperthermia [letter] American Journal of Psychiatry. 144(4):526, 1987 Apr. J:rgensen PF. Willeberg P. Jensen P. Hansen LL. Northeved A. Continuous monitoring of body temperature in pigs using non-invasive ear canal sensors. Acta Veterinaria Scandinavica. 27(3):456-60, 1986. Van Obbergh LJ. Crean PM. Malignant hyperthermia: routine monitoring and early detection. Acta Anaesthesiologica Belgica. 37(4):267-9, 1986. Green JH. Ellis FR. Halsall PJ. Campbell IT. Currie S. Caddy J. Thermoregulation, plasma catecholamine and metabolite levels during submaximal work in individuals susceptible to malignant hyperpyrexia. Acta Anaesthesiologica Scandinavica. 31(2):122-6, 1987 Feb. Edge KR. Brown S. Isaacs H. Masseter spasm as the presenting feature of malignant hyperpyrexia syndrome. A case report. South African Journal of Surgery. 25(1):37-8, 1987 Mar. Condrescu M. L:opez JR. Medina P. Alamo L. Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia. Muscle & Nerve. 10(3):238-41, 1987 Mar-Apr. L:opez JR. Medina P. Alamo L. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia. Muscle & Nerve. 10(1):77-9, 1987 Jan. Marruecos Sant L. Cabezas Canelos I. Mu~noz Casadevall J. Escolano Vill:en F. Hyperthermia and rhabdomyolysis caused by a monoamine oxidase inhibitor (letter) [Spa] Medicina Clinica. 88(7):301, 1987 Feb 21. Nelson TE. Flewellen EH. Belt MW. Kennamer DL. Winsett OE. Comparison of Ca++ uptake and spontaneous Ca++ release from sarcoplasmic reticulum vesicles isolated from muscle of malignant hyperthermia diagnostic patients. Journal of Pharmacology & Experimental Therapeutics. 240(3):785-8, 1987 Mar. Murray JB. Neuroleptic malignant syndrome. Journal of General Psychology. 114(1):39-46, 1987 Jan. Schulte-Sasse V. Eberlein HJ. Information service for malignant hyperthermia emergencies (letter) [Ger] Deutsche Medizinische Wochenschrift. 112(15):614, 1987 Apr 10. Ranklev E. Fletcher R. Anaesthetic management of the malignant hyperthermia susceptible parturient [letter] Canadian Journal of Anaesthesia. 34(1):106, 1987 Jan. Klip A. Britt BA. Elliott ME. Walker D. Ramlal T. Pegg W. Changes in cytoplasmic free calcium caused by halothane. Role of the plasma membrane and intracellular Ca2+ stores. Biochemistry & Cell Biology. 64(11):1181-9, 1986 Nov. Kozak-Reiss G. Gascard JP. Redouane-B:enichou K. Detection of peranesthetic malignant hyperthermia by muscle contracture tests and NMR spectroscopy [Fre] Annales Francaises D Anesthesie Et De Reanimation. 5(6):584-9, 1986. Hein HA. Roewer N. Jantzen JP. Malignant hyperthermia: are we really prepared? [letter] Anesthesiology. 66(3):448-9, 1987 Mar. Weingarten AE. Korsh JI. Neuman GG. Stern SB. Postpartum uterine atony after intravenous dantrolene. Anesthesia & Analgesia. 66(3):269-70, 1987 Mar. Pl:otz J. Postoperative hyperthermic syndrome with a questionable relationship to malignant hyperthermia and the need for elucidating susceptibility [Ger] Anaesthesist. 35(12):751-4, 1986 Dec. Schulte-Sasse U. Eberlein HJ. What significance is undefined malignant hyperthermia-sensitivity for the doctor and patient? [Ger] Anaesthesist. 35(12):705-7, 1986 Dec. Ranklev E. Henriksson KG. Fletcher R. Germundsson K. Oldfors A. Kalimo H. Clinical and muscle biopsy findings in malignant hyperthermia susceptibility. Acta Neurologica Scandinavica. 74(6):452-9, 1986 Dec. Buitrago PM. D:iaz de Ter:an JC. Ramos JF. Sota M. Villanueva MA. Results of a national survey on malignant hyperthermia (letter) [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 33(6):460, 1986 Nov-Dec. P:erez del Palomar Chavarri R. Go~ni Belzunegui A. Domingo Cuevas I. Mandibular spasm and malignant hyperthermia [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 33(6):440-2, 1986 Nov-Dec. Lagarde P. Reis J. Hemmendinger S. Cazenave JP. Warter JM. Singer L. Is the neuroleptic malignant syndrome comparable to anesthesia-induced malignant hyperthermia? (letter) [Fre] Presse Medicale - Paris. 15(29):1376-7, 1986 Sep 13. Wang JJ. Lee JC. Tzeng JI. Chan JH. Liu SE. Lee TY. Hyperkalemia induced by succinylcholine injection in woman with metabolic acidosis [Chi] Ma Tsui Hsueh Tsa Chi. 24(4):290-6, 1986 Dec. Hein HA. Jantzen JP. Roewer N. Sudden death: is there a human stress syndrome? [letter] Jama. 257(10):1328-9, 1987 Mar 13. Pinsky L. Birth defects and predisposition to malignant hyperthermia [letter] of Pediatrics. 110(3):494, 1987 Mar. Addonizio G. Susman VL. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Journal of Clinical Psychiatry. 48(3):102-5, 1987 Mar. Ohnishi ST. Effects of halothane, caffeine, dantrolene and tetracaine on the calcium permeability of skeletal sarcoplasmic reticulum of malignant hyperthermic pigs. Biochimica Et Biophysica Acta. 897(2):261-8, 1987 Feb 26. Gravenstein MA. Lydon JC. Uttech K. Mini-spike dispensing pin--an efficient way to prepare dantrolene [letter] Anesthesiology. 66(2):254, 1987 Feb. Rubin AS. Zablocki AD. Hyperkalemia, verapamil, and dantrolene. Anesthesiology. 66(2):246-9, 1987 Feb. Steenson AJ. Torkelson RD. King's syndrome with malignant hyperthermia. Potential outpatient risks. American Journal of Diseases of Children. 141(3):271-3, 1987 Mar. Ranklev E. Fletcher R. Investigation of malignant hyperthermia in Sweden. Acta Anaesthesiologica Scandinavica. 30(8):693-6, 1986 Nov. Gielen M. Viering W. 3-in-1 lumbar plexus block for muscle biopsy in malignant hyperthermia patients. Amide local anaesthetics may be used safely. Acta Anaesthesiologica Scandinavica. 30(7):581-3, 1986 Oct. Adnet P. Krivosic-Horber R. Guevart E. Theunynck D. Vincent A. Experimental study of dantrolene sodium in anesthetic malignant hyperthermia in the pietrain-strain pig [Fre] Cahiers D Anesthesiologie. 34(6):463-7, 1986 Oct. McDonell WN. Seeler DC. Basrur PK. Evaluation of a commercial creatine kinase screening test for malignant hyperthermia (porcine stress syndrome). Canadian Journal of Veterinary Research. 50(4):494-501, 1986 Oct. Fletcher JE. Rosenberg H. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients. British Journal of Anaesthesia. 58(12):1433-9, 1986 Dec. Peterson DR. Davis N. Sudden infant death syndrome and malignant hyperthermia diathesis. Australian Paediatric Journal. 22 Suppl 1:33-5, 1986. Verburg MP. Britt BA. Oerlemans FT. Scott B. van Egmond J. De Bruijn CH. Comparison of metabolites in skeletal muscle biopsies from normal humans and those susceptible to malignant hyperthermia. Anesthesiology. 65(6):654-7, 1986 Dec. Sold M. Tsch:op M. S:orensen N. Symptoms of acute cerebral hernia following induction of anesthesia in hydrocephalus--malignant hyperthermia in reality [Ger] Anaesthesist. 35(10):634-8, 1986 Oct. Loghmanee F. Tobak M. Fatal malignant hyperthermia associated with recreational cocaine and ethanol abuse. American Journal of Forensic Medicine & Pathology. 7(3):246-8, 1986 Sep. Marckmann P. A case of fatal non-rigid malignant hyperthermia [Dan] Ugeskrift For Laeger. 148(44):2839-40, 1986 Oct 27. Wuis EW. Driessen JJ. Evers J. Vree TB. van der Kleyn E. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case. European Journal of Anaesthesiology. 3(3):219-23, 1986 May. Sethna NF. Rockoff MA. Cardiac arrest following inhalation induction of anaesthesia in a child with Duchenne's muscular dystrophy. Canadian Anaesthetists Society Journal. 33(6):799-802, 1986 Nov. Mickelson JR. Ross JA. Reed BK. Louis CF. Enhanced Ca2+-induced calcium release by isolated sarcoplasmic reticulum vesicles from malignant hyperthermia susceptible pig muscle. Biochimica Et Biophysica Acta. 862(2):318-28, 1986 Nov 17. Krivosic-Horber R. Theunynck D. Krivosic I. Adnet P. Gu:evart E. Examination of the family of a patient susceptible to anesthetic malignant hyperthermia (published erratum appears in Ann Fr Anesth Reanim 1986;5(5):558) [Fre] Annales Francaises D Anesthesie Et De Reanimation. 5(3):326-9, 1986. Oehmichen M. Pedal I. Schmidt V. Schlote W. Form variants of globular hyaline microthrombi. Light microscopy, immunohistochemical and scanning and transmission electron microscopy observations [Ger] Zeitschrift Fur Rechtsmedizin - Journal of Legal Medicine. 97(1):29-40, 1986. Ingall TJ. Tennant C. Neuroleptic malignant syndrome. Medical Journal of Australia. 145(9):454-5, 1986 Nov 3. Lekas MD. Weissburg A. Padre-Mendoza T. Surgery on patients with malignant hyperthermia. Ear, Nose, & Throat Journal. 65(9):38-44, 1986 Sep. Schiffner H. Heckemann R. Schnabel P. Malignant hyperthermia following halothane anesthesia for more than 3 hours [Ger] Anaesthesiologie Und Reanimation. 11(4):215-20, 1986. Farag HM. Naguib M. Gyasi H. Ibrahim AW. Anesthesia for a patient with eosinophilic myositis. Anesthesia & Analgesia. 65(8):903-4, 1986 Aug. Morrell DF. Harrison GG. The screening of atracurium in MHS swine. British Journal of Anaesthesia. 58(4):444-6, 1986 Apr. Allen GC. Vecuronium and malignant hyperthermia [letter] Anesthesia & Analgesia. 65(2):212, 1986 Feb. Watson CB. Reierson N. Norfleet EA. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia. Anesthesiology. 65(3):312-4, 1986 Sep. Britt BA. Scott EA. Kleiman A. Jones P. Steward DJ. Failure of the tourniquet-twitch test as a diagnostic or screening test for malignant hyperthermia. Anesthesia & Analgesia. 65(10):1047-50, 1986 Oct. Ellis FR. Halsall PJ. Harriman DG. The work of the Leeds Malignant Hyperpyrexia Unit, 1971-84. Anaesthesia. 41(8):809-15, 1986 Aug. Vane LA. Braz JR. Ganem EM. Malignant hyperthermia [Por] Revista Paulista De Medicina. 104(1):51-4, 1986 Jan-Feb. O'Brien PJ. Porcine malignant hyperthermia susceptibility: increased calcium -sequestering activity of skeletal muscle sarcoplasmic reticulum. Canadian Journal of Veterinary Research. 50(3):329-37, 1986 Jul. O'Brien PJ. Porcine malignant hyperthermia susceptibility: hypersensitive calcium -release mechanism of skeletal muscle sarcoplasmic reticulum. Canadian Journal of Veterinary Research. 50(3):318-28, 1986 Jul. D'Allaire S. DeRoth L. Physiological responses to treadmill exercise and ambient temperature in normal and malignant hyperthermia susceptible pigs. Canadian Journal of Veterinary Research. 50(1):78-83, 1986 Jan. MacGillivray RG. Jann H. Vanker E. Gemmell L. Mahomedy AE. Development of malignant hyperthermia obscured by cardiopulmonary bypass. Canadian Anaesthetists Society Journal. 33(4):509-14, 1986 Jul. Wang JM. Stanley TH. Duchenne muscular dystrophy and malignant hyperthermia--two case reports. Canadian Anaesthetists Society Journal. 33(4):492-7, 1986 Jul. Greene ER Jr. Malignant hyperthermia: removal of volatile anesthetic agents from the breathing circuit using activated charcoal [letter] Anesthesiology. 65(2):240-1, 1986 Aug. Jensen AG. Bach V. Werner MU. Nielsen HK. Jensen MH. A fatal case of malignant hyperthermia following isoflurane anaesthesia. Acta Anaesthesiologica Scandinavica. 30(4):293-4, 1986 May. Rutberg H. H:akanson E. Malignant hyperthermia: clinical course and metabolic changes in two patients. Acta Anaesthesiologica Scandinavica. 30(3):211-4, 1986 Apr. Skoog SJ. Belman AB. Anesthetic induction trismus, more than a closed-mouth problem. Journal of Urology. 136(3):686-7, 1986 Sep. Shaenboen MJ. Finkel PH. Malignant hyperthermia: review of the syndrome with report of a case. Journal of the American Osteopathic Association. 86(6):383-9, 1986 Jun. Stieglitz P. Malignant hyperthermia in France [Fre] Annales Francaises D Anesthesie Et De Reanimation. 5(2):96-9, 1986. Kancir CB. Carpopedal spasm during anesthesia with halothane: malignant hyperthermia or tetany? [Fre] Annales Francaises D Anesthesie Et De Reanimation. 5(2):170-2, 1986. Solomons CC. Platelets and malignant hyperthermia [letter] Anesthesiology. 65(1):100-1, 1986 Jul. Rose DJ. Malignant hyperpyrexia susceptibility and childbirth [letter] Anaesthesia. 41(6):668, 1986 Jun. Viering WA. Sengers RC. Stadhouders AM. Gielen MJ. Festen C. Malignant hyperthermia: case-finding of subjects at risk [Dut] Nederlands Tijdschrift Voor Geneeskunde. 130(22):1002-4, 1986 May 31. Allen PD. Ryan JF. Jones DE. Mabuchi K. Virga A. Roberts J. Sreter F. Sarcoplasmic reticulum calcium uptake in cryostat sections of skeletal muscle from malignant hyperthermia patients and controls [letter] Muscle & Nerve. 9(5):474-5, 1986 Jun. Lewis GW. Cattran C. Malignant hyperthermia: choice of anaesthesia for muscle biopsy [letter] Canadian Anaesthetists Society Journal. 33(3 Pt 1):419-20, 1986 May. Douglas MJ. McMorland GH. The anaesthetic management of the malignant hyperthermia susceptible parturient. Canadian Anaesthetists Society Journal. 33(3 Pt 1):371-8, 1986 May. Ohnishi ST. Waring AJ. Fang SR. Horiuchi K. Flick JL. Sadanaga KK. Ohnishi T. Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs. Archives of Biochemistry & Biophysics. 247(2):294-301, 1986 Jun. Whistler T. Isaacs H. Badenhorst M. No abnormal low molecular weight proteins identified in human malignant hyperthermic muscle. Anesthesiology. 64(6):795-7, 1986 Jun. Popp M. Seeling W. Malignant hyperthermia in a 41-year-old woman [Ger] Anaesthesist. 35(3):203-5, 1986 Mar. Iwatsuki N. Shiratori T. Fudeta H. Shiozawa S. Amaha K. Contracture response to isoflurane and pentazocine in muscles of a patient with malignant hyperthermia [Jpn] Masui - Japanese Journal of Anesthesiology. 35(3):468-72, 1986 Mar. Flewellen EH. Serum creatine kinase screening for susceptibility to malignant hyperthermia [letter] Jama. 255(24):3363-4, 1986 Jun 27. Williams CH. Malignant hyperthermia [letter] Jama. 255(24):3362-3, 1986 Jun 27. Ward RJ. Eisele JW. Reay DT. Horton WG. Hemolysis and hyperkalemia complicate malignant hyperpyrexia during anesthetic death. Journal of Forensic Sciences. 31(2):543-5, 1986 Apr. Ranklev E. Fletcher R. Blomquist S. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility. British Journal of Anaesthesia. 58(6):646-8, 1986 Jun. Tera Bueno G. Llaurad:o Paz G. Riesgo Benito MJ. Anesthesia in the pig for different types of experimental surgery. Incidence of malignant hyperthermia [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 33(1):1-3, 1986 Jan-Feb. Sudo RT. Souza MR. Zapata G. Suarez-Kurtz G. Halothane-cooling contractures of mammalian muscles. Journal of Pharmacology & Experimental Therapeutics. 237(2):600-7, 1986 May. Merry SN. Werry JS. Merry AF. Birchall N. The neuroleptic malignant syndrome in an adolescent. Journal of the American Academy of Child Psychiatry. 25(2):284 -6, 1986 Mar. Quinlan JG. Iaizzo PA. Gronert GA. Taylor SR. Use of dantrolene plus multiple pulses to detect stress-susceptible porcine muscle. Journal of Applied Physiology. 60(4):1313-20, 1986 Apr. Brownell AK. Paasuke RT. Use of local anesthetics in malignant hyperthermia [editorial] Canadian Medical Association Journal. 134(9):993-4, 1986 May 1. Paasuke RT. Brownell AK. Amide local anaesthetics and malignant hyperthermia [editorial] Canadian Anaesthetists Society Journal. 33(2):126-9, 1986 Mar. Braude BM. Press P. Moyes DG. Isaacs H. Danilewitz MD. Kolb ME. Unexpected hyperthermia manifesting during outpatient anesthesia. Anesthesiology. 64(5):647-50, 1986 May. Walsh MP. Brownell AK. Littmann V. Paasuke RT. Electrophoresis of muscle proteins is not a method for diagnosis of malignant hyperthermia susceptibility. Anesthesiology. 64(4):473-9, 1986 Apr. Thiagarajah S. Management of an unsuspected case of malignant hyperpyrexia. Middle East Journal of Anesthesiology. 8(4):269-75, 1986 Feb. Galloway GJ. Denborough MA. Suxamethonium chloride and malignant hyperpyrexia. British Journal of Anaesthesia. 58(4):447-50, 1986 Apr. Souliere CR Jr. Weintraub SJ. Kirchner JC. Markedly delayed postoperative malignant hyperthermia. Archives of Otolaryngology -- Head & Neck Surgery. 112(5):564 -6, 1986 May. Crider B. Nightingale P. Hill AB. Intraoperative hyperpyrexia--keep an open mind [letter] Anesthesiology. 64(3):413, 1986 Mar. Mora CT. Eisenkraft JB. Papatestas AE. Intravenous dantrolene in a patient with myasthenia gravis. Anesthesiology. 64(3):371-3, 1986 Mar. Gallant EM. Fletcher TF. Goettl VM. Rempel WE. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies [published erratum appears in Muscle Nerve 1986 Sep;9(7):648-9] Muscle & Nerve. 9(2):174-84, 1986 Feb. Lopez JR. Alamo LA. Jones DE. Papp L. Allen PD. Gergely J. Sr:eter FA. Ca2+]i in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+ selective microelectrodes [letter. Muscle & Nerve. 9(1):85-6, 1986 Jan. Suarez-Kurtz G. Sudo RT. The temperature dependence of halothane-induced contractures of skeletal muscle. Muscle & Nerve. 9(1):47-50, 1986 Jan. Moore DC. Ester or amide local anesthetics in malignant hyperthermia--who knows? [letter] Anesthesiology. 64(2):294-6, 1986 Feb. Anonymous. Improper diagnostic test may account for high incidence of malignant hyperthermia associated with masseter spasm [letter] Anesthesiology. 64(2):291-3, 1986 Feb. Ellis FR. Halsall PJ. Susceptibility to malignant hyperpyrexia [letter] Anaesthesia. 41(1):85-6, 1986 Jan. Paasuke RT. Brownell AK. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. Jama. 255(6):769-71, 1986 Feb 14. Merz B. Defect of intracellular calcium channels is culprit in malignant hyperthermia [news] Jama. 255(6):710-1, 1986 Feb 14. Merz B. Malignant hyperthermia: nightmare for anesthesiologists--and patients [news] Jama. 255(6):709-11, 714-5, 1986 Feb 14. Sipio JC. Bellinger MF. Malignant hyperthermia and pediatric urology. Journal of Urology. 135(3):583-5, 1986 Mar. Reid WH. Discussion of "Fatal malignant hyperthermia as a result of ingestion of tranylcypromine (Parnate) combined with white wine and cheese" [letter] of Forensic Sciences. 31(1):8-10, 1986 Jan. Koo JY. Chien CP. Coma following ECT and intravenous droperidol: case report. Journal of Clinical Psychiatry. 47(2):94-5, 1986 Feb. Kawamoto M. Yuge O. Kikuchi H. Kodama K. Morio M. No myocardial involvement in nonrigid malignant hyperthermia. Anesthesiology. 64(1):93-4, 1986 Jan. Peterson DR. Davis N. Malignant hyperthermia diathesis and sudden infant death syndrome [letter] Anesthesia & Analgesia. 65(2):209, 1986 Feb. Britt BA. Scott EA. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia. Anesthesia & Analgesia. 65(2):171-5, 1986 Feb. Rosenberg H. Fletcher JE. Masseter muscle rigidity and malignant hyperthermia susceptibility. Anesthesia & Analgesia. 65(2):161-4, 1986 Feb. Addonizio G. Susman V. Neuroleptic malignant syndrome and use of anesthetic agents [letter] American Journal of Psychiatry. 143(1):127-8, 1986 Jan. Lascault G. Waxman MB. Grosgogeat Y. In vitro electrophysiological effects of sodium dantrolene on isolated preparations of Purkinje fibers and ventricular myocardium of sheep [Fre] Archives Des Maladies Du Coeur Et Des Vaisseaux. 78(13):1961 -7, 1985 Dec. Krivosic-Horber R. Theunynck D. Adnet P. Capnography and anesthetic-induced malignant hyperthermia [Fre] Agressologie. 26(11):929-32, 1985 Nov. Vatashsky A. Udassin R. Capnography in general anesthesia [Heb] Harefuah. 109(10):283-8, 1985 Nov 15. Ording H. Hald A. Sj:ntoft E. Malignant hyperthermia triggered by heating in anaesthetized pigs. Acta Anaesthesiologica Scandinavica. 29(7):698-701, 1985 Oct. Rosenberg H. Malignant hyperthermia. Hospital Practice (office Edition). 20(3):139, 144-5, 148 passim, 1985 Mar 15. Radwan HE. Juneja M. Joseph M. Malignant hyperthermia in a Saudi child. Middle East Journal of Anesthesiology. 8(2):157-64, 1985 Jun. Dunn CM. Maltry DE. Eggers GW Jr. Value of mass spectrometry in early diagnosis of malignant hyperthermia [letter] Anesthesiology. 63(3):333, 1985 Sep. Biscardi HM. Muldoon SM. Condon BF. Diagnosis of malignant hyperthermia: implications for the military. Military Medicine. 150(6):293-6, 1985 Jun. Neubauer KR. Kaufman RD. Another use for mass spectrometry: detection and monitoring of malignant hyperthermia. Anesthesia & Analgesia. 64(8):837-9, 1985 Aug. Uhr:in V. Bulla J. Kul:i:skov:a L. Polt:arsky J. Muscle fibers of pigs sensitive to halothane and resistant to it [Slo] Veterinarni Medicina. 30(4):217-30, 1985 Apr. Buzello W. Williams CH. Chandra P. Watkins ML. Dozier SE. Vecuronium and porcine malignant hyperthermia. Anesthesia & Analgesia. 64(5):515-9, 1985 May. Niebr:oj-Dobosz I. Kwiatkowski H. Mayzner-Zawadzka E. Experimental porcine malignant hyperthermia: macromolecular characterization of muscle plasma membranes. Medical Biology. 62(4):250-4, 1984. Baudendistel L. Goudsouzian N. Cote' C. Strafford M. End-tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia. Anaesthesia. 39(10):1000-3, 1984 Oct. Denborough MA. Collins SP. Hopkinson KC. Rhabdomyolysis and malignant hyperpyrexia. British Medical Journal - Clinical Research. 288(6434):1878, 1984 Jun 23. Pazdera J. Siler R. Hruban V. Cepica S. Possibilities and risks of determining susceptibility to malignant hyperthermia [Cze] Veterinarni Medicina. 28(12):745-52, 1983 Dec. Anonymous. Fatal heat stroke in a long distance runner [letter] British Medical Journal - Clinical Research. 287(6404):1548-9, 1983 Nov 19. Pazdera J. Hruban V. Hor:ak V. Anundi H. Malignant hyperthermia [Cze] Veterinarni Medicina. 28(6):375-80, 1983. Pazdera J. Hradeck:y J. Cvejn J. Zich V. Changes in reactivity to halothane after administration of mephenytoin [Cze] Veterinarni Medicina. 28(5):269-72, 1983. L'ahu:ck:y R. Fischer K. Augustini C. Biochemical and biophysical indicators in muscle biopsies (m. longissimus dorsi) in relation to the halothane and creatine kinase test in pigs [Slo] Veterinarni Medicina. 28(4):223-9, 1983. Rutberg H. Henriksson KG. Jorfeldt L. Larsson J. M:artensson J. Schildt B. Metabolic changes in a case of malignant hyperthermia. British Journal of Anaesthesia. 55(5):461-7, 1983 May. Harriman DG. Ellis FR. Sudden infant death syndrome--a possible cause [letter] British Medical Journal - Clinical Research. 286(6362):391, 1983 Jan 29. Antel JP. Arnason BG. Genetic predisposition to environmental factors. Research Publications - Association For Research In Nervous & Mental Disease. 60:255-71, 1983. Archibald AL. Imlah P. The halothane sensitivity locus and its linkage relationships. Animal Blood Groups & Biochemical Genetics. 16(4):253-63, 1985. Gullotta F. Recent diagnostic and pathogenetic aspects of neuromuscular diseases [Ita] Pathologica. 77(1048):121-31, 1985 Mar-Apr. Campos Su:arez JM. Escolano Vill:en F. Catal:a Puigb:o E. Villar Landeira JM. Sanz Maz:o M. Sodium dantrolene [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 32(4):179 -83, 1985 Jul-Aug. Campos Su:arez JM. Escolano Vill:en F. Catal:a Puigb:o E. Villar Landeira JM. Malignant hyperthermia [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 32(4):169 -78, 1985 Jul-Aug. Gibb WR. Lees AJ. The neuroleptic malignant syndrome--a review. Quarterly Journal of Medicine. 56(220):421-9, 1985 Aug. Levenson JL. Neuroleptic malignant syndrome. American Journal of Psychiatry. 142(10):1137-45, 1985 Oct. Jenkins LC. Scoates PJ. Anaesthetic implications of calcium channel blockers. Canadian Anaesthetists Society Journal. 32(4):436-47, 1985 Jul. Mendez HM. Opitz JM. Noonan syndrome: a review. American Journal of Medical Genetics. 21(3):493-506, 1985 Jul. Guz:e BH. Baxter LR Jr. Current concepts. Neuroleptic malignant syndrome. New England Journal of Medicine. 313(3):163-6, 1985 Jul 18. Mehta MP. Gergis SD. Sokoll MD. Anesthesia and neuromuscular diseases. Middle East Journal of Anesthesiology. 8(1):49-63, 1985 Feb. Cheah KS. Cheah AM. Malignant hyperthermia: molecular defects in membrane permeability. Experientia. 41(5):656-61, 1985 May 15. Stromberg BV. Complications in plastic surgical anesthesia. Clinics In Plastic Surgery. 12(1):91-5, 1985 Jan. Nalda MA. Gonz:alez-Machado JL. Malignant hyperthermia [Spa] Medicina Clinica. 84(2):74-7, 1985 Jan 19. Azar I. The response of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology. 61(2):173-87, 1984 Aug. Aquaron R. Role of intracellular free calcium in malignant hyperthermia [Fre] Therapie. 39(1):29-37, 1984 Jan-Feb. Stumpf DA. Mitochondrial disorders. Rinsho Shinkeigaku - Clinical Neurology. 23(12):1046-55, 1983 Dec. Willner J. Malignant hyperthermia. Pediatric Annals. 13(2):128, 130, 132-4, 1984 Feb. Duncan GH. Moore P. Nitrous oxide and the dental patient: a review of adverse reactions. Journal of the American Dental Association. 108(2):213-9, 1984 Feb. Reuther C. Brandes B. Incidence of hyperthermia during immobilization of European otters (Lutra lutra) with ketamine hydrochloride [Ger] Dtw - Deutsche Tierarztliche Wochenschrift. 91(2):66-8, 1984 Feb 7. Mori K. Shingu K. Malignant hyperthermia, syndrome malin, and heat stroke [Jpn] Nippon Rinsho - Japanese Journal of Clinical Medicine. 41(9):2167-84, 1983 Sep. Britt BA. Dantrolene. Canadian Anaesthetists Society Journal. 31(1):61-75, 1984 Jan. Marmor M. Malignant hyperthermia. Survey of Ophthalmology. 28(2):117-27, 1983 Sep-Oct. Gallant EM. Ahern CP. Malignant hyperthermia: responses of skeletal muscles to general anesthetics. Mayo Clinic Proceedings. 58(11):758-63, 1983 Nov. Blanck TJ. Gruener RP. Malignant hyperthermia. Biochemical Pharmacology. 32(15):2287-9, 1983 Aug 1. Schulte-Sasse U. Eberlein HJ. Malignant hyperthermia [Ger] Anaesthesist. 32(4):141-57, 1983 Apr. Nelson TE. Flewellen EH. Current concepts. The malignant hyperthermia syndrome. New England Journal of Medicine. 309(7):416-8, 1983 Aug 18. Byrd JP. Malignant hyperthermia. Southern Medical Journal. 76(7):890-3, 1983 Jul. Viby-Mogensen J. Cholinesterase and succinylcholine. Danish Medical Bulletin. 30(3):129-50, 1983 May. Marjanen LA. Shaw DC. Denborough MA. Comparison of adenylate kinase from normal and malignant hyperpyrexic porcine muscle. Biochemical Medicine. 29(2):164-70, 1983 Apr. Tejwani GA. Regulation of fructose-bisphosphatase activity. Advances In Enzymology & Related Areas of Molecular Biology. 54:121-94, 1983. Rodgers IR. Malignant hyperthermia: a review of the literature. Mount Sinai Journal of Medicine. 50(1):95-8, 1983 Jan-Feb. Pollock RA. Britt BA. Malignant hyperthermia in the head and neck surgery patient: an update and review. Laryngoscope. 93(3):318-25, 1983 Mar. Kripke BJ. Blanck TJ. Sizemore DA. Comunale FL. Christiansen J. Gruener R. Association of post-anaesthetic hyperthermia with abnormal muscle characteristics: a case report. Canadian Anaesthetists Society Journal. 30(3 Pt 1):290-4, 1983 May. Grinberg R. Edelist G. Gordon A. Postoperative malignant hyperthermia episodes in patients who received "safe" anaesthetics. Canadian Anaesthetists Society Journal. 30(3 Pt 1):273-6, 1983 May. Taiclet L. Malignant hyperthermia. Anesthesia Progress. 32(4):140-2, 1985 Jul-Aug. Waite PD. Ballard JB. Yonfa A. Malignant hyperthermia in a patient receiving nitrous oxide. Journal of Oral & Maxillofacial Surgery. 43(11):907-9, 1985 Nov. Runciman WB. Malignant hyperthermia. Recognition, prevention and management. Dental Anaesthesia & Sedation. 13(2):54-8, 1984 Nov. Barba MW. Post AC. Duncan WK. Dental treatment of a malignant hyperthermia-susceptible child. Pediatric Dentistry. 7(1):61-5, 1985 Mar. Ahmad I. Fox GC. Zeig NJ. Bodner A. Malignant hyperthermia. Journal of the Medical Society of New Jersey. 82(4):303-5, 1985 Apr. Burger BW. Malsch E. Mayer BW. Masseter contracture and tachycardia causing termination of anesthesia. Anesthesia Progress. 31(6):257-62, 1984 Nov-Dec. Precious DS. McFadden LR. Landry PE. Apyretic malignant hyperthermia. Apropos of a case [Fre] Revue De Stomatologie Et De Chirurgie Maxillo-Faciale. 85(6):488-92, 1984. Scheitler LE. Getzendanner L. Gussack GS. O'Neill BH. Siemer KM. Malignant hyperthermia during oral surgery. Anesthesia Progress. 31(4):170-4, 1984 Jul-Aug. Papasova S. Kostov P. The problem of malignant hyperthermia [Bul] Stomatologiia - Sofia. 65(3):48-50, 1983 May-Jun. Simmons PS. Smithson WA. Gronert GA. Haymond MW. Acute myelogenous leukemia and malignant hyperthermia in a patient with type 1b glycogen storage disease. Journal of Pediatrics. 105(3):428-31, 1984 Sep. Davidson DB. Myall RW. Malignant hyperthermia: dental treatment of patients at risk. Special Care In Dentistry. 4(2):81-3, 1984 Mar-Apr. Adriani J. Sundin R. Malignant hyperthermia in dental patients. Journal of the American Dental Association. 108(2):180-4, 1984 Feb. Keltner NL. McIntyre CW. Neuroleptic malignant syndrome. Journal of Neurosurgical Nursing. 17(6):362-6, 1985 Dec. Lloyd EL. Scott DH. Cooling technique for malignant hyperthermia [letter] Lancet. 2(8446):97, 1985 Jul 13. Anonymous. Drug reactions during anaesthesia [editorial] Lancet. 1(8439):1195-6, 1985 May 25. Mavity CB. OR crisis. Malignant hyperthermia. Todays Or-Nurse. 7(1):8-11, 1985 Jan. Rogers AL. Sturgeon CL Jr. Malignant hyperthermia. A peroperative emergency. Aorn Journal. 41(2):369-74, 1985 Feb. Anonymous. Home study program. Malignant hyperthermia. Aorn Journal. 41(2):368-79, 1985 Feb. Rasore-Quartino A. De Bellis P. Bertamino F. Rovei S. Atypical form of malignant hyperthermia. Observation of a case caused by ketamine [Ita] Pathologica. 77(1052):609-17, 1985 Nov-Dec. Driessen JJ. Wuis EW. Gielen MJ. Prolonged vecuronium neuromuscular blockade in a patient receiving orally administered dantrolene. Anesthesiology. 62(4):523-4, 1985 Apr. Michel PA. Fronefield HP. Use of atracurium in a patient susceptible to malignant hyperthermia [letter] Anesthesiology. 62(2):213, 1985 Feb. Liskow BI. Relationship between neuroleptic malignant syndrome and malignant hyperthermia [letter] American Journal of Psychiatry. 142(3):390, 1985 Mar. Condrescu M. L:opez JR. Alamo L. Medina P. Ca2+ transport and (Ca2+ - Mg2+) ATPase activity in vesicles of the sarcoplasmic reticulum of patients susceptible to malignant hyperthermia syndrome [Spa] Acta Cientifica Venezolana. 36(5-6):407-8, 1985. Villani A. De Cosmo G. Primieri P. Bosco M. Beccia FM. Rhabdomyolysis in general anesthesia: clinical contribution [Ita] Minerva Anestesiologica. 51(11-12):571-4, 1985 Nov-Dec. Gahne B. Juneja RK. Prediction of the halothane (Hal) genotypes of pigs by deducing Hal, Phi, Po2, Pgd haplotypes of parents and offspring: results from a large-scale practice in Swedish breeds. Animal Blood Groups & Biochemical Genetics. 16(4):265-83, 1985. Fishbein WN. Muldoon SM. Deuster PA. Armbrustmacher VW. Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?. Biochemical Medicine. 34(3):344-54, 1985 Dec. L:opez JR. Alamo LA. Jones D. Papp L. Allen P. Gergely J. Streter F. Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome [Spa] Acta Cientifica Venezolana. 36(1):102-4, 1985. Call L. Garc:ia M. Ib:a~nez E. Llaberia J. Malignant hyperthermia in a patient undergoing tonsillectomy [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 32(6):312-4, 1985 Nov-Dec. Williams CH. Dozier SE. Buzello W. Gehrke CW. Wong JK. Gerhardt KO. Plasma levels of norepinephrine and epinephrine during malignant hyperthermia in susceptible pigs. Journal of Chromatography. 344:71-80, 1985 Nov 8. Solera J. Rallo B. Malignant hyperthermia (letter) [Spa] Medicina Clinica. 85(10):431-2, 1985 Oct 5. Grimault P. Bethoux JP. Meunier A. Girard-Longhini C. Malignant hyperthermia caused by anesthetics. Apropos of a case [Fre] Chirurgie. 111(3):265-72, 1985. Britt BA. Malignant hyperthermia. Canadian Anaesthetists Society Journal. 32(6):666-78, 1985 Nov. Jantzen JP. Hackett GH. Ellermeyer W. Giesecke AH. Malignant hyperthermia: successful management of a probable case. Texas Medicine. 81(11):37-42, 1985 Nov. Ahern CP. Milde JH. Gronert GA. Electrical stimulation triggers porcine malignant hyperthermia. Research In Veterinary Science. 39(2):257-8, 1985 Sep. Greil R. Gattringer C. Abbrederis K. Rhabdomyolysis as a late complication of anesthesia--a case of malignant hyperthermia? [Ger] Wiener Klinische Wochenschrift. 97(21):813-6, 1985 Nov 8. Anonymous. Neuroleptic malignant syndrome [letter] New England Journal of Medicine. 313(20):1292-3, 1985 Nov 14. Riedesel DH. Hildebrand SV. Unusual response following use of succinylcholine in a horse anesthetized with halothane. Journal of the American Veterinary Medical Association. 187(5):507-8, 1985 Sep 1. Smith CL. Bush GH. Anaesthesia and progressive muscular dystrophy. British Journal of Anaesthesia. 57(11):1113-8, 1985 Nov. Kiwitt A. Pingel E. A case of malignant hyperthermia in operative obstetrics [Ger] Zentralblatt Fur Gynakologie. 107(15):966-9, 1985. Ziegan JB. Weigel B. Salomon FV. Pathological myophosphorylase reaction in malignant hyperthermia [Ger] Zeitschrift Fur Rechtsmedizin - Journal of Legal Medicine. 94(4):289-99, 1985. Escolano Vill:en F. Aguilar S:anchez JL. Castrillo Ferrando A. Beser Gasc:on P. Sabat:e Pes A. Campos Su:arez JM. Villar Landeira JM. Malignant hyperthermia caused by neuroleptics [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 32(4):189 -91, 1985 Jul-Aug. de Pascual Mettler I. Borrego Dionis AM. Gonz:alez Machado JL. An original technic for the preparation of an injectable solution of sodium dantrolene from oral capsules (Dantralen) or from the pure substance [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 32(4):166-8, 1985 Jul-Aug. Gonz:alez Machado JL. Malignant hyperthermia: a severe anesthesia complication (editorial) [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 32(4):139, 1985 Jul-Aug. Yamamato S. Yoshimura R. Tatsumi Y. The liver and disseminated intravascular coagulation [Jpn] Rinsho Byori - Japanese Journal of Clinical Pathology. Spec No 63:126-33, 1985 Jun. Kousseff BG. Nichols P. A new autosomal recessive syndrome with Noonan-like phenotype, myopathy with congenital contractures and malignant hyperthermia. Birth Defects Original Article Series. 21(2):111-7, 1985. Ilias WK. Williams CH. Fulfer RT. Dozier SE. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro. British Journal of Anaesthesia. 57(10):994-6, 1985 Oct. Ranklev E. Monti M. Fletcher R. Microcalorimetric studies in malignant hyperpyrexia susceptible individuals. British Journal of Anaesthesia. 57(10):991-3, 1985 Oct. Ayling JH. Ellis FR. Halsall PJ. Currie S. Thermoregulatory responses to cooling in patients susceptible to malignant hyperpyrexia. British Journal of Anaesthesia. 57(10):983-90, 1985 Oct. Anonymous. Laboratory diagnosis of malignant hyperpyrexia susceptibility (MHS). European MH Group [letter] British Journal of Anaesthesia. 57(10):1038, 1985 Oct. Rinaldi M. Damato R. Losito R. Marzocco P. Spina A. Tartarino A. Suspected case of malignant hyperthermia of sporadic onset [Ita] Minerva Pediatrica. 37(9):361-4, 1985 May 15. Noda B. Higa K. Naitoh H. Dan K. A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium [Jpn] Masui - Japanese Journal of Anesthesiology. 34(6):822-7, 1985 Jun. Berman AT. Garbarino JL. Rosenberg H. Heiman-Patterson T. Bosacco SJ. Weiss AA. Muscle biopsy: proper surgical technique. Clinical Orthopaedics & Related Research. (198):240-3, 1985 Sep. O'Brien PJ. Rooney MT. Reik TR. Thatte HS. Rempel WE. Addis PB. Louis CF. Porcine malignant hyperthermia susceptibility: erythrocytic osmotic fragility. American Journal of Veterinary Research. 46(7):1451-6, 1985 Jul. Lee MB. Adragna MG. Edwards L. The use of a platelet nucleotide assay as a possible diagnostic test for malignant hyperthermia [published erratum appears in Anesthesiology 1986 Mar;64(3):405] Anesthesiology. 63(3):311-5, 1985 Sep. Fletcher JE. Rosenberg H. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity. Anesthesiology. 63(2):190-4, 1985 Aug. Moxon MA. Malignant hyperthermia--or not?. Anaesthesia. 40(7):693-5, 1985 Jul. Ranklev E. Fletcher R. Krantz P. Malignant hyperpyrexia and sudden death. American Journal of Forensic Medicine & Pathology. 6(2):149 -50, 1985 Jun. Boutros AR. Intraoperative anesthetic consultation. Urologic Clinics of North America. 12(3):541-8, 1985 Aug. Smith BE. Anesthetic emergencies. Clinical Obstetrics & Gynecology. 28(2):391-404, 1985 Jun. Campbell IT. Exercise, cyclic AMP and malignant hyperpyrexia susceptibility [letter] British Journal of Anaesthesia. 57(8):837-8, 1985 Aug. Jacquot C. Alibeu JP. Gelas P. Stieglitz P. Temporary registration of cases of peranesthetic malignant hyperthermia in France [Fre] Annales Francaises D Anesthesie Et De Reanimation. 4(3):318 -20, 1985. Baumgarten RK. Reynolds WJ. Early detection of malignant hyperthermia [letter] Anesthesiology. 63(1):123, 1985 Jul. Ording H. Incidence of malignant hyperthermia in Denmark. Anesthesia & Analgesia. 64(7):700-4, 1985 Jul. Kaplan RF. Kellner KR. More on malignant hyperthermia during delivery [letter] American Journal of Obstetrics & Gynecology. 152(5):608-9, 1985 Jul 1. Jardon OM. Heat stroke, stress, and malignant hyperthermia. Nebraska Medical Journal. 70(6):195-9, 1985 Jun. Keilani MR. Al-Shanableh JS. Verapamil and malignant hyperthermia--case reports. Middle East Journal of Anesthesiology. 8(1):37-45, 1985 Feb. Baraka A. Calcium channel blockers cardiovascular versus skeletal muscles. Middle East Journal of Anesthesiology. 8(1):27-35, 1985 Feb. Britt BA. Malignant hyperthermia. Canadian Anaesthetists Society Journal. 32(3 Pt 2):S40-1, 1985 May. Lee DS. Adams JP. Zimmerman JE. Malignant hyperthermia: a possible new variant. Canadian Anaesthetists Society Journal. 32(3 Pt 1):268-71, 1985 May. Duncan PG. Availability of dantrolene in Canadian hospitals [editorial] Canadian Anaesthetists Society Journal. 32(3 Pt 1):205-9, 1985 May. Fletcher JE. Rosenberg H. Low molecular weight proteins in human malignant hyperthermia muscle [letter] Anesthesiology. 62(6):849-50, 1985 Jun. Gallant EM. Foldes FF. Rempel WE. Gronert GA. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia. Anesthesia & Analgesia. 64(6):601-6, 1985 Jun. Faust DK. Malignant hyperthermia. Alaska Medicine. 27(1):1-2, 1985 Jan-Mar. Castilla Cort:azar A. Alonso Alonso JJ. Aguirre Errasti C. Malignant syndrome caused by neuroleptics. Rapid response to biperiden in a case of brief development (letter) [Spa] Medicina Clinica. 84(14):588, 1985 Apr 13. Ehler WJ. Mack JW Jr. Brown DL. Davis RF. Avoidance of malignant hyperthermia in a porcine model for experimental open heart surgery. Laboratory Animal Science. 35(2):172-5, 1985 Apr. Scholtes JL. Gribomont BF. Anesthesiologic management of the patient threatened by malignant hyperthermia [Fre] Cahiers D Anesthesiologie. 33(2):159-60, 1985 Mar. Berkowitz A. Rosenberg H. Femoral block with mepivacaine for muscle biopsy in malignant hyperthermia patients. Anesthesiology. 62(5):651-2, 1985 May. Gumpenberger H. Atypical course of malignant hyperthermia [Ger] Anaesthesist. 34(3):134-6, 1985 Mar. Renfordt E. Wardin B. Electroconvulsive and dantrolene treatment of acute febrile catatonia. A case report [Ger] Nervenarzt. 56(3):153-6, 1985 Mar. Fried AB. Potter GK. Malignant hyperthermia and local anesthesia. Journal of the American Podiatric Medical Association. 75(4):184-91, 1985 Apr. Lowe MK. Malignant hyperthermia, a surgeon's nightmare. Journal of Foot Surgery. 24(2):139-41, 1985 Mar-Apr. Kimura H. Yoshida K. Ohsawa M. Arai T. Tsujimura T. An autopsy case of malignant hyperthermia. Forensic Science International. 27(1):25-30, 1985 Jan. Martin ML. Lucid EJ. Walker RW. Neuroleptic malignant syndrome. Annals of Emergency Medicine. 14(4):354-8, 1985 Apr. Suresh MS. Nelson TE. Malignant hyperthermia: is etomidate safe?. Anesthesia & Analgesia. 64(4):420-4, 1985 Apr. Mirchandani H. Reich LE. Fatal malignant hyperthermia as a result of ingestion of tranylcypromine (Parnate) combined with white wine and cheese. Journal of Forensic Sciences. 30(1):217-20, 1985 Jan. Schulte-Sasse U. Komar K. Eberlein HJ. Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia [Ger] Deutsche Medizinische Wochenschrift. 110(12):457-61, 1985 Mar 22. VanDerSpek AF. Wilton N. Suxamethonium spasm [letter] British Journal of Anaesthesia. 57(3):353-4, 1985 Mar. O'Brien PJ. Rand JS. Canine stress syndrome [letter] of the American Veterinary Medical Association. 186(5):432-3, 1985 Mar 1. Wang RT. Aftergood DE. Carlson HE. Hypercalcemia in the neuroleptic malignant syndrome. Archives of Internal Medicine. 145(1):143-4, 1985 Jan. Rosenberg H. Fletcher JE. More about masseter spasm and malignant hyperthermia [letter] Anesthesiology. 62(2):212, 1985 Feb. Fig`a-Talamanca L. Gualandi C. Di Meo L. Di Battista G. Neri G. Lo Russo F. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology. 35(2):258-61, 1985 Feb. Adragna MG. Medical protocol by habit--the avoidance of amide local anesthetics in malignant hyperthermia susceptible patients [letter] Anesthesiology. 62(1):99-100, 1985 Jan. French MM. Phillips KF. When seconds count: treating malignant hyperthermia. Rn. 47(11):26-31, 74, 1984 Nov. Mulrooney L. Anaesthetic and post-anaesthetic recovery nursing. Malignant hyperpyrexia --a killer. Natnews. 21(7):suppl 6-9, 1984 Jul. Okamura M. Nagatomo R. Countermeasures and nursing care in malignant hyperthermia during the operation [Jpn] Kango Gijutsu - Japanese Journal of Nursing Art. 30(4):464-9, 1984 Mar. Takagi Y. Preoperative checklist to prevent anesthetic complications [Jpn] Kango Gijutsu - Japanese Journal of Nursing Art. 30(4):441-4, 1984 Mar. Wolfe RD. Foster WS. Malignant hyperthermia. Kentucky Nurse. 31(6):10, 31, 1983 Nov-Dec. Fuerst DL. Toth AJ Jr. Dantrolene sodium and management of malignant hyperthermia. Aana Journal. 51(4):406-10, 1983 Aug. Eng GD. Becker MJ. Muldoon SM. Electrodiagnostic tests in the detection of malignant hyperthermia. Muscle & Nerve. 7(8):618-25, 1984 Oct. O'Brien PJ. Forsyth GW. Olexson DW. Thatte HS. Addis PB. Canine malignant hyperthermia susceptibility: erythrocytic defects- -osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis. Canadian Journal of Comparative Medicine. 48(4):381-9, 1984 Oct. Sunohara N. Takagi A. Nonaka I. Sugita H. Satoyoshi E. Idiopathic hyperCKemia. Neurology. 34(4):544-7, 1984 Apr. Olson KR. Benowitz NL. Environmental and drug-induced hyperthermia. Pathophysiology, recognition, and management. Emergency Medicine Clinics of North America. 2(3):459-74, 1984 Aug. Kiel JL. Erwin DN. Thermochemiluminescent assay of porcine, rat, and human erythrocytes for antioxidative deficiencies. Analytical Biochemistry. 143(2):231-6, 1984 Dec. V:ogeli P. Stranzinger G. Schneebeli H. Hagger C. K:unzi N. Gerwig C. Relationships between the H and A-O blood types, phosphohexose isomerase and 6-phosphogluconate dehydrogenase red cell enzyme systems and halothane sensitivity, and economic traits in a superior and an inferior selection line of swiss landrace pigs. Journal of Animal Science. 59(6):1440-50, 1984 Dec. Eliet B. Carmes C. Rochet D. Eustratiades N. Quesnel J. Malignant hyperthermia [Fre] Cahiers D Anesthesiologie. 32(5):387-9, 1984 Sep. Sunohara N. Takagi A. Nonaka I. Tomi H. Satoyoshi E. Scoliosis and malignant hyperthermia [Jpn] Rinsho Shinkeigaku - Clinical Neurology. 24(11):1149-54, 1984 Nov. Gibbs JM. Unexplained hyperpyrexia during labour [letter] Anaesthesia & Intensive Care. 12(4):375, 1984 Nov. Nagase M. Naganuma Y. Ryo K. Sato N. Kawashima Y. Treatment of malignant hyperthermia by dantrolene sodium administered through a nasogastric tube [Jpn] Masui - Japanese Journal of Anesthesiology. 33(9):1021-6, 1984 Sep. Kirmayer AH. Klide AM. Purvance JE. Malignant hyperthermia in a dog: case report and review of the syndrome. Journal of the American Veterinary Medical Association. 185(9):978-82, 1984 Nov 1. Marjanen LA. Collins SP. Denborough MA. Calmodulin and malignant hyperpyrexia. Biochemical Medicine. 32(2):283-7, 1984 Oct. Ellis FR. Malignant hyperpyrexia. Archives of Disease In Childhood. 59(11):1013-5, 1984 Nov. Schwartz L. Rockoff MA. Koka BV. Masseter spasm with anesthesia: incidence and implications. Anesthesiology. 61(6):772-5, 1984 Dec. Alvarez Escudero J. Gilsanz Rodr:iguez F. Cienfuegos Alvarez J. Malignant hyperthermia in pigs (letter) [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 31(5):211, 1984 Sep-Oct. Gen:is Batlle D. Rubio Goday M. Gonz:alez L:opez JL. Mac:ia Martorell R. Alvarez Villuendas A. Sala Montero J. Amado Tob:ia JB. Malignant syndrome caused by neuroleptics. A case produced by loxapine (letter) [Spa] Medicina Clinica. 83(10):432-3, 1984 Oct 6. Iwatsuki N. Koga Y. Amaha K. Contracture responses of the muscle from a patient with malignant hyperthermia to drugs [Jpn] Masui - Japanese Journal of Anesthesiology. 33(7):731-6, 1984 Jul. Di Prospero S. Bianchi S. Di Lazzaro M. Camilli-Giammei T. Malignant hyperthermia: biochemico-metabolic aspects and personal experiences [Ita] Clinica Terapeutica. 110(6):549-53, 1984 Sep 30. Rampton AJ. Kelly DA. Shanahan EC. Ingram GS. Occurrence of malignant hyperpyrexia in a patient with osteogenesis imperfecta. British Journal of Anaesthesia. 56(12):1443-6, 1984 Dec. Nakazato A. Shime H. Morooka K. Nonaka I. Takagi A. Anesthesia-induced rhabdomyolysis in a patient with Fukuyama-type congenital muscular dystrophy [Jpn] No To Hattatsu. 16(5):386-92, 1984 Sep. McGrath CJ. Lee JC. Rempel WE. Halothane testing for malignant hyperthermia in swine: dose-response effects. American Journal of Veterinary Research. 45(9):1734-6, 1984 Sep. Blanck TJ. Fisher YI. Thompson M. Muldoon S. Low molecular weight proteins in human malignant hyperthermic muscle. Anesthesiology. 61(5):589-92, 1984 Nov. Anonymous. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. British Journal of Anaesthesia. 56(11):1267-9, 1984 Nov. Stanec A. Stefano G. Cyclic AMP in normal and malignant hyperpyrexia susceptible individuals following exercise. British Journal of Anaesthesia. 56(11):1243-6, 1984 Nov. Ording H. Ranklev E. Fletcher R. Investigation of malignant hyperthermia in Denmark and Sweden. British Journal of Anaesthesia. 56(11):1183-90, 1984 Nov. Ellis FR. European Malignant Hyperpyrexia Group [editorial] British Journal of Anaesthesia. 56(11):1181-2, 1984 Nov. Pohlann R. Schemel D. Lyhs L. Malignant hyperthermia in halothane-sensitive swine following maximal neuromotor stress [Ger] Archiv Fur Experimentelle Veterinarmedizin. 38(3):302-10, 1984 May. Flewellen EH. Nelson TE. Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia [letter] Anesthesiology. 61(4):477, 1984 Oct. Cupryn JP. Kennedy A. Byrick RJ. Malignant hyperthermia in pregnancy. American Journal of Obstetrics & Gynecology. 150(3):327-8, 1984 Oct 1. Feil G. Elevated creatine kinase activity (letter) [Ger] Deutsche Medizinische Wochenschrift. 109(38):1462, 1984 Sep 21. Marjanen LA. Denborough MA. Electrophoretic analysis of proteins in malignant hyperpyrexia susceptible skeletal muscle. International Journal of Biochemistry. 16(8):919-29, 1984. Kim DH. Sreter FA. Ohnishi ST. Ryan JF. Roberts J. Allen PD. Meszaros LG. Antoniu B. Ikemoto N. Kinetic studies of Ca2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles. Biochimica Et Biophysica Acta. 775(3):320-7, 1984 Sep 5. Badgwell JM. Heavner JE. Masseter spasm heralds malignant hyperthermia--current dilemma or merely academia gone mad [letter] Anesthesiology. 61(2):230-1, 1984 Aug. Castot A. Simons J. De Gialluly E. Muzard O. Lagier G. Efthymiou ML. Fournier E. 2 cases of intra-anesthetic malignant hyperthermia with fatal outcome. Is prevention possible? [Fre] Therapie. 39(3):311-7, 1984 May-Jun. Kotsuka Y. Furuse A. Teruya M. Asano K. Cardiopulmonary bypass in the treatment of malignant hyperthermia [Jpn] Kyobu Geka - Japanese Journal of Thoracic Surgery. 37(4):286 -91, 1984 Apr. Wingard DW. Diagnosis of malignant hyperthermia [letter] Canadian Anaesthetists Society Journal. 31(4):490, 1984 Jul. Fletcher JE. Rosenberg H. Hilf M. Effects of midazolam on directly stimulated muscle biopsies from control and malignant hyperthermia positive patients. Canadian Anaesthetists Society Journal. 31(4):377-81, 1984 Jul. Armen R. Kanel G. Reynolds T. Phencyclidine-induced malignant hyperthermia causing submassive liver necrosis. American Journal of Medicine. 77(1):167-72, 1984 Jul. Mulchanova V. Beneva T. Stoianova S. Saev S. Velinov P. Malignant hyperthermia with report of a case [Bul] Khirurgiia - Sofia. 37(2):93-6, 1984. Heffron JJ. Mitochondrial and plasma membrane changes in skeletal muscle in the malignant hyperthermia syndrome. Biochemical Society Transactions. 12(3):360-2, 1984 Jun. Cheah KS. Skeletal-muscle mitochondria and phospholipase A2 in malignant hyperthermia. Biochemical Society Transactions. 12(3):358-60, 1984 Jun. Ellis FR. Halsall PJ. Allam P. Hay E. A biochemical abnormality found in muscle from unstressed malignant -hyperpyrexia-susceptible humans. Biochemical Society Transactions. 12(3):357-8, 1984 Jun. Ellis FR. Richards ID. Malignant hyperpyrexia: A role for the community physician. Community Medicine. 6(2):136-9, 1984 May. McGrath CJ. Lee JC. Rempel WE. Noneffectiveness of verapamil in preventing halothane-induced malignant hyperthermia in susceptible swine. American Journal of Veterinary Research. 45(5):935-7, 1984 May. Younker D. DeVore M. Hartlage P. Malignant hyperthermia and glucose-6-phosphate dehydrogenase deficiency. Anesthesiology. 60(6):601-3, 1984 Jun. Flewellen EH. Nelson TE. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?. Anesthesia & Analgesia. 63(7):693-7, 1984 Jul. Solomons CC. Masson NC. Platelet model for halothane-induced effects on nucleotide metabolism applied to malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 28(2):185-90, 1984 Apr. Cardan E. Balogh A. Cucuianu M. A case of malignant hyperthermia [Rum] Revista De Chirurgie, Oncologie Radiologie Orl Oftalmologie Stomatologie - Chirurgie. 33(1):77-80, 1984 Jan-Feb. Galloway GJ. Denborough MA. Phosphorus-31 nuclear magnetic resonance studies of muscle metabolism in malignant hyperpyrexia [letter] British Journal of Anaesthesia. 56(6):663-4, 1984 Jun. Verburg MP. Van Bennekom CA. Oerlemans FT. De Bruyn CH. Malignant hyperthermia: adenine incorporation and adenine metabolism in human platelets, influenced by halothane. Advances In Experimental Medicine & Biology. 165 Pt B:443-6, 1984. Alarc:on Zurita A. Piz:a Bu~nola C. Morey Molina A. Marco Franco JE. Bestard Palmer J. Mas D:egano J. Acute renal failure in a patient anesthetized with halothane [Spa] Revista Clinica Espanola. 172(2):115-6, 1984 Jan 31. White MD. Denborough MA. Dantrolene and calcium uptake by the sarcoplasmic reticulum of malignant hyperpyrexia-susceptible pigs. General Pharmacology. 15(2):129-32, 1984. Ellis FR. Halsall PJ. Suxamethonium spasm. A differential diagnostic conundrum. British Journal of Anaesthesia. 56(4):381-4, 1984 Apr. Watson CB. Norfleet EA. An effective way to disseminate protocols for managing malignant hyperthermia [letter] Anesthesiology. 60(5):510-1, 1984 May. Ruitenbeek W. Verburg MP. Janssen AJ. Stadhouders AM. Sengers RC. In vivo induced malignant hyperthermia in pigs. II. Metabolism of skeletal muscle mitochondria. Acta Anaesthesiologica Scandinavica. 28(1):9-13, 1984 Feb. Stadhouders AM. Viering WA. Verburg MP. Ruitenbeek W. Sengers RC. In vivo induced malignant hyperthermia in pigs. III. Localization of calcium in skeletal muscle mitochondria by means of electronmicroscopy and microprobe analysis. Acta Anaesthesiologica Scandinavica. 28(1):14-26, 1984 Feb. Verburg MP. Oerlemans FT. van Bennekom CA. Gielen MJ. de Bruyn CH. Crul JF. In vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium. Acta Anaesthesiologica Scandinavica. 28(1):1-8, 1984 Feb. Rowland LP. Myoglobinuria, 1984. Canadian Journal of Neurological Sciences. 11(1):1-13, 1984 Feb. Britt BA. Scott E. Frodis W. Clements MJ. Endrenyi L. Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle. Canadian Anaesthetists Society Journal. 31(2):130-54, 1984 Mar. Cabanac M. Malignant hyperthermia or heat stroke? (letter) [Fre] Presse Medicale - Paris. 13(8):506, 1984 Feb 25. Nelson TE. Dantrolene does not block calcium pulse-induced calcium release from a putative calcium channel in sarcoplasmic reticulum from malignant hyperthermia and normal pig muscle. Febs Letters. 167(1):123-30, 1984 Feb 13. Solomons CC. Masson N. Malignant hyperthermia: platelet bioassay [letter] Anesthesiology. 60(3):265-6, 1984 Mar. Ruhland G. Hinkle AJ. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia. Anesthesiology. 60(2):159-60, 1984 Feb. Murphy AL. Conlay L. Ryan JF. Roberts JT. Malignant hyperthermia during a prolonged anesthetic for reattachment of a limb. Anesthesiology. 60(2):149-50, 1984 Feb. Rosenberg H. Gronert GA. Postoperative malignant hyperthermia [letter] Canadian Anaesthetists Society Journal. 31(1):115-6, 1984 Jan. Gronert GA. Susceptibility to malignant hyperthermia [letter] Anesthesia & Analgesia. 63(1):91-2, 1984 Jan. Willner J. Phosphorylase activity and malignant hyperthermia [letter] Anesthesia & Analgesia. 63(1):88-9, 1984 Jan. Anonymous. Malignant hyperthermia [letter] New England Journal of Medicine. 310(3):200-1, 1984 Jan 19. Bruton NH. Maree SM. A case approach: the pathophysiology of thyroid storm. Aana Journal. 51(3):295-301, 303, 1983 Jun. Skarpa M. Dayan AD. Follenfant M. James DA. Moore WB. Thomson PM. Lucke JN. Morgan M. Lovell R. Medd R. Toxicity testing of atracurium. British Journal of Anaesthesia. 55 Suppl 1:27S-29S, 1983. Rowland LP. Molecular genetics, pseudogenetics, and clinical neurology. The Robert Wartenberg Lecture. Neurology. 33(9):1179-95, 1983 Sep. Mar:in Ruiz R. Zepeda J. Malignant hyperthermia. Report of a case [Spa] Ginecologia Y Obstetricia De Mexico. 51(317):241-4, 1983 Sep. Kawai H. Imai K. Masuda K. Nishino H. Fujimoto H. Yoshida Y. Saito S. Miyoshi K. Antigenicities of human myoglobin in various tissues and sera in various disorders, and of myoglobin in animals: results by radioimmunoassay system. Tokushima Journal of Experimental Medicine. 30(3-4):79-84, 1983 Dec. J:rgensen PF. Malignant hyperthermia in pigs modified by low-potassium diets. Acta Veterinaria Scandinavica. 24(4):512-4, 1983. Cherfas MD. Sokolov EIa. Shchukovski:i VV. Kulagina GA. Agadzhanov VA. Malignant hyperthermia syndrome during repeated surgery [Rus] Anesteziologiia I Reanimatologiia. (6):56-8, 1983 Nov-Dec. Bora VM. Polazhinets MN. Shelepets TM. Malignant hyperthermia during fluothane anesthesia [Rus] Klinicheskaia Khirurgiia. (12):46, 1983 Dec. Minciu E. Marcovici H. Zolog A. The fever syndrome in neurologic pathology [Rum] Revista De Medicina-Interna, Neurologie, Psihiatrie, Neurochirurgie, Dermato-Venerologie - Neurologie, Psihiatrie, Neurochirurgie. 28(4):265-8, 1983 Oct-Dec. Hildebrand SV. Howitt GA. Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane. American Journal of Veterinary Research. 44(12):2280-4, 1983 Dec. Wagner W. Feldmann E. Malignant hyperthermia - therapy results with dantrolene. A case report [Ger] Anasthesie, Intensivtherapie, Notfallmedizin. 18(5):270-1, 1983 Oct. Heraut LA. Poujol C. Bouche P. Fardeau M. Cathala HP. Effort-induced malignant hyperthermia. Electromyographic anomalies with a myogenic component. 10 cases [Fre] Presse Medicale - Paris. 12(43):2737-40, 1983 Nov 26. Payne JP. Anaesthetic deaths. British Journal of Hospital Medicine. 30(6):411-4, 1983 Dec. Gerrard JM. Duncan PG. Koshyk SA. Glover SM. McCrea JM. Halothane stimulates the aggregation of platelets of both normal individuals and those susceptible to malignant hyperthermia. British Journal of Anaesthesia. 55(12):1249-57, 1983 Dec. Cooper JM. Jones HR. Williamson JW. Treatment of malignant hyperthermia with dantrolene. Journal of the Mississippi State Medical Association. 24(10):259-61, 1983 Oct. Madani SA. Madani MS. Malignant hyperthermia: a case report and general overview of an anesthesia emergency. Delaware Medical Journal. 55(10):567-70, 575-6, 1983 Oct. Sullivan JS. Galloway GJ. Denborough MA. The effect of the calcium ion antagonist 8-(N,N-diethylamino)-octyl-3,4,5 -trimethoxybenzoate on malignant hyperpyrexia-susceptible porcine skeletal muscle. Clinical & Experimental Pharmacology & Physiology. 10(5):587 -93, 1983 Sep-Oct. Seeler DC. McDonell WN. Basrur PK. Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. Canadian Journal of Comparative Medicine. 47(3):284-90, 1983 Jul. Schulte-Sasse U. Hess W. Eberlein HJ. Postoperative malignant hyperthermia and dantrolene therapy. Canadian Anaesthetists Society Journal. 30(6):635-40, 1983 Nov. Cardan E. Hyperthermia [letter] Anaesthesia. 38(11):1106-7, 1983 Nov. Campbell IT. Ellis FR. Evans RT. Mortimer MG. Studies of body temperatures, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiologica Scandinavica. 27(5):349-55, 1983 Oct. Basrur PK. Frombach S. McDonell WN. Platelet morphology and membrane bound calcium in porcine stress syndrome. Scanning Electron Microscopy. (Pt 1):209-14, 1983. Takagi A. Sunohara N. Ishihara T. Nonaka I. Sugita H. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers. Muscle & Nerve. 6(7):510-4, 1983 Sep. Haber J. Hammer DJ. Butler B. Malignant hyperthermia. A review and case report. Journal of the American Podiatry Association. 73(8):422-6, 1983 Aug. Rosenberg H. Heiman-Patterson T. Duchenne's muscular dystrophy and malignant hyperthermia: another warning [letter] Anesthesiology. 59(4):362, 1983 Oct. Flewellen EH. Nelson TE. Jones WP. Arens JF. Wagner DL. Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology. 59(4):275-80, 1983 Oct. Gronert GA. Controversies in malignant hyperthermia [editorial] Anesthesiology. 59(4):273-4, 1983 Oct. Iwatsuki N. Koga Y. Amaha K. Enflurane induces contracture of in vitro muscle from a patient with malignant hyperthermia. Tohoku Journal of Experimental Medicine. 140(2):221-2, 1983 Jun. Alitalo I. Schulman A. Halothane induced porcine malignant hyperthermia reversed by dantrolene. Nordisk Veterinaermedicin. 35(5-6):239-42, 1983 May-Jun. Nelson TE. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. Journal of Clinical Investigation. 72(3):862-70, 1983 Sep. Ohnishi ST. Taylor S. Gronert GA. Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene. Febs Letters. 161(1):103-7, 1983 Sep 5. White MD. Collins JG. Denborough MA. The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs. Biochemical Journal. 212(2):399-405, 1983 May 15. Stevens JJ. A case of thyrotoxic crisis that mimicked malignant hyperthermia [letter] Anesthesiology. 59(3):263, 1983 Sep. Iwatsuki N. Koga Y. Amaha K. Calcium channel blocker for treatment of malignant hyperthermia [letter] Anesthesia & Analgesia. 62(9):861-2, 1983 Sep. Pl:otz J. Malignant hyperthermia. III. Progress report on serum CK activity, questionable screening test, effect of dantrolene in family members with a hereditary disposition [Ger] Anaesthesist. 32(4):158-64, 1983 Apr. Halsall PJ. Ellis FR. The control of muscle contracture by the action of dantrolene on the sarcolemma. Acta Anaesthesiologica Scandinavica. 27(3):229-32, 1983 Jun. Bosman J. Proceedings of case conferences at the Johannesburg Hospital. Malignant hyperthermia. South African Journal of Surgery. 21(1):67-9, 1983 Mar. Oku S. Liew CC. Britt BA. Analysis of sarcoplasmic reticulum proteins in patients susceptible to malignant hyperthermia. Journal of the Neurological Sciences. 60(1):127-35, 1983 Jul. Manley SV. Kelly AB. Hodgson D. Malignant hyperthermia-like reactions in three anesthetized horses. Journal of the American Veterinary Medical Association. 183(1):85-9, 1983 Jul 1. Hall GM. Lucke JN. Porcine malignant hyperthermia. IX: Changes in the concentrations of intramuscular high-energy phosphates, glycogen and glycolytic intermediates. British Journal of Anaesthesia. 55(7):635-40, 1983 Jul. Schneider V. Bratzke H. Malignant hyperthermia following an old gunshot head injury [Ger] Zeitschrift Fur Rechtsmedizin - Journal of Legal Medicine. 90(1):71-80, 1983. Nelson TE. Flewellen EH. Arnett DW. Prolonged electromechanical coupling time intervals in skeletal muscle of pigs susceptible to malignant hyperthermia. Muscle & Nerve. 6(4):263-8, 1983 May. Matsubara I. Sumiya T. Yoshimura T. Yamazaki R. Kubota M. Goto Y. Atypical malignant hyperthermia [Jpn] Masui - Japanese Journal of Anesthesiology. 32(3):339-42, 1983 Mar. Lucke J. Hall G. Thermogenesis in stress-susceptible pigs: a review. Journal of the Royal Society of Medicine. 76(6):514-7, 1983 Jun. Amaranath L. Lavin TJ. Trusso RA. Boutros AR. Evaluation of creatinine phosphokinase screening as a predictor of malignant hyperthermia. A prospective study. British Journal of Anaesthesia. 55(6):531-3, 1983 Jun. Khalil SN. Williams JP. Bourke DL. Management of a malignant hyperthermia susceptible patient in labor with 2-chloroprocaine epidural anesthesia. Anesthesia & Analgesia. 62(1):119-21, 1983 Jan. Flewellen EH. Nelson TE. Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?. Anesthesia & Analgesia. 62(1):115-8, 1983 Jan. Johnson GC. Santos AB. More on ECT and malignant hyperthermia [letter] American Journal of Psychiatry. 140(2):266-7, 1983 Feb. Kelfer HM. Singer WD. Reynolds RN. Malignant hyperthermia in a child with Duchenne muscular dystrophy. Pediatrics. 71(1):118-9, 1983 Jan. Henderson VW. Questions about dantrolene for neuroleptic malignant syndrome [letter] American Journal of Psychiatry. 140(1):137-9, 1983 Jan. Wingard DW. Malignant hyperthermia [letter] Archives of Ophthalmology. 101(5):820-1, 1983 May. Nelson TE. Flewellen EH. Gloyna DF. Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma. Anesthesia & Analgesia. 62(6):545-52, 1983 Jun. Gullotta F. Spiess-Kiefer C. Muscle biopsy studies in malignant hyperthermia [Ger] Anasthesie, Intensivtherapie, Notfallmedizin. 18(1):21-7, 1983 Feb. Lorkin PA. Lehmann H. Investigation of malignant hyperthermia: analysis of skeletal muscle proteins from normal and halothane sensitive pigs by two dimensional gel electrophoresis. Journal of Medical Genetics. 20(1):18-24, 1983 Feb. Wingard DW. Controversies regarding the prophylactic use of dantrolene for malignant hyperthermia [letter] Anesthesiology. 58(5):489-90, 1983 May. Giger U. Kaplan RF. Halothane-induced ATP depletion in platelets from patients susceptible to malignant hyperthermia and from controls. Anesthesiology. 58(4):347-52, 1983 Apr. Leary SL. Anderson LC. Manning PJ. Bache RJ. Zweber BA. Recurrent malignant hyperthermia in a Greyhound. Journal of the American Veterinary Medical Association. 182(5):521-2, 1983 Mar 1. Gronert GA. Muscle blood flow and hyperkalaemia in MH [letter] British Journal of Anaesthesia. 55(3):254-5, 1983 Mar. Hall GM. Lucke JN. Adenosine and leg blood flow during porcine malignant hyperthermia [letter] British Journal of Anaesthesia. 55(3):253, 1983 Mar. Vaughn J. Casson H. Hirshman CA. Anesthetic management of a child with asthma and presumed susceptibility to malignant hyperthermia. Anesthesiology. 58(3):283-5, 1983 Mar. Rosenberg H. Reed S. In vitro contracture tests for susceptibility to malignant hyperthermia. Anesthesia & Analgesia. 62(4):415-20, 1983 Apr. Traynor CA. Van Dyke RA. Gronert GA. Phosphorylase ratio and susceptibility to malignant hyperthermia. Anesthesia & Analgesia. 62(3):324-6, 1983 Mar. Pellicci PM. Paget S. Tsairis P. Post-anesthetic myoglobinuria with acute renal failure (normothermic malignant hyperthermia). A case report. Journal of Bone & Joint Surgery - American Volume. 65(3):413 -4, 1983 Mar. Brownell AK. Paasuke RT. Elash A. Fowlow SB. Seagram CG. Diewold RJ. Friesen C. Malignant hyperthermia in Duchenne muscular dystrophy. Anesthesiology. 58(2):180-2, 1983 Feb. Caroff S. Rosenberg H. Gerber JC. Neuroleptic malignant syndrome and malignant hyperthermia [letter] Lancet. 1(8318):244, 1983 Jan 29. Newberg LA. Lambert EH. Gronert GA. Failure to induce malignant hyperthermia in myotonic goats. British Journal of Anaesthesia. 55(1):57-60, 1983 Yoshii F. Ishihara T. Shinohara Y. Nomura K. Takagi A. A case of malignant syndrome with persistent nystagmus and diplopia [Jpn] Rinsho Shinkeigaku - Clinical Neurology. 22(5):385-92, 1982 Jardon OM. Physiologic stress, heat stroke, malignant hyperthermia--a perspective. Military Medicine. 147(1):8-14, 1982 Jafek BW. Solomons CC. Masson NC. Mahowald MC. Gumprecht TF. Current concepts of malignant hyperthermia. Otolaryngology - Head & Neck Surgery. 89(6):891-7, 1981 Nov -Dec. Byrick RJ. Rose DK. Ranganathan N. Management of a malignant hyperthermia patient during cardiopulmonary bypass. Canadian Anaesthetists Society Journal. 29(1):50-4, 1982 Jan. Triner L. Sherman J. Potential value of expiratory carbon dioxide measurement in patients considered to be susceptible to malignant hyperthermia [letter] Anesthesiology. 55(4):482, 1981 Oct. Rommelsheim K. Lauven P. Westhofen P. Stenger I. Stoeckel H. Dantrolen solution of high active substance concentration. Preliminary communication (author's transl) [Ger] Anasthesie, Intensivtherapie, Notfallmedizin. 15(5):423-7, 1980 Oct. Flewellen EH. Nelson TE. In vivo and in vitro responses to magnesium sulphate in porcine malignant hyperthermia. Canadian Anaesthetists Society Journal. 27(4):363-9, 1980 Jul. Mastaglia FL. Drug-induced disorders of muscle. British Journal of Hospital Medicine. 24(1):8, 11-6, 1980 Jul. Mitchell G. Heffron JJ. Porcine stress syndromes. Advances In Food Research. 28:167-230, 1982. Takagi A. Physiology and biochemistry of muscle fibers and the effect of disease. Skinned fiber technic [Jpn] No To Shinkei - Brain & Nerve. 34(10):929-38, 1982 Oct. Mastaglia FL. Adverse effects of drugs on muscle. Drugs. 24(4):304-21, 1982 Oct. Bais R. Edwards JB. Creatine kinase. Critical Reviews in Clinical Laboratory Sciences. 16(4):291 -335, 1982 Jun. Marjanen LA. Denborough MA. Adenylate kinase and malignant hyperpyrexia. British Journal of Anaesthesia. 54(9):949-52, 1982 Sep. Marjanen LA. Denborough MA. Effect of halothane on adenylate kinase in porcine malignant hyperpyrexia. Clinica Chimica Acta. 122(2):225-30, 1982 Jul 1. Kolb ME. Horne ML. Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology. 56(4):254-62, 1982 Apr. Oku S. Britt BA. Creatinine phosphokinase and adenylate kinase activities in skeletal muscle of malignant hyperthermia susceptible patients (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 30(8):819-25, 1981 Aug. Krishna G. Haselby KA. Rao CC. Current concepts in pediatric anesthesia with emphasis on the newborn infant. Surgical Clinics of North America. 61(5):997-1012, 1981 Oct. Reynolds RC. General anesthetic agents (what every surgeon should know about anesthesia, but has been afraid to ask). Otolaryngologic Clinics of North America. 14(3):489-500, 1981 Aug. Lambert PA. Guinot G. Chabannes JP. Some aspects of the French contribution during the past ten years to the study and use of injectable long-acting neuroleptics. Acta Psychiatrica Belgica. 81(2):103-14, 1981 Mar-Apr. Mayzner-Zawadzka E. Experimental malignant hyperthermia [Pol] Polski Tygodnik Lekarski. 35(52):2073-76, 1980 Dec 29. Wade JG. Stevens WC. Isoflurane: an anesthetic for the eighties?. Anesthesia & Analgesia. 60(9):666-82, 1981 Sep. Cerri CG. Willner JH. Britt BA. Wood DS. Adenylate kinase deficiency and malignant hyperthermia. Human Genetics. 57(3):325-6, 1981. Mozley PD. Malignant hyperthermia following intravenous iodinated contrast media. Report of a fatal case. Diagnostic Gynecology & Obstetrics. 3(1):81-6, 1981 Spring. Cunitz G. Muscular diseases and the use of muscle relaxants [Ger] Klinische Anasthesiologie Und Intensivtherapie. 22:252-67, 1980. Gronert GA. Malignant hyperthermia. Anesthesiology. 53(5):395-423, 1980 Nov. Denborough MA. The pathopharmacology of malignant hyperpyrexia. Pharmacology & Therapeutics. 9(3):357-65, 1980. Lister D. Endocrine control of pig growth. Proceedings of the Nutrition Society. 39(2):161-8, 1980 May. Whittaker M. Plasma cholinesterase variants and the anaesthetist. Anaesthesia. 35(2):174-97, 1980 Feb. Hall GM. Lucke JN. Lovell R. Lister D. Porcine malignant hyperthermia. VII: Hepatic metabolism. British Journal of Anaesthesia. 52(1):11-7, 1980 Jan. McGoldrick DE. Malignant hyperthermia: a review. Journal of the American Medical Womens Association. 35(4):95 -8, 1980 Apr. Hall GM. Lucke JN. Lister D. Malignant hyperthermia--pearls out of swine?. British Journal of Anaesthesia. 52(2):165-71, 1980 Feb. Ellis FR. Inherited muscle disease. British Journal of Anaesthesia. 52(2):153-64, 1980 Feb. Buxton PH. Pathology of muscle. British Journal of Anaesthesia. 52(2):139-51, 1980 Feb. Kafer ER. Respiratory and cardiovascular functions in scoliosis and the principles of anesthetic management. Anesthesiology. 52(4):339-51, 1980 Apr. Stephens R. Monitor developed for patient protection [interview by Ray Maultsaid] Lamp. 37(1):43-4, 1980 Jan. Gallant EM. Godt RE. Gronert GA. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs. Journal of Pharmacology & Experimental Therapeutics. 213(1):91 -6, 1980 Apr. Anonymous. Malignant hyperthermia [Dan] Tandlaegebladet. 86(20):707-9, 1982 Nov. Anonymous. Malignant hyperthermia. Dental Anaesthesia & Sedation. 11(2):69-70, 1982 Aug. Cole NL. Goldberg MH. Loftus M. Kwok V. Surgical management of patients with osteogenesis imperfecta. Journal of Oral & Maxillofacial Surgery. 40(9):578-84, 1982 Sep. Dungy AF. Hospital aspects of dental trauma. Dental Clinics of North America. 26(3):555-64, 1982 Jul. Carson JM. Van Sickels JE. Preoperative determination of susceptibility to malignant hyperthermia. Journal of Oral & Maxillofacial Surgery. 40(7):432-5, 1982 Jul. Sporn P. Malignant hyperthermia-results of familial investigations in Austria (author's transl) [Ger] Wiener Klinische Wochenschrift - Supplementum. 132:1-28, 1981. Knudson DH. Rost M. Grann L. Malignant hyperthermia: a case report. South Dakota Journal of Medicine. 34(10):5-7, 1981 Oct. Amato R. Giordano A. Patrignani F. Segatore I. Malignant hyperthermia in the course of general anesthesia in oral surgery. A case report. Journal of the International Association of Dentistry For Children. 12(1):25-8, 1981 Jan. Godin DV. Herring FG. MacLeod PJ. Malignant hyperthermia: characterization of erythrocyte membranes from individuals at risk. Journal of Medicine; Clinical, Experimental & Theoretical. 12(1):35-49, 1981. S:umnig W. Freitag B. Malignant hyperthermia--a life endangering anesthesia incident during rhinological cyst surgery (author's transl) [Ger] Zahn-, Mund-, Und Kieferheilkunde Mit Zentralblatt. 68(2):140 -4, 1980. Forman G. Malignant hyperpyrexia: successful management following oral surgery. British Journal of Oral Surgery. 18(2):107-11, 1980 Sep. Anderson IL. Rawstron RE. Dunlop DJ. Screening for malignant hyperthermia susceptibility. New Zealand Medical Journal. 91(661):417-9, 1980 Jun 11. Gallagher DM. Hyer RL. Effective use of dantrolene in a patient susceptible to malignant hyperthermia. Journal of Oral Surgery. 38(6):438-40, 1980 Jun. Paladino TR. Malignant hyperthermia during general anesthesia: medico-legal considerations. Medical Trial Technique Quarterly. 28(3):242-54, 1982 Winter. Wells P. Identifying learning needs: a teaching for emergency procedures. Aorn Journal. 36(4):639-44, 1982 Oct. Zakarian T. Nursing care study malignant hyperpyrexia - a rare anaesthetic hazard. Nursing Times. 77(48):2047-9, 1981 Nov 25-Dec 1. Thomas J. Malignant hyperthermia: fighting a fatal fever. Nursing Mirror. 153(15):48, 1981 Oct 7. Mitchell G. Heffron JJ. Plasma cortisol levels in pigs susceptible and resistant to malignant hyperthermia. Journal of the South African Veterinary Association. 52(2):109 -12, 1981 Jun. Rosenburg H. Malignant hyperpyrexia. American Journal of Nursing. 81(8):1484-6, 1981 Aug. Mamoli B. Sporn B. Steinbereithner K. Dal-Bianco P. Electrophysiologic investigations in a family with malignant hyperthermia (author's transl) [Ger] Fortschritte Der Neurologie, Psychiatrie Und Ihrer Grenzgebiete. 48(6):314-23, 1980 Jun. Noble E. Malignant hyperthermia need not be lethal. Canadian Nurse. 76(8):33-7, 1980 Sep. Gever LN. Dantrium: the approved drug to control malignant hyperthermia. Nursing. 10(7):62, 1980 Jul. Fernsebner B. A protocol for malignant hyperthermia. Aorn Journal. 31(5):814-8, 1980 Apr. Schulte-Sasse U. Tarnow J. Eberlein HJ. Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl) [Ger] Anaesthesist. 31(5):241-4, 1982 May. Niebr:oj-Dobosz I. Mayzner-Zawadzka E. Experimental porcine malignant hyperthermia: the activity of certain transporting enzymes and myofibrillar calcium-binding protein content in the muscle fibre. British Journal of Anaesthesia. 54(8):885-91, 1982 Aug. Boheler J. Hamrick JC Jr. McKnight RL. Eger EI 2d. Isoflurane and malignant hyperthermia [letter] Anesthesia & Analgesia. 61(8):712-3, 1982 Aug. Joseph MM. Shah K. Viljoen JF. Malignant hyperthermia associated with isoflurane anesthesia [letter] Anesthesia & Analgesia. 61(8):711-2, 1982 Aug. Somers CJ. McLoughlin JV. Malignant hyperthermia in pigs: calcium ion uptake by mitochondria from skeletal muscle of susceptible animals given neuroleptic drugs and halothane. Journal of Comparative Pathology. 92(2):191-8, 1982 Apr. Cheah KS. Cheah AM. Skeletal muscle mitochondrial phospholipase A2 and the interaction of mitochondria and sarcoplasmic reticulum in porcine malignant hyperthermia. Biochimica Et Biophysica Acta. 638(1):40-9, 1981 Nov 12. Burke RE. Fahn S. Mayeux R. Weinberg H. Louis K. Willner JH. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology. 31(8):1022-5, 1981 Aug. Peters KR. Nance P. Wingard DW. Malignant hyperthyrodism or malignant hyperthermia?. Anesthesia & Analgesia. 60(8):613-5, 1981 Aug. Gronert GA. Milde JH. Variations in onset of porcine malignant hyperthermia. Anesthesia & Analgesia. 60(7):499-503, 1981 Jul. Blanck TJ. Gruener R. Suffecool SL. Thompson M. Calcium uptake by isolated sarcoplasmic reticulum: examination of halothane inhibition, pH dependence, and Ca2+ dependence of normal and malignant hyperthermic human muscle. Anesthesia & Analgesia. 60(7):492-8, 1981 Jul. Flewellen EH. Burkitt's lymphoma and malignant hyperthermia [letter] Anesthesia & Analgesia. 59(12):955, 1980 Dec. Nelson TE. Malignant hyperthermia [letter] Anesthesia & Analgesia. 59(11):890-2, 1980 Nov. Harrison GG. Pancuronium and the triggering of malignant hyperthermia [letter] Anesthesia & Analgesia. 59(11):889, 1980 Nov. Lees DE. Gadde PL. Macnamara TE. Malignant hyperthermia in association with Burkitt's lymphoma: report of a third case. Anesthesia & Analgesia. 59(7):514-5, 1980 Jul. Gronert GA. Thompson RL. Onofrio BM. Human malignant hyperthermia: awake episodes and correction by dantrolene. Anesthesia & Analgesia. 59(5):377-8, 1980 May. Wingard DW. A stressful situation [editorial] Anesthesia & Analgesia. 59(5):321-2, 1980 May. Mitchell G. Heffron JJ. van Rensburg AJ. A halothane-induced biochemical defect in muscle of normal and malignant hyperthermia-susceptible Landrace pigs. Anesthesia & Analgesia. 59(4):250-6, 1980 Apr. Waterman PM. Albin MS. Smith RB. Malignant hyperthermia: a case report. Anesthesia & Analgesia. 59(3):220-1, 1980 Mar. Morton RH. Use of a designed experiment for the study of muscle fibre size. Statistics In Medicine. 1(2):139-43, 1982 Apr-Jun. Hall GM. Lucke JN. Orchard C. Lovell R. Lister D. Effect of dantrolene on leg metabolism in porcine malignant hyperthermia. Anaesthesia. 37(12):1167-70, 1982 Dec. Bardsley ME. Wheatley AM. Fowler CJ. McCrodden JM. McLoughlin JV. Tipton KF. Metabolism of monoamines in malignant hyperthermia-susceptible pigs. British Journal of Anaesthesia. 54(12):1313-8, 1982 Dec. Kleinknecht D. Parent A. Blot P. Bochereau G. Lallement PY. Pourriat JL. Rhabdomyolysis with acute renal failure and malignant neuroleptic syndrome [Fre] Annales De Medecine Interne. 133(8):549-52, 1982. J:rgensen PF. Influence of nutrition on malignant hyperthermia in pigs. Acta Veterinaria Scandinavica. 23(4):539-49, 1982. Vasil'chenko AI. Malignant hyperthermia during anesthesia and surgery [Rus] Klinicheskaia Khirurgiia. (12):47-8, 1982 Dec. Schanus EG. Lovrien RE. Taylor CA. Malignant hyperthermia (MH) in humans: deficiencies in the protective enzymes systems for oxidative damage. Progress In Clinical & Biological Research. 97:95-111, 1982. Fletcher R. Blennow G. Olsson AK. Ranklev E. T:ornebrandt K. Malignant hyperthermia in a myopathic child. Prolonged postoperative course requiring dantrolene. Acta Anaesthesiologica Scandinavica. 26(5):435-8, 1982 Oct. Jolly DT. McKim JC. Corrin MH. A family with intussusception and malignant hyperthermia. Canadian Medical Association Journal. 127(8):737-8, 1982 Oct 15. Yamashita M. Honda K. Iha H. Kondo S. Matsuki A. Oyama T. A case of acute hyperpyrexia with violent shivering immediately after operation under epidural anaesthesia supplemented by nitrous oxide. Canadian Anaesthetists Society Journal. 29(6):632-5, 1982 Nov. Oka S. Igarashi Y. Takagi A. Nishida M. Sato K. Nakada K. Ikeda K. Malignant hyperpyrexia and Duchenne muscular dystrophy: A case report. Canadian Anaesthetists Society Journal. 29(6):627-9, 1982 Nov. Britt BA. Frodis W. Scott E. Clements MJ. Endrenyi L. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia. Canadian Anaesthetists Society Journal. 29(6):550-62, 1982 Nov. Sullivan JS. Galloway GJ. Denborough MA. Clodanolene sodium and malignant hyperpyrexia [letter] British Journal of Anaesthesia. 54(11):1237, 1982 Nov. Mortier W. Biesel C. Pharmacological in-vitro studies in malignant hyperthermia in childhood. Brain & Development. 4(5):347-52, 1982. Nissen RL. Yonkers AJ. Malignant hyperthermia. Laryngoscope. 92(10 Pt 1):1183-6, 1982 Oct. Denborough MA. Galloway GJ. Hopkinson KC. Malignant hyperpyrexia and sudden infant death. Lancet. 2(8307):1068-9, 1982 Nov 13. Hoffmann-Lundgren B. K:uhn K. Hausd:orfer J. Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens [Ger] Anasthesie, Intensivtherapie, Notfallmedizin. 17(3):169-70, 1982 Jun. Campbell IT. Ellis FR. Halsall PJ. Hogge MS. Anthropometric studies of human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiologica Scandinavica. 26(4):363-7, 1982 Aug. Harrison GG. Chapman DC. Dantrolene sodium in the treatment of malignant hypertension [letter] South African Medical Journal. 62(15):503-4, 1982 Oct 2. Joannard A. Peranesthetic familial malignant hyperthermia [Fre] Pediatrie. 37(3):231-4, 1982 Apr-May. Tollefson G. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia. Journal of Clinical Psychopharmacology. 2(4):266-70, 1982 Aug. McCarron MM. Boettger ML. Peck JJ. A case of neuroleptic malignant syndrome successfully treated with amantadine. Journal of Clinical Psychiatry. 43(9):381-2, 1982 Sep. Sullivan JS. Denborough MA. The isolation and chemical characterization of skeletal muscle microsomes from swine susceptible to malignant hyperpyrexia. International Journal of Biochemistry. 14(8):741-5, 1982. Hall GM. Lucke JN. Orchard C. Lovell R. Lister D. Porcine malignant hyperthermia. VIII: leg metabolism. British Journal of Anaesthesia. 54(9):941-7, 1982 Sep. Dolan PF. Dantrolene and malignant hyperthermia [letter] Anesthesiology. 57(3):246-7, 1982 Sep. el-Ilriby M. Rushton SC. Malignant hyperpyrexia? [letter] Anaesthesia. 37(8):862-3, 1982 Aug. Ohmori M. Kobayashi S. Ohtsuki Y. Ogawa K. Malignant hyperthermia. Acta Pathologica Japonica. 32(4):649-56, 1982 Jul. Pera J. Decoux M. Guyon M. Sage M. Reflections on the malignant neuroleptic (letter) [Fre] Nouvelle Presse Medicale. 11(29):2230, 1982 Jun 19. Sullivan JS. Ardlie NG. Denborough MA. Platelet function in malignant hyperpyrexia [letter] British Journal of Anaesthesia. 54(8):900-1, 1982 Aug. Bernhardt D. Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl) [Ger] Anaesthesist. 31(5):252-4, 1982 May. Malz H. Gullotta F. Klein H. Aebert K. "Malignant hyperthermia" following NLA and spinal anaesthesia (author's transl) [Ger] Anaesthesist. 31(5):248-51, 1982 May. Schuh FT. Maier C. Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl) [Ger] Anaesthesist. 31(5):245-7, 1982 May. Grote B. Dantrolene and malignant hyperthermia [Ger] Anaesthesist. 31(5):211-2, 1982 May. M:ulchanov V. Beneva T. Stoianova S. Saev S. Velinov P. Case of malignant hyperthermia [Bul] Khirurgiia - Sofia. 35(2):204-9, 1982. Cooper J. Medow N. Dibble C. Mortality rate in strabismus surgery. Journal of the American Optometric Association. 53(5):391-5, 1982 May. Franks RD. Aoueille B 3d. Mahowald MC. Masson N. ECT use for a patient with malignant hyperthermia. American Journal of Psychiatry. 139(8):1065-6, 1982 Aug. Coons DJ. Hillman FJ. Marshall RW. Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report. American Journal of Psychiatry. 139(7):944-5, 1982 Jul. Denborough MA. Heat stroke and malignant hyperpyrexia [letter] Medical Journal of Australia. 1(5):204-5, 1982 Mar 6. Daoudai P. Delacour JL. Treatment of neuroleptic malignant syndrome with dantrolene [letter] Lancet. 2(8291):217, 1982 Jul 24. Goekoop JG. Carbaat PA. Treatment of neuroleptic malignant syndrome with dantrolene [letter] Lancet. 2(8288):49-50, 1982 Jul 3. Anonymous. Malignant hyperthermia [letter] Archives of Ophthalmology. 100(5):841-3, 1982 May. Williams AC. Malignant hyperpyrexia? [letter] Anaesthesia. 37(1):95-6, 1982 Jan. McPherson E. Taylor CA Jr. The genetics of malignant hyperthermia: evidence for heterogeneity. American Journal of Medical Genetics. 11(3):273-85, 1982 Mar. de Rohan Chabot P. Elkharrat D. Conso F. Bismuth C. Goulon M. Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl) [Fre] Nouvelle Presse Medicale. 11(14):1067-9, 1982 Mar 27. Davis TP. Gehrke CW Jr. Williams CH. Gehrke CW. Gerhardt KO. Pre-column derivatization and high-performance liquid chromatography of biogenic amines in blood of normal and malignant hyperthermic pigs. Journal of Chromatography. 228:113-22, 1982 Mar 12. Brownell AK. Szabo M. The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results. Canadian Anaesthetists Society Journal. 29(3):218-21, 1982 May. Boles JM. Lecam B. Mialon P. Pennec Y. Garre M. Malignant hyperthermia induced by neuroleptics. Rapid cure with dantrolene (letter) [Fre] Nouvelle Presse Medicale. 11(9):674, 1982 Feb 27. Gallant EM. Gronert GA. Taylor SR. Cellular membrane potentials and contractile threshold in mammalian skeletal muscle susceptible to malignant hyperthermia. Neuroscience Letters. 28(2):181-6, 1982 Feb 12. Huckell VF. Staniloff HM. Britt BA. Morch JE. Electrocardiographic abnormalities associated with malignant hyperthermia susceptibility. Journal of Electrocardiology. 15(2):137-41, 1982 Apr. Gohil P. Forman WM. Malignant hyperthermia: description and case report. Journal of Foot Surgery. 21(1):7-11, 1982 Spring. Nelson TE. Schochet SS Jr. Malignant hyperthermia: a disease of specific myofiber type?. Canadian Anaesthetists Society Journal. 29(2):163-7, 1982 Mar. Marchildon MB. Malignant hyperthermia. Current concepts. Archives of Surgery. 117(3):349-51, 1982 Mar. Forrest WH Jr. A collaborative clinical trial on trial. Anesthesiology. 56(4):249-50, 1982 Apr. Dohlman LE. Malignant hyperthermia: a consideration for plastic surgeons. Plastic & Reconstructive Surgery. 69(3):547-51, 1982 Mar. Meyers EF. Meyers RW. Thermic stress syndrome [letter] Jama. 247(15):2098-9, 1982 Apr 16. Heffron JJ. Mitchell G. Dreyer JH. Muscle fibre type, fibre diameter and pH1 values of M. longissimus dorsi of normal, malignant hyperthermia- and PSE-susceptible pigs. British Veterinary Journal. 138(1):45-50, 1982 Jan-Feb. Lutsky I. Witkowski J. Henschel EO. HLA typing in a family prone to malignant hyperthermia. Anesthesiology. 56(3):224-6, 1982 Mar. Haegy JM. Laplatte G. Gollner JL. Eulry F. Clement R. Schneider F. Exercise-induced malignant hyperthermia in a patient with familial ichthyosis vulgaris. Muscular carnitine deficiency as contributing factor (author's transl) [Fre] Nouvelle Presse Medicale. 11(2):115-7, 1982 Jan 16. Flewellen EH. Nelson TE. Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. Canadian Anaesthetists Society Journal. 29(1):42-9, 1982 Jan. Lips FJ. Newland M. Dutton G. Malignant hyperthermia triggered by cyclopropane during cesarean section. Anesthesiology. 56(2):144-6, 1982 Feb. Dantzer R. Hatey F. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase activities in pigs with different susceptibility to the malignant hyperthermia syndrome by halothane. Reproduction, Nutrition, Developpement. 21(1):103-8, 1981. Aldrete JA. Advances in the diagnosis and treatment of malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 25(6):477-83, 1981 Dec. Waldron-Mease E. Klein LV. Rosenberg H. Leitch M. Malignant hyperthermia in a halothane-anesthetized horse. Journal of the American Veterinary Medical Association. 179(9):896-8, 1981 Nov 1. Cornelio F. Di Donato S. Testa D. Mora M. Gori G. Peluchetti D. Rimoldi M. "Carnitine deficient" myopathy and cardiomyopathy with fatal outcome. Italian Journal of Neurological Sciences. 1(2):95-100, 1980 Mar. Lokhvitski:i SV. Shusterov AI. 2 cases of malignant hyperthermia [Rus] Anesteziologiia I Reanimatologiia. (6):69-71, 1981 Nov-Dec. Anderson TE. Drummond DS. Breed AL. Taylor CA. Malignant hyperthermia in myelomeningocele: a previously unreported association. Journal of Pediatric Orthopedics. 1(4):401-3, 1981. McGrath CJ. Rempel WE. Jessen CR. Addis PB. Crimi AJ. Malignant hyperthermia-triggering liability of selected inhalant anesthetics in swine. American Journal of Veterinary Research. 42(4):604-7, 1981 Apr. Gronert GA. Milde JH. Hyperbaric nitrous oxide and malignant hyperpyrexia [letter] British Journal of Anaesthesia. 53(11):1238, 1981 Nov. Sullivan JS. Denborough MA. Temperature dependence of muscle function in malignant hyperpyrexia -susceptible swine. British Journal of Anaesthesia. 53(11):1217-22, 1981 Nov. Lieding KG. Graham MD. Malignant hyperthermia. Cause and treatment. Archives of Otolaryngology. 107(12):758-60, 1981 Dec. L:opez Mart:inez J. Solera Santos J. P:erez Picouto F. Guerra L. Becerra Hidalgo JB. Caparr:os T. Malignant hyperthermia with shock and hemorrhagic diathesis [Spa] Revista Clinica Espanola. 162(5):211-4, 1981 Sep 15. Zsigmond EK. Routine temperature monitoring during anesthesia [letter] Jama. 246(23):2678, 1981 Dec 11. Bourgeois M. Tignol J. Villeger M. Henry P. Daubech JF. Laforge E. Durand J. Neuroleptic malignant syndrome. Reappraisal apropos of 2 cases [Fre] Annales Medico-Psychologiques. 139(5):547-56, 1981 May. Rosenberg H. Fisher CA. Reed SB. Addonizio VP. Platelet aggregation in patients susceptible to malignant hyperthermia. Anesthesiology. 55(6):621-4, 1981 Dec. Hackl JM. Engl J. Hofst:adter F. Bonelli S. Rumpl E. Dworzak E. Puschendorf B. Possible malignant hyperthermia as reaction to an overdose of myotonolytic, antidepressive and sedative drugs (author's transl) [Ger] Wiener Klinische Wochenschrift. 93(15):475-9, 1981 Aug 7. Ording HO. Sodium dantrolene in the treatment of malignant hyperthermia [Dan] Ugeskrift For Laeger. 143(38):2423-4, 1981 Sep 14. Harrison GG. Dantrolene sodium in the treatment of malignant hyperthermia. A case report. South African Medical Journal. 60(23):909-10, 1981 Dec 5. Bursick DM. Waterman PM. Jannetta PJ. Malignant hyperthermia: a neurosurgical case and a review of the syndrome. Neurosurgery. 9(4):421-5, 1981 Oct. Willner JH. Cerri CG. Wood DS. High skeletal muscle adenylate cyclase in malignant hyperthermia. Journal of Clinical Investigation. 68(5):1119-24, 1981 Nov. Bensinger RE. Haschke RH. The ophthalmologist and malignant hyperthermia. American Journal of Ophthalmology. 92(4):584-6, 1981 Oct. Waterman PM. Malignant hyperthermia syndrome. American Journal of Ophthalmology. 92(4):461-5, 1981 Oct. Harvengt C. Recently registered drugs in Belgium [Fre] Acta Clinica Belgica. 36(1):53-5, 1981. Schanus EG. Schendel F. Lovrien RE. Rempel WE. McGrath C. Malignant hyperthermia (MH): porcine erythrocyte damage from oxidation and glutathione peroxidase deficiency. Progress In Clinical & Biological Research. 55:323-39, 1981. Nelson TE. Chausmer AB. Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs. Journal of Pharmacology & Experimental Therapeutics. 219(1):107-11, 1981 Oct. Sawyer DC. Malignant hyperthermia. Journal of the American Veterinary Medical Association. 179(4):341-4, 1981 Aug 15. Schuh FT. Malignant hyperthermia. Immediate treatment and procedure in another anesthesia [Ger] Deutsche Medizinische Wochenschrift. 106(43):1431-2, 1981 Oct 23. Schuh FT. Malignant hyperthermia. Intraoperative early diagnosis and indicating signs [Ger] Deutsche Medizinische Wochenschrift. 106(43):1428-30, 1981 Oct 23. Schulte-Sasse U. Eberlein HJ. Malignant hyperthermia--now a controllable potentially lethal anesthesia complication [Ger] Deutsche Medizinische Wochenschrift. 106(43):1405-8, 1981 Oct 23. Mitchell G. Heffron JJ. Some muscle and growth characteristics of pigs susceptible to stress. British Veterinary Journal. 137(4):374-80, 1981 Jul-Aug. Fletcher R. Ranklev E. Olsson AK. Leander S. Malignant hyperthermia syndrome in an anxious patient. British Journal of Anaesthesia. 53(9):993-5, 1981 Sep. Lewandowski KB. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations. British Journal of Anaesthesia. 53(9):981-4, 1981 Sep. McPherson EW. Taylor CA Jr. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies. American Journal of Medical Genetics. 8(2):159-65, 1981. Felice-Johnson J. Sudds T. Bennett G. Malignant hyperthermia: current perspectives. American Journal of Hospital Pharmacy. 38(5):646-51, 1981 May. Joecks J. R:ucker E. Malignant hyperthermia--a course with non-fatal outcome [Ger] Zeitschrift Fur Arztliche Fortbildung - Jena. 75(8):369-71, 1981 Apr 15. Shimonaka H. Yamamoto M. Suzuki A. Suezawa Y. Tanahashi T. Uematsu H. Ohtsuka S. Miyagishima T. Althesin anesthesia and malignant hyperthermia (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 30(5):458-65, 1981 May. Shimonaka H. Yamamoto M. Malignant hyperthermia--postoperative changes of serum LDH and CPK isozymes (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 30(2):141-9, 1981 Feb. Kukoyi EA. Addis PB. McGrath CJ. Rempel WE. Martin FB. Porcine stress syndrome and postmortem muscle characteristics of two purebreds and three specific terminal crosses. Journal of Animal Science. 52(2):278-84, 1981 Feb. Bagshaw RJ. Cox RH. Rosenberg H. Dantrolene treatment of malignant hyperthermia [letter] Journal of the American Veterinary Medical Association. 178(10):1129, 1981 May 15. Kaplan R. Malignant hyperthermia [Heb] Harefuah. 100(9):430-2, 1981 May 1. Steiss JE. Bowen JM. Williams CH. Electromyographic evaluation of malignant hyperthermia-susceptible pigs. American Journal of Veterinary Research. 42(7):1173-6, 1981 Jul. Oku S. Sole MJ. Britt BA. Liew CC. Analysis of non-histone chromatin proteins in porcine malignant hyperthermia. Journal of the Neurological Sciences. 50(3):373-9, 1981 Jun. Dodd MJ. Phattiyakul P. Silpasuvan S. Suspected malignant hyperthermia in a strabismus patient. A case report. Archives of Ophthalmology. 99(7):1247-50, 1981 Jul. McGrath CJ. Rempel WE. Addis PB. Crimi AJ. Acepromazine and droperidol inhibition of halothane-induced malignant hyperthermia (porcine stress syndrome) in swine. American Journal of Veterinary Research. 42(2):195-8, 1981 Feb. Denborough MA. Sudden infant death syndrome and malignant hyperpyrexia [letter] Medical Journal of Australia. 1(12):649-50, 1981 Jun 13. Reynolds AC. Reynolds EV. Henschel EO. Physical exercise in malignant hyperthermia screening [letter] Lancet. 2(8241):303, 1981 Aug 8. Campbell IT. Ellis FR. Evans RT. Metabolic rate and blood hormone and metabolite levels of individuals susceptible to malignant hyperpyrexia at rest and in response to food and mild exercise. Anesthesiology. 55(1):46-52, 1981 Jul. Drechsler H. On the treatment of malignant hyperthermia. A simple method of preparing a dantrolene sodium solution (author's transl) [Ger] Anaesthesist. 30(5):257-8, 1981 May. Sedwick LA. Romano PE. Malignant hyperthermia. Considerations for the ophthalmologist. Survey of Ophthalmology. 25(6):378-82, 1981 May-Jun. Schvaneveldt JA. Stankiewicz JA. Malignant hyperpyrexia: an update for the otolaryngologist. Laryngoscope. 91(6):918-26, 1981 Jun. Heffron JJ. Mitchell G. Influence of pH, temperature, halothane and its metabolites on osmotic fragility of erythrocytes of malignant hyperthermia-susceptible and resistant pigs. British Journal of Anaesthesia. 53(5):499-504, 1981 May. Courtine JC. Blot P. Malignant neuroleptic syndrome (letter) [Fre] Nouvelle Presse Medicale. 10(21):1749, 1981 May 9. Sina AG. Caramella F. Pagani L. Pietrobono P. Bragheri R. Malignant hyperthermia. The need for anesthesia in a patient manifesting this syndrome [Ita] Minerva Anestesiologica. 46(11):1163-7, 1980 Nov. Mitchell G. Heffron JJ. The occurrence of pale, soft, exudative musculature in Landrace pigs susceptible and resistant to the malignant hyperthermia syndrome. British Veterinary Journal. 136(5):500-6, 1980 Sep-Oct. G:omez-Arnau J. Gilsanz F. M:arquez M. Avello F. Anesthesia and "ophthalmoplegia plus" [Spa] Revista Espanola De Anestesiologia Y Reanimacion. 28(1):44-5, 1981 Jan. Barnes PK. Recent advances in anaesthesia. Practitioner. 224(1348):1045-9, 1980 Oct. Weitz H. H:ubner G. Rhabdomyolysis in a severe case of malignant hyperthermia--a light and electron microscopical study (author's transl) [Ger] Pathology, Research & Practice. 169(3-4):276-86, 1980 Nov. Bloom DA. Iwamoto K. Reynolds RC. Ehrlich RM. Management of malignant hyperthermia. Journal of Urology. 125(4):594-7, 1981 Apr. Utke G. Quos A. Wegener R. Malignant hypothermia, 3 cases (author's transl) [Ger] Zentralblatt Fur Chirurgie. 105(23):1573-82, 1980. Muteki T. Tokutomi Y. Ueda N. Nakamura Y. Matsuoka H. Iwai Y. Yoshitake K. Tsuda H. A case report of malignant hyperthermia (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 29(8):821-7, 1980 Aug. Sagy M. Barzilay Z. Boichis H. Malignant hyperthermia syndrome [Heb] Harefuah. 99(7):169-71, 1980 Oct 1. Tran:c:ik J. Me:skov:a M. Altusov:a H. Hul:inov:a I. Malignant hyperthermia syndrome (author's transl) [Slo] Bratislavske Lekarske Listy. 74(6):665-70, 1980 Dec. Cheah KS. Cheah AM. Mitochondrial calcium transport and calcium-activated phospholipase in porcine malignant hyperthermia. Biochimica Et Biophysica Acta. 634(1):70-84, 1981 Jan 14. Ording H. Hanel HH. Viby-Mogensen J. Plasma cholinesterase and malignant hyperthermia [letter] British Journal of Anaesthesia. 53(3):317-8, 1981 Mar. Evans RT. Iqbal J. Ellis FR. Halsall PJ. Dietz AA. Lubrano T. Rubinstein HM. Collaborative study of the frequency of the fluoride-resistant cholinesterase variant in patients with malignant hyperpyrexia. British Journal of Anaesthesia. 53(3):245-7, 1981 Mar. Whittaker M. Britten JJ. Malignant hyperthermia and the fluoride-resistant gene. British Journal of Anaesthesia. 53(3):241-4, 1981 Mar. Hall GM. Plasma cholinesterase and malignant hyperthermia [editorial] British Journal of Anaesthesia. 53(3):199-200, 1981 Mar. Shulman M. Braverman B. Ivankovich AD. Gronert G. Sevoflurane triggers malignant hyperthermia in swine [letter] Anesthesiology. 54(3):259-60, 1981 Mar. Landauer B. Treatment of malignant hyperthermia with dantrolene [Ger] Anaesthesist. 29(9):507-8, 1980 Sep. Scholtes JL. Ikabu NM. Gribomont BF. Uneventful recovery in a case of severe malignant hyperthermia. Acta Anaesthesiologica Belgica. 31(2):139-46, 1980. Bleichner G. Squara P. Parent A. Hypertonia and malignant hyperthermia due to morphine and neuroleptic [letter] Lancet. 1(8216):386-7, 1981 Feb 14. McGrath CJ. Rempel WE. Jessen CR. Addis PB. Crimi AJ. Ruff J. Protection from halothane-induced porcine malignant hyperthermia syndrome by droperidol. Laboratory Animal Science. 30(6):992-5, 1980 Dec. Inagaki M. Koyama A. Sakata S. Tonogai R. Yamada Y. Kawai H. Iwasa M. Kondo A. Miyoshi K. Serum myoglobin levels following administration of succinylcholine during nitrous oxide-oxygen-halothane anesthesia (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 29(12):1476-82, 1980 Nov. Fitzgibbons DC. Malignant hyperthermia following preoperative oral administration of dantrolene. Anesthesiology. 54(1):73-5, 1981 Jan. Gronert GA. Puzzles in malignant hyperthermia [editorial] Anesthesiology. 54(1):1-2, 1981 Jan. Junger H. Kuhnle P. Schorer R. New aspects in the clinical picture of malignant hyperthermia (author's transl) [Ger] Zeitschrift Fur Kinderchirurgie Und Grenzgebiete. 30(1):35-7, 1980 May. Marti HR. Clinical demonstrations of hereditary disorders of metabolism [Ger] Schweizerische Medizinische Wochenschrift - Journal Suisse De Medecine. 110(49):1857-63, 1980 Dec 6. Harnisch R. Abigt J. Kohne E. H:order MH. Malignant hyperthermia. 2 unusual courses [Ger] Intensivmedizinische Praxis. (2):59-66, 1980. Hall GM. Lucke JN. Lovell R. Lister D. Peripheral substrate exchange in malignant hyperthermia in the pig. Biochemical Society Transactions. 8(5):575, 1980 Oct. Jones SE. Thomas CH. Malignant hyperthermia in a patient with an ankylosed jaw. Anaesthesia. 35(10):987-90, 1980 Oct. van den Hende C. Muylle E. Vlaminck K. Oyaert W. Halothane-induced malignant hyperthermia (MH) in the Belgian Landrace breed of pigs: some findings concerning the role of subcellular fractions (author's transl) [Dut] Tijdschrift Voor Diergeneeskunde. 105(24):1054-9, 1980 Dec 15. Ellis FR. Halsall PJ. Malignant hyperpyrexia. British Journal of Hospital Medicine. 24(4):318-21, 323, 325 -7, 1980 Oct. Hall GM. Dantrolene and the treatment of malignant hyperthermia. British Journal of Anaesthesia. 52(9):847-9, 1980 Sep. Gallant EM. Histochemical observations on muscle from normal and malignant hyperthermia-susceptible swine. American Journal of Veterinary Research. 41(7):1069-71, 1980 Jul. Ahern CP. Somers CJ. Wilson P. McLoughlin JV. Halothane-induced malignant hyperthermia: creatine phosphate concentration in skeletal muscle as an early indicator of the onset of the syndrome. Journal of Comparative Pathology. 90(2):177-86, 1980 Apr. Hoff B. Taylor C. Kruel J. Dantrolene therapy for malignant hyperthermia [letter] Critical Care Medicine. 8(11):699-700, 1980 Nov. Hall GM. Cooper GM. Lucke JN. Lister D. 4-aminopyridine fails to induce porcine malignant hyperthermia [letter] British Journal of Anaesthesia. 52(7):707, 1980 Jul. Harrison GG. Morrell DF. Minaxolone and malignant hyperthermia [letter] British Journal of Anaesthesia. 52(7):706-7, 1980 Jul. Mitchell HW. Denborough MA. Smooth muscle contracture in malignant hyperpyrexia [letter] British Journal of Anaesthesia. 52(6):637, 1980 Jun. Fairhurst AS. Hamamoto V. Macri J. Modification of ryanodine toxicity by dantrolene and halothane in a model Journal of malignant hyperthermia. Anesthesiology. 53(3):199-204, 1980 Sep. Rosenberg H. Malignant hyperpyrexia [letter] Muscle & Nerve. 3(5):443-4, 1980 Sep-Oct. Tettambel M. Malignant hyperthermia in an obstetric patient. Journal of the American Osteopathic Association. 79(12):773-5, 1980 Aug. Artru AA. Gronert GA. Cerebral metabolism during porcine malignant hyperthermia. Anesthesiology. 53(2):121-26, 1980 Aug. Altrogge DM. Topel DG. Cooper MA. Hallberg JW. Draper DD. Urinary and caudate nuclei catecholamine levels in stress-susceptible and normal swine. Journal of Animal Science. 51(1):74-7, 1980 Jul. Mambo NC. Silver MD. McLaughlin PR. Huckell VF. McEwan PM. Britt BA. Morch JE. Malignant hyperthermia susceptibility. A light and electron microscopic study of endomyocardial biopsy specimens from nine patients. Human Pathology. 11(4):381-8, 1980 Jul. Sunohara N. Takagi A. Nonaka I. Satoyoshi E. Kojima S. Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl) [Jpn] Rinsho Shinkeigaku - Clinical Neurology. 20(6):448-54, 1980 Jun. Suer RP. Fisher WB. Pearson RW. Triplett DA. Burkitt's lymphoma: tumor lysis following malignant hyperthermia. Cancer Treatment Reports. 64(2-3):327-30, 1980 Feb-Mar. Solomons CC. McDermott N. Mahowald M. Screening for malignant hyperthermia with a platelet bioassay [letter] New England Journal of Medicine. 303(11):642, 1980 Sep 11. Eubanks JR Jr. Malignant hyperthermia. Journal of the Medical Association of the State of Alabama. 49(12):36, 39, 1980 Jun. Meredith MJ. Williams LA. A case report of malignant hyperthermia in a large white pig. British Veterinary Journal. 136(2):195-7, 1980 Mar-Apr. Koz:owski PB. Morphology of the muscles and brain in case of malignant hyperthermia [Pol] British Veterinary Journal. 31(1):147-52, 1980. Anonymous. Dantrolene for malignant hyperthermia during anesthesia. Medical Letter On Drugs & Therapeutics. 22(15):61-2, 1980 Jul 25. Jardon OM. Malignant hyperthermia [letter] Jama. 244(5):436, 1980 Aug 1. Willner JH. Wood DS. Cerri C. Britt B. Increased myophosphorylase a in malignant hyperthermia. New England Journal of Medicine. 303(3):138-40, 1980 Jul 17. Lambert W. Dantrolene and caffeine contracture test [letter] Canadian Anaesthetists Society Journal. 27(3):304-5, 1980 May. Rosenberg H. Dantrolene and caffeine contracture test [letter] Canadian Anaesthetists Society Journal. 27(3):303-4, 1980 May. Melvoll R. Stovner J. Whittaker M. Suxamethonium-induced jaw stiffness and myalgia associated with atypical cholinesterase: case report. Canadian Anaesthetists Society Journal. 27(3):283-5, 1980 May. Sewall K. Flowerdew RM. Bromberger P. Severe muscular rigidity at birth: malignant hyperthermia syndrome?. Canadian Anaesthetists Society Journal. 27(3):279-82, 1980 May. Harrison GG. Morrell DF. Response of mhs swine to i.v. infusion of lignocaine and bupivacaine. British Journal of Anaesthesia. 52(4):385-7, 1980 Apr. Okumura F. Crocker BD. Denborough MA. Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia. British Journal of Anaesthesia. 52(4):377-83, 1980 Apr. P:uschel K. Brinkmann B. Malignant hyperthermia. Present implications in forensic medicine (author's transl) [Ger] Anaesthesist. 29(2):99-102, 1980 Feb. Pl:otz J. Malignant hyperthermia. II. Investigation of the patient's family (author's transl) [Ger] Anaesthesist. 29(2):94-8, 1980 Feb. Pl:otz J. Braun J. Gericke B. Malignant hyperthermia. I. Observations in connection with its pathogenesis and course (author's transl) [Ger] Anaesthesist. 29(2):89-93, 1980 Feb. Sporn P. Steinbereithner K. Sluga E. Linsmayer H. Schenk E. Fatal hyperthermic crisis after premedication. Human stress syndrome or trigger effect of promethacine (author's transl) [Ger] Anaesthesist. 29(2):85-8, 1980 Feb. Grote B. Malignant hyperthermia [Ger] Anaesthesist. 29(2):53-4, 1980 Feb. Rettig B. Weitz H. Malignant hyperthermia. A case report (author's transl) [Ger] Anaesthesist. 29(2):103-6, 1980 Feb. Shinohara S. Toyosaki M. Takata K. Tanaka S. Nagaoka I. Iasa M. Kawai H. A case of malignant hyperpyrexia suggesting a gross muscle breakdown (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 29(1):68-74, 1980 Jan. Morio M. Malignant hyperthemia (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 29(1):1-10, 1980 Jan. Green RA. Mitchell G. Heffron JJ. Effects of temperature, adenosine triphosphate and magnesium concentrations on the contraction of actomyosin isolated from halothane -sensitive and -insensitive German Landrace pigs. British Journal of Anaesthesia. 52(3):319-23, 1980 Mar. Hartigan PJ. Ahern CP. McLoughlin VJ. Endocardial cushion defects in a litter of malignant hyperthermia -susceptible pigs. Veterinary Record. 106(7):152, 1980 Feb 16. Davies AO. Malignant temperature probe [letter] Canadian Anaesthetists Society Journal. 27(2):179-80, 1980 Mar. Frank JP. Harati Y. Butler IJ. Nelson TE. Scott CI. Central core disease and malignant hyperthermia syndrome. Annals of Neurology. 7(1):11-7, 1980 Jan. Flewellen EH. Nelson TE. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. Anesthesiology. 52(4):303-8, 1980 Apr. Caroff SN. The neuroleptic malignant syndrome. Journal of Clinical Psychiatry. 41(3):79-83, 1980 Mar. Korczyn AD. Shavit S. Shlosberg I. The chick as a model for malignant hyperpyrexia. European Journal of Pharmacology. 61(2):187-9, 1980 Jan 25. Flewellen EH. Nelson TE. Bee DE. Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect). Canadian Anaesthetists Society Journal. 27(1):16-21, 1980 Jan. Britt BA. Endrenyi L. Frodis W. Scott E. Kalow W. Comparison of effects of several inhalation anaesthetics on caffeine -induced contractures of normal and malignant hyperthermic skeletal muscle. Canadian Anaesthetists Society Journal. 27(1):12-5, 1980 Jan. Britt BA. Endrenyi L. Scott E. Frodis W. Effect of temperature, time and fascicle size on the caffeine contracture test. Canadian Anaesthetists Society Journal. 27(1):1-11, 1980 Jan. Zsigmond EK. Malignant hyperthermia--a misnomer [letter] Jama. 243(6):513, 1980 Feb 8. Godin DV. Bridges MA. MacLeod PJ. Erythrocyte membrane enzyme abnormalities in two hereditary disorders of muscle. Journal of Medicine; Clinical, Experimental & Theoretical. 10(4):287-302, 1979. Dvo:r:ak M. The effect of halothane anesthesia on the function of the adrenal cortex and some metabolites in the blood plasma of pigs not susceptible to malignant hyperthermia [Cze] Veterinarni Medicina. 24(9):513-23, 1979 Sep. Suchenwirth RM. Koechel R. Clinical myology [Ger] Mmw - Munchener Medizinische Wochenschrift. 119(50):1627-35, 1977 Dec 16. Lees DE. Macnamara T. Ketamine-induced hyperthermia--postictal or malignant?. Anesthesiology. 47(4):390-1, 1977 Oct. Gullo A. Mocavero G. Romano E. Del Prete D. Silvestri L. Malignant hyperthermia. Review of literature and case reports [Ita] Minerva Anestesiologica. 45(12):961-80, 1979 Dec. Dobrovolsky W. Malignant hyperthermia--an overview. Oral Health. 69(6):47-51, 64, 1979 Jun. Carter JG. Gergis SD. Sokoll MD. Malignant hyperthermia. Middle East Journal of Anaesthesiology. 5(5):337-47, 1979 Oct. Britt BA. Preanesthetic diagnosis of malignant hyperthermia. International Anesthesiology Clinics. 17(4):63-96, 1979 Winter. Harrison GG. Porcine malignant hyperthermia. International Anesthesiology Clinics. 17(4):25-61, 1979 Winter. Kalow W. Britt BA. Chan FY. Epidemiology and inheritance of malignant hyperthermia. International Anesthesiology Clinics. 17(4):119-39, 1979 Winter. Denborough MA. Etiology and pathophysiology of malignant hyperthermia. International Anesthesiology Clinics. 17(4):11-23, 1979 Winter. Rawlins MD. Drug interactions and anaesthesia. British Journal of Anaesthesia. 50(7):689-93, 1978 Jul. Hall GM. Body temperature and anaesthesia. British Journal of Anaesthesia. 50(1):39-44, 1978 Jan. Britt BA. McComas AJ. Endrenyi L. Kalow W. Motor unit counting and the caffeine contracture test in malignant hyperthermia. Anesthesiology. 47(6):490-7, 1977 Dec. Fenoglio JJ Jr. Irey NS. Myocardial changes in malignant hyperthermia. American Journal of Pathology. 89(1):51-8, 1977 Oct. Bergstrom L. Osteogenesis imperfecta: otologic and maxillofacial aspects. Laryngoscope. 87(9 Pt 2 Suppl 6):1-42, 1977 Sep. Gallo P. Iafrate E. Malignant hyperthermia [Ita] Recenti Progressi In Medicina. 62(3):239-61, 1977 Mar. Stephen CR. Malignant hyperpyrexia. Annual Review of Medicine. 28:153-7, 1977. Miller RC. Connor WG. Heusinkveld RS. Boone ML. Prospects for hyperthermia in human cancer therapy.Part I: hyperthermic effects in man and spontaneous animal tumors. Radiology. 123(2):489-95, 1977 May. Lucke JN. Hall GM. Lister D. Anaesthesia of pigs sensitive to malignant hyperthermia. Veterinary Record. 100(3):45-8, 1977 Jan 15. Patel AU. Stark DC. Miller R. The anesthetic management of a diabetic patient susceptible to malignant hyperpyrexia: a case report. Mount Sinai Journal of Medicine. 45(4):495-502, 1978 Jul-Aug. Reed SB. Strobel GE Jr. An in-vitro model of malignant hyperthermia: differential effects of inhalation anesthetics on caffeine-induced muscle contractures. Anesthesiology. 48(4):254-9, 1978 Apr. Winder RL. Simon JF Jr. Wingard DW. Malignant hyperthermia and stress: a concern in dental therapy. Journal of Pedodontics. 3(2):142-54, 1979 Winter. Trieger N. M.H. and other "hot stuff" [editorial] Anesthesia Progress. 26(3):65, 1979 May-Jun. Gallagher DM. Malignant hyperthermia [letter] Oral Surgery, Oral Medicine, Oral Pathology. 48(5):415, 1979 Nov. Bronstein SL. Ryan DE. Solomons CC. Mahowald MC. Dantrolene sodium in the management of patients at risk from malignant hyperthermia. Journal of Oral Surgery. 37(10):719-24, 1979 Oct. Lucke JN. Hall GM. Lister D. Malignant hyperthermia in the pig and the role of stress. Annals of the New York Academy of Sciences. 317:326-37, 1979. Anonymous. Malignant hyperthermia [letter] Journal of the American Dental Association. 98(6):898-9, 1979 Jun. Brockhouse RT. Malignant hyperthermia. Journal of the American Dental Association. 98(4):581-3, 1979 Apr. Kalow W. Malignant hyperthermia. Human Genetics - Supplement. (1):69-70, 1978. Krakowiak FJ. Vatral JJ. Moore RC Jr. Pickett AB. Nylander JE. Gullett FC. Malignant hyperthermia. Report of two cases. Oral Surgery, Oral Medicine, Oral Pathology. 47(3):218-22, 1979 Mar. Free CW. Jaimon MP. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. New Zealand Medical Journal. 88(626):493-4, 1978 Dec 27. Goupil MT. Roche WC. Preoperative and operative considerations in malignant hyperpyrexia. Journal of the American Dental Association. 96(6):1033-6, 1978 Jun. Dorion RB. Caution--lethal entrapments. Oral Health. 67(8):11-2, 1977 Aug. Edwards DB. Be alert for symptoms of malignant hyperthermia. Dental Student. 55(9):33-4, 39, 1977 Jun. Freeman NS. King RA. Plezia RA. Shearer HT. Office emergencies: an outline of causes, symptoms, and treatment. Journal of the American Dental Association. 94(1):91-6, 1977 Jan. Poirson B. Malignant hyperthermia [Fre] Soins. 22(13-14):49-50, 1977 Jul 5-20. Zelechowski GP. Hidden killer= malignant hyperthermia. Nursing. 7(9):55, 1977 Sep. Gifford SW. Malignant hyperpyrexia: a dread complication. Aana Journal. 45(1):49-56, 1977 Feb. Hrizo RW. "My family's fight with malignant hyperthermia". Rn. 40(2):20-2, 1977 Feb. Mormede P. Dantzer R. Behavioural and pituitary-adrenal characteristics of pigs differing by their susceptibility to the malignant hyperthermia syndrome induced by halothane anesthesia. 2. Pituitary-adrenal function. Annales De Recherches Veterinaires. 9(3):569-76, 1978. Rivera VM. Patten BM. Neuromyopathy in malignant hyperthermia. Journal of Clinical Psychiatry. 39(1):67-71, 1978 Jan. Gronert GA. Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia. Anesthesia & Analgesia. 58(5):367-71, 1979 Sep-Oct. Faust DK. Gergis SD. Sokoll MD. Management of suspected malignant hyperpyrexia in an infant. Anesthesia & Analgesia. 58(1):33-5, 1979 Jan-Feb. Lees DE. Schuette W. Bull JM. Whang-Peng J. Atkinson ER. Macnamara TE. An evaluation of liquid-crystal thermometry as a screening device for intraoperative hyperthermia. Anesthesia & Analgesia. 57(6):669-74, 1978 Nov-Dec. Tsueda K. Dubick MN. Wright BD. Sachatello CR. Intraoperative hyperthermic crisis in two children with undifferentiated lymphoma. Anesthesia & Analgesia. 57(4):511-4, 1978 Jul-Aug. Mayhew JF. Rudolph J. Tobey RE. Malignant hyperthermia in a six-month old infant: a case report. Anesthesia & Analgesia. 57(2):262-4, 1978 Mar-Apr. Rosenberg H. Malignant hyperthermia syndrome [letter]. Anesthesia & Analgesia. 56(3):466, 1977 May-Jun. Hitt BA. Mazze RI. Cook TL. Beppu WJ. Kosek JC. Thermoregulatory defect in rats during anesthesia. Anesthesia & Analgesia. 56(1):9-15, 1977 Jan-Feb. Bracali AM. Sette MP. Marana E. Risk and choice of anesthetics for patients with previous malignant hyperthermia syndrome [Ita] Minerva Anestesiologica. 45(10):749-53, 1979 Oct. Monin G. Sellier P. Ollivier L. Blood characteristics of some french pig populations. Relationships with the malignant hyperthermia syndrome (author's transl) [Fre] Annales De Recherches Veterinaires. 10(4):535-47, 1979. Augustyniak B. Uszy:nski M. Case of unidentified fever in the postoperative period - malignant hyperthermia syndrome? [Pol] Ginekologia Polska. 50(11):969-72, 1979 Nov. Jardon OM. Barak AJ. Wingard DW. Elevated muscle choline pool in malignant hyperthermic swine. Surgical Forum. 30:487-9, 1979. Nelson TE. Flewellen EH. Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion. Texas Reports On Biology & Medicine. 38:105-20, 1979. Macrae WA. Miller KM. Watson AA. Malignant hyperpyrexia. Medicine, Science & the Law. 19(4):261-4, 1979 Oct. Caranasos GJ. Drug reactions and interactions in the patient undergoing surgery. Medical Clinics of North America. 63(6):1245-55, 1979 Nov. Nelson TE. Flewellen EH. Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?. Canadian Anaesthetists Society Journal. 26(6):484-8, 1979 Nov. Bernstein RA. Malignant neuroleptic syndrome: an atypical case. Psychosomatics. 20(12):840, 845-6, 1979 Dec. Youngberg JA. Anesthetic management of a pregnant patient with malignant hyperpyrexia susceptibility. Journal of the Medical Association of Georgia. 68(12):1046-8, 1979 Dec. Harriman DG. Preanesthetic investigation of malignant hyperthermia: microscopy. International Anesthesiology Clinics. 17(4):97-117, 1979 Winter. Ryan JF. Treatment of acute hyperthermia crises. International Anesthesiology Clinics. 17(4):153-68, 1979 Winter. Relton JE. Anesthesia for elective surgery in patients susceptible to malignant hyperthermia. International Anesthesiology Clinics. 17(4):141-51, 1979 Winter. Steward DJ. Malignant hyperthermia--the acute crisis. International Anesthesiology Clinics. 17(4):1-9, 1979 Winter. Anonymous. Malignant hyperthermia. International Anesthesiology Clinics. 17(4):vii-x, 1-182, 1979 Winter. Britt BA. Malignant hyperthermia: preface. International Anesthesiology Clinics. 17(4):vii-x, 1979 Winter. Halsall PJ. Cain PA. Ellis FR. Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized. British Journal of Anaesthesia. 51(10):949-54, 1979 Oct. Actis Dato A. Panero GB. De Michelis M. Malignant hyperthermia treated with refrigerant venous catheterization [Ita] Minerva Medica. 70(48):3309-14, 1979 Nov 3. Gallant EM. Godt RE. Gronert GA. Role of plasma membrane defect of skeletal muscle in malignant hyperthermia. Muscle & Nerve. 2(6):491-4, 1979 Nov-Dec. Anonymous. Dantrolene sodium approved for malignant hyperthermia. Fda Drug Bulletin. 9(5):27, 1979 Nov. Cheah KS. Cheah AM. Mitochondrial calcium, erythrocyte fragility and porcine malignant hyperthermia. Febs Letters. 107(2):265-8, 1979 Nov 15. Friesen CM. Brodsky JB. Dillingham MF. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report. Canadian Anaesthetists Society Journal. 26(4):319-21, 1979 Jul. Liebensch:utz F. Mai C. Pickerodt VW. Increased carbon dioxide production in two patients with malignant hyperpyrexia and its control by dantolene. British Journal of Anaesthesia. 51(9):899-903, 1979 Sep. Gronert GA. Heffron JJ. Taylor SR. Skeletal muscle sarcoplasmic reticulum in porcine malignant hyperthermia. European Journal of Pharmacology. 58(2):179-87, 1979 Sep 15. Ahern CP. McLoughlin JV. Wheatley AM. Wilson P. Wilson CW. Althesin as an anaesthetic in experimental animals susceptible to halothane-initiated malignant hyperthermia [proceedings] British Journal of Pharmacology. 67(3):425P, 1979 Nov. Halsall PJ. Ellis FR. A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene. British Journal of Anaesthesia. 51(8):753-6, 1979 Aug. Mathieu A. Bogosian AJ. Ryan JF. Crone RK. Crocker D. Recrudescence after survival of an initial episode of malignant hyperthermia. Anesthesiology. 51(5):454-5, 1979 Nov. Jardon OM. Wingard DW. Barak AJ. Connolly JF. Malignant hyperthermia. A potentially fatal syndrome in orthopaedic patients. Journal of Bone & Joint Surgery - American Volume. 61(7):1064 -70, 1979 Oct. Marichy J. Ceyrat J. Vitani C. David JJ. Dutrieux N. Malignant syndrome in burned children. Nosologic and therapeutic approach [Fre] Anesthesie, Analgesie, Reanimation. 36(3-4):111-5, 1979 Mar -Apr. Nelson TE. Bee DE. Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle. Journal of Clinical Investigation. 64(4):895-901, 1979 Oct. Hoff BH. Kreul JF. Heat stroke [letter] Annals of Internal Medicine. 91(3):503, 1979 Sep. Kaskey GB. Nasr S. A side effect of rapid neuroleptization [letter] American Journal of Psychiatry. 136(9):1232, 1979 Sep. Britt BA. Harrison JE. McNeill KG. In vivo neutron activation analysis for bone calcium (INVAA) in malignant hyperthermia susceptible patients. Canadian Anaesthetists Society Journal. 26(2):117-24, 1979 Mar. Eberlein HJ. Therapy of malignant hyperthermia, preliminary report (letter) [Ger] Anaesthesist. 28(5):247-8, 1979 May. Thompson TN. Malignant hyperthermia from PCP [letter] Journal of Clinical Psychiatry. 40(7):327, 1979 Jul. Falk E. Simonsen J. The histology of myocardium in malignant hyperthermia: a preliminary report of 11 cases. Forensic Science International. 13(3):211-20, 1979 May-Jun. Blanck TJ. Gruener R. Casey WJ. Stern LZ. Malignant hyperthermia. Arizona Medicine. 36(5):351-3, 1979 May. Ward CF. Muscular dystrophy and malignant hyperthermia--similiar signs [letter] Anesthesiology. 51(2):184-5, 1979 Aug. Freitag B. Malignant hyperthermia: clinical aspects and treatment (author's transl) [Ger] Zentralblatt Fur Chirurgie. 104(6):353-8, 1979. Morikawa S. At conclusion of the trial concerning a case of malignant hyperthermia [Jpn] Masui - Japanese Journal of Anesthesiology. 28(5):530-1, 1979 May. Durbin CG Jr. Rosenberg H. A laboratory animal model for malignant hyperpyrexia. Journal of Pharmacology & Experimental Therapeutics. 210(1):70 -4, 1979 Jul. Livaditis A. J:onsson L. The piglet in experimental pediatric surgery. Zeitschrift Fur Versuchstierkunde. 21(2):78-82, 1979. Okumura F. Crocker BD. Denborough MA. Identification of susceptibility to malignant hyperpyrexia in swine. British Journal of Anaesthesia. 51(3):171-6, 1979 Mar. Nelson TE. Flewellen EH. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia. Anesthesiology. 50(2):118-22, 1979 Feb. Willatts SM. Malignant hyperthermia susceptibility. Management during pregnancy and labour. Anaesthesia. 34(1):41-6, 1979 Jan. Morikawa S. Murata M. Murata H. Iwai S. Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 28(2):187-96, 1979 Feb. James P. Vitamin E and malignant hyperthermia [letter] British Medical Journal. 1(6157):200, 1979 Jan 20. Theilade D. Halothane-induced malignant hyperthermia. Report of successful treatment of 2 patients [Dan] Ugeskrift For Laeger. 141(6):384-5, 1979 Feb 5. Martel A. Spigelblatt L. Perreault L. Rosenfeld R. A case of malignant hyperthermia occuring in a dental clinic [Fre] Canadian Anaesthetists Society Journal. 26(1):55-7, 1979 Jan. Lees DE. Kim YD. Schuette W. Bull J. Whang-Peng J. Causes of induced hyperthermia [letter] Anesthesiology. 50(1):69-70, 1979 Jan. Britt BA. Etiology and pathophysiology of malignant hyperthermia. Federation Proceedings. 38(1):44-8, 1979 Jan. Schellnack K. Regling G. Hofmann J. Buntrock P. Martin H. Hecht H. Relationship between malignant hyperthermia and myopathy [Scr] Neurologija. 25 Spec No:109-12, 1977. Mazzia VD. Simon AH. Another look at malignant hyperthermia. Legal Medicine Annual. :167-73, 1978. Watanabe S. Akita T. Mikami H. Himeno K. Further evidence for the existence of the [PHIA, HALn] haplotype in the Landrace breed. Animal Blood Groups & Biochemical Genetics. 9(4):253-6, 1978. Varesi M. Preoperative assay of creatine phosphokinase as a precaution against malignant hyperthermia (author's transl) [Ita] Chirurgia Italiana. 30(6):899-908, 1978 Dec. Dantzer R. Mormede P. Behavioural and pituitary-adrenal characteristics of pigs differing by their susceptibility to the malignant hyperthermia syndrome induced by halothane anesthesia. 1. Behavioural measures. Annales De Recherches Veterinaires. 9(3):559-67, 1978. Litarczek G. Bentia L. Ghiga R. Malignant hyperthermia. Report on a case successfully treated by procaine infusion (author's transl) [Ger] Anaesthesist. 27(12):566-9, 1978 Dec. Matossi L'Orsa R. Miegge C. Bona C. Debernardi F. Carmignani F. Bagliani C. Giustetto A. Malignant hyperpyrexia. Etiopathogenetic and therapeutic considerations [Ita] Minerva Anestesiologica. 44(6):377-90, 1978 Jun. Pertz C. Sundberg JP. Malignant hyperthermia induced by etorphine and xylazine in a fallow deer. Journal of the American Veterinary Medical Association. 173(9):1243, 1978 Nov 1. Dumont A. Minjat M. Blanc JL. Vignon H. Malignant syndrome caused by neuroleptics (3 observations) [Fre] Annales De L Anesthesiologie Francaise. 19(9):777-82, 1978. Delign:e P. Bunodi`ere M. Antipsychotic neuroplegic and neuroleptic agents. IV. Phenothiazines (3) [Fre] Annales De L Anesthesiologie Francaise. 19(9):1J-13J, 1978. Dempsey WC. Mayhew JF. Metz PS. Southern TE. Malignant hyperthermia during repair of a cleft lip in a 6-month-old infant, with survival. Annals of Plastic Surgery. 1(3):315-8, 1978 May. Wulfhorst V. Kessler G. Anaesthesia-induced malignant hyperthermia (author's transl) [Ger] Praktische Anaesthesie, Wiederbelebung Und Intensivtherapie. 13(3):224-8, 1978 Jun. P:uschel K. Brinkmann B. Janssen W. Epidemiological aspects of malignant hyperthermia (author's transl) [Ger] Praktische Anaesthesie, Wiederbelebung Und Intensivtherapie. 13(3):219-23, 1978 Jun. Wolfe JS. Bagenstose JE. Malignant hyperthermia: a complication of orthopedic surgery. Orthopedics - pcm. 1(3):211-4, 1978 May-Jun. Matsubara T. Porcine stress syndrome (PSS) responsible for malignant hyperthermia [Jpn] Jikken Dobutsu - Experimental Animals. 27(4):444-6, 1978 Oct. Wilson JW. Malignant hyperthermia [letter] Southern Medical Journal. 71(11):1454, 1978 Nov. Krolevets IP. Gorbacheva MP. Malignant hyperthermia as a complication of anesthesia [Rus] Anesteziologiia I Reanimatologiia. (5):73-5, 1978 Sep-Oct. Demeyere R. Malignant hyperthermia. Acta Anaesthesiologica Belgica. 29(1):101-20, 1978. Huckell VF. Staniloff HM. Britt BA. Waxman MB. Morch JE. Cardiac manifestations of malignant hyperthermia susceptibility. Circulation. 58(5):916-25, 1978 Nov. Britt BA. Shandling B. Endrenyl L. Kent GM. Perfusion of malignant hyperthermia susceptible and normal isolated pig livers with halothane. Canadian Anaesthetists Society Journal. 25(5):373-9, 1978 Sep. Mann SC. Boger WP. Psychotropic drugs, summer heat and humidity, and hyperpyrexia: a danger restated. American Journal of Psychiatry. 135(9):1097-1100, 1978 Sep. Hugo JM. Ungerer MJ. Erasmus FR. du Toit PW. Muller FO. van Velden DJ. Malignant hyperthermia in a black child. A case report [Afr] South African Medical Journal. 53(20):807-10, 1978 May 20. Kito S. Malignant hyperpyrexia and muscular lesions [Jpn] Nippon Rinsho - Japanese Journal of Clinical Medicine. Suppl:1752-3, 1978 May. Theilade D. Rosendal T. Malignant hyperpyrexia. A case report of successful treatment and subsequent uneventful general anaesthesia. Anaesthesia. 33(7):606-10, 1978 Jul-Aug. Jan KM. Dorsey S. Bornstein A. Medical malpractice [letter] New England Journal of Medicine. 299(13):722, 1978 Sep 28. Lane RJ. Mastaglia FL. Drug-induced myopathies in man. Lancet. 2(8089):562-6, 1978 Sep 9. Bennett D. Cain P. Ellis FR. Halsall J. Louis CF. Effect of halothane on the rate of acid production, lactate production and pyruvate dehydrogenase activity of malignant hyperpyrexia human muscle. British Journal of Anaesthesia. 50(8):799-803, 1978 Aug. de la Bastaie P. Poujol C. Malignant hyperthermia of effort or "heat stroke" (author's transl) [Fre] Nouvelle Presse Medicale. 7(27):2381-5, 1978 Jul 1-8. Viiachki I. Krustev M. Dimitrov R. Case of malignant hyperthermia [Bul] Khirurgiia - Sofia. 31(2):157, 1978. Hall GM. Lucke JN. Lovell R. Lister D. Hepatic metabolism in pig malignant hyperthermia [proceedings] Biochemical Society Transactions. 6(3):587-8, 1978. Williams CH. Hoech GP Jr. Roberts JT. Experimental malignant hyperthermia [letter] Anesthesiology. 49(1):58-60, 1978 Jul. Brandt MR. Kehlet H. J:rgensen PF. Smith M. Would morphine in large doses prevent malignant hyperthermia? [letter] Anesthesiology. 49(1):57, 1978 Jul. Gibbs JM. A case of rhabdomyolysis associated with suxamethonium. Anaesthesia & Intensive Care. 6(2):141-5, 1978 May. Nampo T. Kawashima Y. Meguro K. Aruga K. Yoshikawa H. Ohtani Y. Tanimura O. Takei H. Malignant hyperpyrexia following the reversal of muscle relaxant: a case report of non-rigidity type (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 27(6):640-6, 1978 Jun. Cohen CA. Malignant hyperthermia in a greyhound [letter] Journal of the American Veterinary Medical Association. 172(11):1254, 1256, 1978 Jun 1. Schuster DE. Malignant hyperpyrexia [letter] Medical Journal of Australia. 1(2):98-9, 1978 Jan 28. Seay AR. Ziter FA. Malignant hyperpyrexia in a patient with Schwartz-Jampel syndrome. Journal of Pediatrics. 93(1):83-4, 1978 Jul. James P. Vitamin E and malignant hyperthermia [letter] British Medical Journal. 1(6123):1345, 1978 May 20. Haberman ML. Malignant hyperthermia. An allergic reaction to thioridazine therapy. Archives of Internal Medicine. 138(5):800-1, 1978 May. Blume H. Schmidt EW. Cayuela S. Ostheimer U. Perge V. Stankovic R. Wellstein A. Clinical and laboratory aspects of malignant hyperthermia in children with special reference to creatine kinase isoenzymes (author's transl) [Ger] Anaesthesist. 27(3):108-14, 1978 Mar. Lucke JN. Denny H. Hall GM. Lovell R. Lister D. Porcine malignant hyperthermia. VI: the effects of bilateral adrenalectomy and pretreatment with bretylium on the halothane-induced response. British Journal of Anaesthesia. 50(3):241-6, 1978 Mar. Eng GD. Epstein BS. Engel WK. McKay DW. McKay R. Malignant hyperthermia and central core disease in a child with congenital dislocating hips. Archives of Neurology. 35(4):189-97, 1978 Apr. Wagner H. Bartel B. A further case of malignant hyperthermia. A contribution towards extending the present catalogue (author's transl) [Ger] Anaesthesist. 27(2):84-6, 1978 Feb. Jessen K. Hansen E. Kratholm S. Lunding M. Ording H. Mogensen JV. Malignant hyperthermia [Dan] Ugeskrift For Laeger. 140(3):95-9, 1978 Jan 16. Schneider H. Krahn J. A case of malignant hyperthermia unrelated to anaesthesia (author's transl) [Ger] Praktische Anaesthesie, Wiederbelebung Und Intensivtherapie. 13(1):59-62, 1978 Feb. Ellis FR. Cain PA. Harriman DG. Toothill C. Plasma cholinesterase and malignant hyperpyrexia [letter] British Journal of Anaesthesia. 50(1):86, 1978 Jan. Lucke JN. Denny HR. The role of the sympathetic nervous system in the pathogenesis of halothane-induced malignant hyperthermia in the pietrain pig [proceedings] British Journal of Anaesthesia. 50(1):75-6, 1978 Jan. Hull MT. Muller J. Albrecht WH. Morphologic abnormalities in a case of malignant hyperthermia. Anesthesiology. 48(3):223-8, 1978 Mar. Bagshaw RJ. Cox RH. Knight DH. Detweiler DK. Malignant hyperthermia in a Greyhound. Journal of the American Veterinary Medical Association. 172(1):61-2, 1978 Jan 1. McKnight DJ. Marshall BM. Catamenial pneumothorax and malignant hyperthermia. Canadian Anaesthetists Society Journal. 25(1):60-2, 1978 Jan. Lari S. Caroli G. Urso L. Fabozzi A. Cipressi M. Intraoperative malignant hyperthermia. Clinical experience [Ita] Chirurgia Degli Organi Di Movimento. 63(6):613-20, 1977. Desbarax PM. Anesthesia and resuscitation in myopathies. Acta Anaesthesiologica Belgica. 28(3):141-56, 1977. Denborough MA. Malignant hyperpyrexia [editorial] Medical Journal of Australia. 2(23):757-8, 1977 Dec 3. Ginestet D. Plumecoq C. Farine K. Brion S. "Heat stroke" and/or "Malin's syndrome" in a patient treated with fluphenazine decanoate [Fre] Encephale. 3(4):327-31, 1977. Fabre S. Gervais C. Manuel C. Vic Dupont V. Toxic syndrome induced by neuroleptics: report of 7 cases [Fre] Encephale. 3(4):321-6, 1977. Bushman JA. The price of anaesthesia. British Journal of Hospital Medicine. 18(6):584, 586, 1977 Dec. Hall GM. Lucke JN. Lister D. Failure of methylprednisolone in porcine malignant hyperthermia [letter] Lancet. 2(8052-8053):1359, 1977 Dec 24-31. Palmer EG. Topel DG. Christian LL. Microscopic observations of muscle from swine susceptible to malignant hyperthermia. Journal of Animal Science. 45(5):1032-6, 1977 Nov. Mathews JE. Malignant hyperthermia. American Journal of Surgery. 134(6):803-4, 1977 Dec. Andresen E. Jensen P. Close linkage established between the HAL locus for halothane sensitivity and the PHI (phosphohexose isomerase) locus in pigs of the Danish Landrace breed. Nordisk Veterinaermedicin. 29(11):502-4, 1977 Nov. Bolis GB. Bolis Ferranti MG. A case of malignant hyperthermia, in a child, induced by an anesthetic [Ita] Lavori Dell Istituto Di Anatomia E Istologia Patologica, Universita Degli Studi Perugia. 37(2):71-81, 1977. Kalow W. Britt BA. Richter A. The caffeine test of isolated human muscle in relation to malignant hyperthermia. Canadian Anaesthetists Society Journal. 24(6):678-94, 1977 Nov. Bernhardt D. H:order MH. Extra-cardial rise of the CPK in the screening of urgent diagnostic (among others, a case of anaesthesia induced myoglobinuria and a case of malignant hypertermia) (author's transl) [Ger] Medizinische Klinik - Munich. 72(46):1967-71, 1977 Nov 18. Bennett D. Cain PA. Ellis FR. Louis CF. Stanton M. Calcium and magnesium contents of malignant hyperpyrexia-susceptible human muscle. British Journal of Anaesthesia. 49(10):979-82, 1977 Oct. Lucke JN. Malignant hyperthermia in a parturient Poland China sow [letter] British Journal of Anaesthesia. 49(10):1070, 1977 Oct. Mayzner-Zawadzka E. Krawczy:nska-Wichrzycka R. Kwiatkowski H. Kami:nski B. Present-day views on the diagnosis of intraoperative malignant hyperthermia syndrome [Pol] Polski Tygodnik Lekarski. 32(43):1683-6, 1977 Oct 24. Yazaki S. Suziki H. Ogawa S. Kuniyoshi K. Tai K. Generalized muscular stiffness with myoglobinuria and increased serum enzymes induced by succinylcholine: a case report (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 26(8):950-5, 1977 Aug. Honda N. Konno K. Itohda Y. Nishino M. Haseba S. Histological and electronmicroscopic findings in muscle biopsies from the survivor of malignant hyperthermia (author's transl) [Jpn] Masui - Japanese Journal of Anesthesiology. 26(7):786-90, 1977 Jul. Cain PA. Ellis FR. Anaesthesia for patients susceptible to malignant hyperpyrexia. A study Journal of pancuronium and methylprednisolone. British Journal of Anaesthesia. 49(9):941-4, 1977 Sep. Hall GM. Lucke JN. Lister D. Porcine malignant hyperthermia. V: Fatal hyperthermia in the Pietrain pig, associated with the infusion of alpha-adrenergic agonists. British Journal of Anaesthesia. 49(9):855-63, 1977 Sep. Gronert GA. Milde JH. Theye RA. Role of sympathetic activity in porcine malignant hyperthermia. Anesthesiology. 47(5):411-5, 1977 Nov. Maurer H. Medico-legal assessment of malignant hyperthermia [Ger] Beitrage Zur Gerichtlichen Medizin. 35:41-5, 1977. Brinkmann B. P:uschel K. On histomorphological changes of the heart and skeleton muscles in malignant hyperpyrexia (author's transl) [Ger] Zeitschrift Fur Rechtsmedizin - Journal of Legal Medicine. 80(2):117-33, 1977 Aug 26. Austin KL. Denborough MA. Drug treatment of malignant hyperpyrexia. Anaesthesia & Intensive Care. 5(3):207-13, 1977 Aug. Fisk GC. Malignant hyperpyrexia [editorial] Anaesthesia & Intensive Care. 5(3):195-6, 1977 Aug. Isaacs H. Malignant hyperpyrexia [editorial] South African Medical Journal. 52(10):387-8, 1977 Aug 27. de la Fuente J. Urz:ua J. Allende M. Malignant hypertermia (author's transl) [Spa] Revista Medica De Chile. 105(6):396-401, 1977 Jun. Kaplan AM. Bergeson PS. Gregg SA. Curless RG. Malignant hyperthermia associated with myopathy and normal muscle enzymes. Journal of Pediatrics. 91(3):431-4, 1977 Sep. Smith C. Bampton PR. Inheritance of reaction to halothane anaesthesia in pigs. Genetical Research. 29(3):287-92, 1977 Jun. Chapman CJ. Drugs and genes: therapeutic implications. Drugs. 14(2):120-7, 1977 Aug. Greenfield S. Bronsther B. Abrams MW. Rosenberg H. The malignant hyperthermia syndrome: an unusual complication of anesthesia. Clinical Pediatrics. 16(9):808-11, 1977 Sep. Nelson TE. Denborough MA. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia. Clinical & Experimental Pharmacology & Physiology. 4(3):315 -22, 1977 May-Jun. Honda N. Konno K. Itohda Y. Nishino M. Matsushima S. Haseba S. Honda Y. Gotoh Y. Malignant hyperthermia and althesin. Canadian Anaesthetists Society Journal. 24(4):514-21, 1977 Jul. Whittaker M. Spencer R. Searle J. Plasma cholinesterase and malignant hyperthermia [letter] British Journal of Anaesthesia. 49(4):393, 1977 Apr. Harrison GG. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine. British Journal of Anaesthesia. 49(4):315-7, 1977 Apr. Moeller R. Bernage C. Laxenaire MC. Abnormal reactions during combined pentothal-suxamethonium-halothane anesthesia [Fre] Anesthesie, Analgesie, Reanimation. 34(1):193-8, 1977 Jan -Feb. Hoevenaars F. Sengers RC. Stadhouders AM. Gielen MJ. Brunings WL. Trijbels JM. Bookelman H. Malignant hyperpyrexia: a frequently unrecognized complication of anesthesia [Dut] Nederlands Tijdschrift Voor Geneeskunde. 121(24):976-81, 1977 Jun 11. Navas JJ. Ultrastructure of skeletal muscle in a case of malignant hyperpyrexia. Imj - Illinois Medical Journal. 151(6):433-6, 1977 Jun. Katz JD. Malignant hyperthermia during regional anesthesia [letter]. Anesthesiology. 47(1):75, 1977 Jul. Hall GM. Lucke JN. Lister D. Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig. Anaesthesia. 32(5):472-4, 1977 May. Somers CJ. Wilson P. Ahern CP. McLoughlin JV. Energy phosphate turnover and glycolysis in skeletal muscle of the Pietrain pig: the effects of premedication with azaperone and pentobarbitone anaesthesia. Journal of Comparative Pathology. 87(2):177-83, 1977 Apr. Hankiewicz J. Scieszkowa M. Clinical interpretation of increased serum creatine kinase activity [Pol] Polski Tygodnik Lekarski. 32(13):505-8, 1977 Mar 28. Rush JL. Foltz EL. Malignant hyperthermia. Journal of Neurosurgery. 46(3):385-90, 1977 Mar. Nelson TE. Austin KL. Denborough MA. Screening for malignant hyperpyrexia. British Journal of Anaesthesia. 49(2):169-72, 1977 Feb. Gronert GA. Heffron JJ. Milde JH. Theye RA. Porcine malignant hyperthermia: role of skeletal muscle in increased oxygen consumption. Canadian Anaesthetists Society Journal. 24(1):103-9, 1977 Jan. Wadhwa RK. Obstetric anesthesia for a patient with malignant hyperthermia susceptibility. Anesthesiology. 46(1):63-4, 1977 Jan. Sz:eplaki F. Comments on the article on hyperpyrexia [Hun] Orvosi Hetilap. 118(1):53-4, 1977 Jan 2. Regling G. Schellnack K. Schramm G. Lindenhayn K. Grossmann G. Hofmann J. Malignant hyperthermia and dysostoses [Ger] Beitrage Zur Orthopadie Und Traumatologie. 23(11):648-56, 1976 Nov. Shoji S. Sugita H. Determination of creatine phosphokinase and its isoenzymes [Jpn] Nippon Rinsho - Japanese Journal of Clinical Medicine. 34 suppl:2501-12, 1976. Goudsouzian NG. Ryan JF. Recent advances in pediatric anesthesia. Pediatric Clinics of North America. 23(2):345-60, 1976 May. Chernokozhev Kh. Malignant hyperthermia during an operation (a review of the literature) [Bul] Khirurgiia - Sofia. 29(1):64-9, 1976. Shibolet S. Lancaster MC. Danon Y. Heat stroke: a review. Aviation Space & Environmental Medicine. 47(3):280-301, 1976 Mar. Himms-Hagen J. Cellular thermogenesis. Annual Review of Physiology. 38:315-51, 1976. Wingard DW. Monitoring temperature during anesthesia [letter]. Jama. 236(23):2604, 1976 Dec 6. Nover A. Rheindorf P. Heinrich I. Malignant hyperpyrexia--an unusual anesthesia-incident [Ger] Bucherei Des Augenarztes. (68):122-8, 1976. Meltzer HY. Hassan SZ. Russo P. Cho HW. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia. Anesthesia & Analgesia. 55(6):797-9, 1976 Nov-Dec. Inoue S. Mori H. Takase S. Okano K. Myopathic syndrome induced by general anesthesia--a case report [Jpn] Masui - Japanese Journal of Anesthesiology. 25(20):971-6, 1976 Oct 1. Oyaert W. Van Den Hende C. Muylle E. Malignant hyperthermia in Belgian landrace pigs [Dut] Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie. 38(5):209-34, 1976. Hall GM. Lucke JN. Lister D. Porcine malignant hyperthemia IV: Neuromuscular blockade. British Journal of Anaesthesia. 48(12):1135-41, 1976 Dec. Pogorel'tsev AG. Kochnev AN. Dorofeev AI. Tishin PE. Favr VV. Case of malignant hyperthermia [Rus] Vestnik Khirurgii Imeni I - I - Grekova. 117(11):111, 1976 Nov. Gullotta F. Wierich W. Dieckmann J. Malignant hyperthermia, chronic alcoholism and tubular aggregates (author's transl) [Ger] Praktische Anaesthesie, Wiederbelebung Und Intensivtherapie. 11(6):410-5, 1976 Dec. Skakun NP. Ole:inik AN. Shendevitski:i VI. Adverse effect of muscle relaxants and narcotics in hereditary diseases (literature survey) [Rus] Khirurgiia. (11):141-5, 1976 Nov. Schellnack K. Regling G. Hofmann J. Buntrock P. Martin H. Hecht H. Malignant hyperthermia in subclinical myotonic dystrophy [Ger] Beitrage Zur Orthopadie Und Traumatologie. 23(10):537-44, 1976 Oct. Williams CH. Some observations on the etiology of the fulminant hyperthermia-stress syndrome. Perspectives In Biology & Medicine. 20(1):120-30, 1976 Autumn. Laxenaire MC. Sigiel M. Suxamethonium [Fre] Anesthesie, Analgesie, Reanimation. 33(1):11-29, 1976 Jan -Feb. Sonnenklar N. Krasna IH. Clinical management of malignant hyperpyrexia. Journal of Pediatric Surgery. 11(5):617-23, 1976 Oct. Britt BA. Endrenyi L. Kalow W. Peters PL. The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Canadian Anaesthetists Society Journal. 23(6):624-35, 1976 Nov. Borden H. Hummer GJ. Landon CW. Paris J. The use of procaine in acquired malignant hyperthermia in a patient with malignant melanoma metastatic to the parathyroid gland: a case report. Canadian Anaesthetists Society Journal. 23(6):616-23, 1976 Nov. Fraser JG. Crumrine RS. Izant RJ Jr. A preplanned treatment for malignant hyperpyrexia. Anesthesia & Analgesia. 55(5):713-6, 1976 Sep-Oct. Short CE. Paddleford RR. McGrath CJ. Williams CH. Preanesthetic evaluation and management of malignant hyperthermia in the pig experimental model. Anesthesia & Analgesia. 55(5):643-53, 1976 Sep-Oct. Itoda Y. Oda S. Nishino M. Imano K. Haseba J. Anesthetic experience in congenital arthrogryposis multiplex [Jpn] Masui - Japanese Journal of Anesthesiology. 25(7):697-703, 1976 Jul. Anonymous. Phosphohexose isomerase (PHI) and porcine halothane sensitivity. Acta Veterinaria Scandinavica. 17(3):370-2, 1976. Hausmanowa-Petrusewicz I. Malignant hyperthermia [Pol] Neurologia I Neurochirurgia Polska. 10(5):609-11, 1976 Sep -Oct. Stovner J. Innes KR. Holen A. Ten cases of malignant hyperthermia in Norway. Canadian Anaesthetists Society Journal. 23(5):518-26, 1976 Sep. Cox P. Clinical pharmacology of antibiotic therapy [letter]. British Journal of Anaesthesia. 48(9):932, 1976 Sep. Hall GM. Masshiter K. Lucke JN. Lister D. Hormonal changes in procine malignant hyperthermia [letter]. British Journal of Anaesthesia. 48(9):930, 1976 Sep. Lister D. Hall GM. Lucke JN. Porcine malignant hyperthermia. III: Adrenergic blockade. British Journal of Anaesthesia. 48(9):831-8, 1976 Sep. van den Hende C. Lister D. Muylle E. Ooms L. Oyaert W. Malignant hyperthermia in Belgian Landrace pigs rested or exercised before exposure to halothane. British Journal of Anaesthesia. 48(9):821-9, 1976 Sep. Klimanek J. Majewski W. Walencik K. A case of malignant hyperthermia during epidural analgesia. Anaesthesia, Resuscitation, & Intensive Therapy. 4(2):143-5, 1976 Apr-Jun. Jago RH. Payne MJ. Malignant hyperpyrexia--the difficulty of diagnosis [letter]. Anaesthesia. 31(7):955-6, 1976 Sep. Scarlato G. Meola G. Pellegrini G. Muscular pathology in malignant hyperpyrexia in man and swine. Comparative study [Ita] Acta Neurologica. 31(1):58-61, 1976 Jan-Feb. Gullotta F. Morphological, histochemical and ultrastructural findings in malignant hyperthermia [Ita] Acta Neurologica. 31(1):56-7, 1976 Jan-Feb. Anido V. Malignant hyperthermia [letter]. Southern Medical Journal. 69(9):1247, 1976 Sep. Menzel H. Gullotta F. Helpap B. Freiberger K. Report on 2 cases of malignant hyperthermia with different clinical courses [Ger] Praktische Anaesthesie, Wiederbelebung Und Intensivtherapie. 10(4):227-35, 1976 AUG. Zinganell K. Sajons M. Hammami G. Mild form of malignant hyperthermia? OR, ABNORMAL REACTION To succinyldicholine? [Ger] Praktische Anaesthesie, Wiederbelebung Und Intensivtherapie. 10(4):222-7, 1976 AUG. Heffron JJ. Isaacs H. Malignant hyperthermia syndrome--evidence for denervation changes in human skeletal muscle. Klinische Wochenschrift. 54(18):865-7, 1976 Sep 15. Scarascia E. Magalini S. Proietti R. Pelosi G. Malignant hyperthermia. Familial screening of CPK [Ita] Minerva Anestesiologica. 42(6):439-44, 1976 Jun. Lambert CD. Young JR. Hypertrophy of the branchial muscles. A case with unusual features. Journal of Neurology, Neurosurgery & Psychiatry. 39(8):810-6, 1976 Aug. Gronert GA. Theye RA. Suxamethonium-induced porcine malignant hyperthermia. British Journal of Anaesthesia. 48(6):513-7, 1976 Jun. Flewellen EH. Letter: Malignant hyperthermia. Jama. 235(18):1967, 1976 May 3. Andr:as H. L:aszl:o F. Ferenc K. Malignant hyperpyrexia [Hun] Orvosi Hetilap. 117(30):1818-23, 1976 Jul 25. Katz JD. Krich LB. Acute febrile reaction complicating spinal anaesthesia in a survivor of malignant hyperthermia. Canadian Anaesthetists Society Journal. 23(3):285-9, 1976 May. Britt BA. Endrenyi L. Peters PL. Kwong FH. Kadijevic L. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Canadian Anaesthetists Society Journal. 23(3):263-84, 1976 May. Nelson TE. Jones EW. Anderson IL. Porcine malignant hyperthermia. American Journal of Pathology. 84(1):197-9, 1976 Jul. Lucke JN. Hall GM. Lister D. Letter: Body temperature and malignant hyperthermia. Lancet. 1(7974):1405, 1976 Jun 26. Tsang HS. Schoenfeld FG. Malignant hyperthermia. Illinois Medical Journal. 149(5):471-3, 1976 May. Gjessing J. Barsa J. Tomlin PJ. A possible means of rapid cooling in the emergency treatment of malignant hyperpyrexia. British Journal of Anaesthesia. 48(5):469-73, 1976 May. Hall GM. Bendall JR. Lucke JN. Lister D. Porcine malignant hyperthermia. II: Heat production. British Journal of Anaesthesia. 48(4):305-8, 1976 Apr. Lucke JN. Hall GM. Lister D. Porcine malignant hyperthermia. I: Metabolic and physiological changes. British Journal of Anaesthesia. 48(4):297-304, 1976 Apr. Gronert GA. Milde JH. Theye RA. Dantrolene in porcine malignant hyperthermia. Anesthesiology. 44(6):488-95, 1976 Jun. Saviello GM. Letter: Treatment of idiopathic malignant hyperthermia. Archives of Ophthalmology. 94(5):867, 1976 May. Quigley HA. Letter: General anesthesia in ophthalmic surgery. Archives of Ophthalmology. 94(5):867, 1976 May. Csongrady A. Bake I. Pf:ander C. Tarmann H. Schneider M. Buttazzoni E. A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl) [Ger] Anaesthesist. 25(2):80-1, 1976 Feb. Bloom DA. Fonkalsrud EW. Reynolds RC. Malignant hyperpyrexia during anesthesia in childhood. Journal of Pediatric Surgery. 11(2):185-90, 1976 Apr. Ellis FR. Clarke IM. Modgill EM. Currie S. Harriman DG. Letter: Serum creatine phosphokinase and malignant hyperpyrexia. British Medical Journal. 1(6009):584, 1976 Mar 6. Hall GM. Lucke JN. Lister D. Proceedings: Neuromuscular blocking drugs in porcine malignant hyperthermia. British Journal of Anaesthesia. 48(3):270-1, 1976 Mar. Williams CH. Stubbs DH. Payne CG. Benedict JD. Role of hypertension in fulminant hyperthermia-stress syndrome. British Medical Journal. 1(6010):628, 1976 Mar 13. Harrison GG. Letter: Malignant hyperthermia. British Journal of Anaesthesia. 48(1):50-1, 1976 Jan. Anand JS. Letter: Reaction to oral trimeprazine. British Journal of Anaesthesia. 48(1):49, 1976 Jan. Gronert GA. Milde JH. Theye RA. Porcine malignant hyperthermia induced by halothane and succinylcholine: failure of treatment with procaine or procainamide. Anesthesiology. 44(2):124-32, 1976 Feb. Ryan DW. Appleyard TN. Letter: Serum creatine phosphokinase and malignant hyperpyrexia. British Medical Journal. 1(6001):96, 1976 Jan 10. Anderson IL. Jones EW. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle. Anesthesiology. 44(1):57-61, 1976 Jan. Gronert GA. Theye RA. Halothane-induced porcine malignant hyperthermia: metabolic and hemodynamic changes. Anesthesiology. 44(1):36-43, 1976 Jan. Gronen WW. Roda PL. Malignant hyperthermia. A case report. Journal of the American Podiatry Association. 66(1):31-4, 1976 Anonymous. Malignant hyperpyrexia. Jpma - Journal of the Pakistan Medical Association. 25(6):122-3, 1975 Jun. Gullotta F. Helpap B. Histological, histochemical, and ultrastructural findings in malignant hyperthermia (author's transl) [Ger] Journal Virchows Archiv - A - Pathological Anatomy & Histology. 367(3):181-94, 1975 Aug 12. Fuchs F. Thermal inactivation of the calcium regulatory mechanism of human skeletal muscle actomyosin: a possible contributing factor in the rigidity of malignant hyperthermia. Anesthesiology. 42(5):584-9, 1975 May. Zsigmond EK. Malignant hyperpyrexia caused by trimeprazine [letter] Journal British Journal of Anaesthesia. 46(9):705-6, 1974 Sep. Constantin B. Disorders of body temperature regulation. 1. Physiopathological study [Fre] Journal Annales De L Anesthesiologie Francaise. 16(2):101-9, 1975 Mar -Apr. Denborough MA. Malignant hyperpyrexia. Comprehensive Therapy. 1(8):51-6, 1975 Dec. Isaacs H. Heffron JJ. Badenhorst M. Predictive tests for malignant hyperpyrexia. British Journal of Anaesthesia. 47(10):1075-80, 1975 Oct. Okumura F. Kuro M. Etiology of malignant hyperthermia [Jpn] Journal Masui - Japanese Journal of Anesthesiology. 24(6):525-37, 1975 Jun. Campion DR. Topel DG. A review of the role of swine skeletal muscle in malignant hyperthermia. Journal of Animal Science. 41(3):779-86, 1975 Sep. Hall GM. Lucke JN. Lister D. Treatment of porcine malignant hyperthermia. A review based on experimental studies. Anaesthesia. 30(3):308-17, 1975 May. Pembrey ME. Pharmacogenetics. Practitioner. 213(1277):647-54, 1974 Nov. Britt BA. Malignant hyperthermia. Clinical Anesthesia. 11(1):61-74, 1975. Nahrwold ML. Cohen PJ. Anesthetics and mitochondrial respiration. Clinical Anesthesia. 11(1):25-44, 1975. Johnson RH. Spaulding JM. Disorders of the autonomic nervous system. Chapter 9. Disturbances of body temperature. Contemporary Neurology Series. (11):153-78, 1974. Rosalki SB. Uses and limitations of enzyme tests. Proceedings of the Royal Society of Medicine. 67(7):633-7, 1974 Jun. Beasley H. Hyperthermia associated with ophthalmic surgery. American Journal of Ophthalmology. 77(1):76-9, 1974 Jan. Dilworth NM. The importance of changes in body temperature in paediatric surgery and anaesthesia. Anaesthesia & Intensive Care. 1(6):480-5, 1973 Nov. Anderson IL. Anaesthesia in the pig. Australian Veterinary Journal. 49(10):474-7, 1973 Oct. Gatz EE. Wingard DW. Malignant hyperthermia. Nebraska Medical Journal. 58(12):434-7, 1973 Dec. Relton JE. Britt BA. Steward DJ. Malignant hyperpyrexia. British Journal of Anaesthesia. 45(3):269-75, 1973 Mar. Kerr DD. Jones EW. Nelson TE. Gatz EE. Treatment of malignant hyperthermia in swine. Anesthesia & Analgesia. 52(5):734-9, 1973 Sep-Oct. Cohen PJ. Effect of anesthetics on mitochondrial function. Anesthesiology. 39(2):153-64, 1973 Aug. Vesell ES. Advances in pharmacogenetics. Progress In Medical Genetics. 9:291-367, 1973. Popinigis J. Brucker RF. Taylor CA. Williams CH. Malignant hyperthermia [Pol] Journal Polski Tygodnik Lekarski. 27(33):1290-3, 1972 Aug 14. Price KA. Matsumoto Y. Frederickson EL. Effect of halothane on isometric twitch and tetanus response and the associated heat production in striated muscle of frogs. Anesthesia & Analgesia. 54(4):527-35, 1975 Jul-Aug. Sordill W. Ladner W. Stern M. Weisenberg M. Malignant hyperthermia. Journal of Oral Surgery. 31(11):825-9, 1973 Nov. Cadwallader JA. Alley MR. Malignant hyperthermia in a crossbred Landrace-Large White pig. New Zealand Veterinary Journal. 23(9):207-11, 1975 Sep. Neal HA. Peterson LJ. DeVore M. Survival of an oral surgery patient with malignant hyperthermia. Journal of Oral Surgery. 33(12):953-60, 1975 Dec. Gormley MB. Look RA. Jarrett WJ. The diagnosis and management of malignant hyperthermia. Journal - Academy of General Dentistry. 23(4):45-6, 1975 Jul -Aug. Schwartz HC. Gracia RM. Malignant hyperthermia. Journal of Oral Surgery. 33(1):57-60, 1975 Jan. Morgan JG. Gatz EE. Facilitation by oxygen of an induced hyperpyrexia during general anesthesia in dogs. Journal of Oral Surgery. 32(11):823-8, 1974 Nov. Britt BA. Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle. Anesthesia Progress. 21(4):108-10, 1974 Jul-Aug. Suzuki C. Occurrence of malignant hyperpyrexia during general anesthesia [Jpn] Journal Kokubyo Gakkai Zasshi - the Journal of the Stomatological Society, Japan. 40(2):176, 1973 Jun. Anonymous. New Zealand Committee on Adverse Drug Reactions. Eighth annual report. New Zealand Medical Journal. 79(500):309-16, 1973 Oct 10. Barrett JT. Recovery from malignant hyperthermia: case report. New Zealand Medical Journal. 77(489):84-6, 1973 Feb. Newson AJ. Malignant hyperthermia: current trends in treatment. New Zealand Medical Journal. 77(489):81-3, 1973 Feb. Jaffe EC. Wedley JR. Malignant hyperpyrexia: an anaesthetic hazard. British Dental Journal. 133(12):538-41, 1972 Dec 19. de Wet JS. Malignant hyperthermia in anaesthesia. II. A review. South African Medical Journal. 46(30):1036-9, 1972 Jul 22. de Wet JS. van de Vijver AE. Uys SP. Malignant hyperthermia in anaesthesia. I. Case report. South African Medical Journal. 46(30):1033-5, 1972 Jul 22. Hardaway RG. Rando JT. Successful intervention of malignant hyperpyrexia. Aana Journal. 43(2):155-61, 1975 Apr. Stallings JO. Lines JA. Malignant hyperpyrexia: anesthesia complication. Aorn Journal. 21(4):642, 644-5, 647, 1975 Mar. Bernhardt D. Malignant hyperthermia [Ger] Journal Zeitschrift Fur Krankenpflege - Revue Suisse Des Infirmieres. 66(4):137-40, 1973 Apr. Heydman AM. Stegman MR. One in ten thousand. Aorn Journal. 16(5):111-21, 1972 Nov. Dunaevski:i VA. Mukovozov IN. Orlov VS. Malignant hyperthermia (review of the Soviet and foreign literature [Rus] Journal Vestnik Khirurgii Imeni I - I - Grekova. 114(4):126-8, 1975 Apr. Sadove MS. Thomason R. Redlin TA. Katz D. Postoperative fever and the halothane controversy. Comprehensive Therapy. 1(1):69-72, 1975 May. Paladino TR. Malignant hyperthermia during general anesthesia: medicolegal considerations. Legal Medicine Annual. :263-71, 1975. Nealon DA. Henderson AR. Lability of human creatine kinase isoenzymes at 37 degrees C: a complication of electrophoretic separation. Journal of Clinical Pathology. 28(10):834-6, 1975 Oct. Lucke JN. Hall GM. Lovell R. Tait A. White YS. Lister D. Proceedings: The metabolic course of porcine malignant hyperthermia. British Journal of Anaesthesia. 47(8):905, 1975 Aug. Caropreso PR. Gittleman MA. Reilly DJ. Patterson LT. Malignant hyperthermia associated with enflurane anesthesia. Archives of Surgery. 110(12):1491-3, 1975 Dec. Isaacs H. Heffron JJ. Badenhorst M. 'Picture frame' fibres in a carrier of the trait for malignant hyperpyrexia. South African Medical Journal. 49(46):1923-6, 1975 Nov 1. Denborough MA. Letter: Serum creatin phosphokinase and malignant hyperpyrexia. British Medical Journal. 4(5993):408, 1975 Nov 15. Ryan DW. Appleyard TN. Malignant hyperpyrexia: Investigation of a family after a fatal case. British Journal of Anaesthesia. 47(9):1001-4, 1975 Sep. Reske-Nielsen E. Haase J. Kelstrup J. Malignant hyperthermia in a family. The ultrastructure of muscle biopsies of healthy members. Acta Pathologica Et Microbiologica Scandinavica - Section A, Pathology. 83(6):651-60, 1975 Nov. Reske-Nielsen E. Haase J. Kelstrup J. Malignant hyperthermia in a family. The neurophysiological and light microscopical study of muscle biopsies of healthy members. Acta Pathologica Et Microbiologica Scandinavica - Section A, Pathology. 83(6):645-50, 1975 Nov. Bayer-Kristensen I. Reske-Nielsen E. Harmsen A. Death from malignant hyperthermia during anaesthesia (author's transl) [Ger] Journal Zeitschrift Fur Rechtsmedizin - Journal of Legal Medicine. 76(2):131-9, 1975 Nov 11. Moller-Sorensen P. Malignant hyperthermia during anesthesia [Dan] Journal Ugeskrift For Laeger. 137(43):2520-1, 1975 Oct 20. Bech A. Agerskov P. Larsen ED. First-aid box for emergency treatment of malignant hyperthermia [Dan] Journal Ugeskrift For Laeger. 137(43):2519-20, 1975 Oct 20. Sutherland FS. Carter JR. Malignant hyperpyrexia during enflurane anesthesia. Journal of the Tennessee Medical Association. 68(10):795-6, 1975 Oct. Hoivik B. Stovner J. Malignant hyperthermia treated with procaine [Nor] Journal Tidsskrift For Den Norske Laegeforening. 95(27):1516-7, 1519, 1975 Sep 30. Stovner J. Sundt T. Mohr B. Lilleaasen P. Malignant hyperthermia following nitrous oxide-halothane anesthesia [Nor] Journal Tidsskrift For Den Norske Laegeforening. 95(27):1512-6, 1975 Sep 30. Marukawa S. Shirasaka Y. Ozaki K. Enoue S. Shin S. Malignant hyperthermia - evaluation of serum creatine phosphokinase and lactate dehydrogenase [Jpn] Journal Masui - Japanese Journal of Anesthesiology. 24(5):489-96, 1975 May. Heffron JJ. Mitchell G. Diagnostic value of serum creatine phosphokinase activity for the porcine malignant hyperthermia syndrome. Anesthesia & Analgesia. 54(4):536-9, 1975 Jul-Aug. Pan TH. Wollack AR. DeMarco JA. Malignant hyperthermia associated with enflurane anesthesia: a case report. Anesthesia & Analgesia. 54(1):47-9, 1975 Jan-Feb. Ellis FR. Clarke IM. Modgill M. Currie S. Harriman DG. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia. British Medical Journal. 3(5982):511-3, 1975 Aug 30. B:ottger P. Doehn M. Horatz K. Kessler G. Malignant hyperthermia due to general anesthesia. Diagnosis and treatment [Ger] Journal Anasthesiologische Und Intensivmedizinische Praxis. 10(1):13 -6, 1975. Schoenfeld J. Lieberman P. Editorial: Malignant hyperthermia [Heb] Journal Harefuah. 89(3):129, 1975 Aug 1. Faber P. Gullotta F. Koenen FW. Clinical and morphological findings in a case of malignant hyperthermia (author's transl) [Ger] Journal Deutsche Medizinische Wochenschrift. 100(39):1974-6, 1975 Sep 26. Z:akov:a M. K:rikl:anov:a Z. Palisa V. New findings on the pathogenesis of fever (author's transl) [Cze] Journal Casopis Lekaru Ceskych. 114(28):853-5, 1975 Jul 11. Williams CH. Houchins C. Shanklin MD. Pigs susceptible to energy metabolism in the fulminant hyperthermia stress syndrome. British Medical Journal. 3(5980):411-3, 1975 Aug 16. Stephen CR. Editorial: Malignant hyperthermia. Southern Medical Journal. 68(7):801-2, 1975 Jul. Newell FW. Current trends in ophthalmic anesthesia. The Second Walter S. Atkinson Lecture. Ophthalmic Surgery. 6(2):15-22, 1975 Summer. Anonymous. Drug fever. Medical Letter On Drugs & Therapeutics. 17(15):63-4, 1975 Jul 18. Mitchell G. Heffron JJ. Procaine in porcine malignant hyperthermia. British Journal of Anaesthesia. 47(6):667-8, 1975 Jun. Britt BA. Endrenyi L. Cadman DL. Calcium uptake into muscle of pigs susceptible to malignant hyperthermia: in vitro and in vivo studies with and without halothane. British Journal of Anaesthesia. 47(6):650-3, 1975 Jun. Britt BA. Endrenyi L. Barclay RL. Cadman DL. Total calcium content of skeletal muscle isolated from humans and pigs susceptible to malignant hyperthermia. British Journal of Anaesthesia. 47(6):647-53, 1975 Jun. Harrison GG. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. British Journal of Anaesthesia. 47(1):62-5, 1975 Jan. Clarke IM. Ellis FR. An evaluation of procaine in the treatment of malignant hyperpyrexia. British Journal of Anaesthesia. 47(1):17-21, 1975 Jan. Peltz B. Carstens J. An unusual case of malignant hyperpyrexia. First reported case in a South African negro. Anaesthesia. 30(3):346-50, 1975 May. H:oivik B. Stovner J. Letter: Procaine and malignant hyperthermia. Lancet. 2(7926):185, 1975 Jul 26. Heffron JJ. Mitchell G. Age dependent variation of serum creatine phosphokinase levels in pigs. Experientia. 31(6):657-8, 1975 Jun 15. Ellis FR. Clarke IM. Mogill EM. Appleyard TN. Dinsdale RC. Letter: New causes of malignant hyperpyrexia. British Medical Journal. 1(5957):575, 1975 Mar 8. Ellis FR. Clarke IM. Appleyard TN. Dinsdale RC. Proceedings: malignant hyperpyrexia induced by nitrous oxide successfully treated by steroids. British Journal of Anaesthesia. 47(5):632, 1975 May. Isaacs H. Heffron JJ. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome. British Journal of Anaesthesia. 47(4):475-81, 1975 Apr. Lucke JN. Lister D. Letter: Althesin and malignant hyperthermia. British Journal of Anaesthesia. 47(3):419, 1975 Mar. Bergman JA. Idiopathic malignant hyperthermia. Review and report of a case. Archives of Ophthalmology. 93(3):232-4, 1975 Mar. Schiller HH. Letter: Chronic viral myopathy and malignant hyperthermia. New England Journal of Medicine. 292(26):1409, 1975 Jun 26. Lewandowski KB. Hollm:en A. Reunanan M. Malignant hyperpyrexia. A study of an affected family. Annales Chirurgiae Et Gynaecologiae Fenniae. 64(2):112-7, 1975. Carbonera D. Gasperi A. Villa S. Scaroni MT. Clinico-therapeutic considerations on a case of malignant hyperthermia during a course of anesthesia [Ita] Journal Minerva Anestesiologica. 41(3):117-21, 1975 Mar. Meltzer HY. Hassan SZ. Moretti R. Hengeveld C. Bruckner D. Letter: Effect of ketamine on creatine phosphokinase levels. Lancet. 1(7917):1195-6, 1975 May 24. Carballo AS. Aborted malignant hyperthermia: case report. Canadian Anaesthetists Society Journal. 22(2):227-31, 1975 Mar. Isherwood DM. Ridley J. Wilson J. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia. British Journal of Obstetrics & Gynaecology. 82(4):346-9, 1975 Apr. Lack JA. Letter: New causes of malignant hyperpyrexia. British Medical Journal. 1(5948):36-7, 1975 Jan 4. Reske-Nielsen E. Haase J. Malignant hyperthermia [Dan] Journal Ugeskrift For Laeger. 137(7):399-400, 1975 Feb 10. Moulds RF. Letter: Malignant hyperpyrexia. Lancet. 1(7908):681, 1975 Mar 22. Lister D. Hall GM. Lucke JN. Letter: Malignant hyperthermia: a human and procine stress syndrome?. Lancet. 1(7905):519, 1975 Mar 1. Lucke JN. Lister D. Hall GM. Letter: Malignant hyperpyrexia. British Medical Journal. 1(5955):454-5, 1975 Feb 22. Kerr DD. Wingard DW. Gatz EE. Prevention of porcine malignant hyperthermia by epidural block. Anesthesiology. 42(3):307-11, 1975 Mar. Nelson TE. Bedell DM. Jones EW. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle. Anesthesiology. 42(3):301-6, 1975 Mar. Britt BA. Endrenyi L. Cadman DL. Fan HM. Fung HY. Porcine malignant hyperthermia: effects of halothane on mitochondrial respiration and calcium accumulation. Anesthesiology. 42(3):292-300, 1975 Mar. McLellan I. Letter: A ppack for the emergency treatment of malignant hyperpyrexia. Anaesthesia. 30(1):99-100, 1975 Jan. Giosa N. Letter: Procaine for malignant hyperthermia. New England Journal of Medicine. 292(16):869-70, 1975 Apr 17. Hunter A. Pinsky L. An evaluation of the possible association of malignant hyperpyrexia with the Noonan syndrome using serum creatine phosphokinase levels. Journal of Pediatrics. 86(3):412-5, 1975 Mar. Heffron JJ. Mitchell G. Letter: Procaine for malignant hyperthermia. New England Journal of Medicine. 292(5):266-7, 1975 Jan 30. Furniss P. Letter: Malignant hyperpyrexia. British Medical Journal. 1(5949):92, 1975 Jan 11. Baraka A. Rebeiz J. Moghrabi R. Malignant hyperthermia. Middle East Journal of Anaesthesiology. 4(3):217-21, 1974 Oct. Konno K. Yamashiro H. Hagiwara M. Haseba J. Honda N. Biochemical and electromyographic studies on a family with malignant hyperpyrexia [Jpn] Journal Masui - Japanese Journal of Anesthesiology. 23(9):854-61, 1974 Sep. Hurse PV. Kakulas BA. Genetic counselling in neuromuscular diseases in Western Australia. Proceedings of the Australian Association of Neurologists. 11:145-53, 1974. Roervik S. Stovner J. Letter: Ketamine-induced acidosis, fever, and creatine-kinase rise. Lancet. 2(7893):1384-5, 1974 Dec 7. Purschke R. Zindler M. Malignant hyperthermia--clinical aspects and treatment of life -endangering complications of anesthesia [Ger] Journal Chirurg. 45(10):472-6, 1974 Oct. Kratholm S. Nielsen E. Malignant hyperthermia: screening of a family by serum-enzymes, electromyography and nerve-conduction. Anaesthesia, Resuscitation, & Intensive Therapy. 2(4):359-63, 1974 Oct-Dec. Judelman H. Pirie DH. Letter: anaesthesia in a patient with previous malignant hyperpyrexia. British Journal of Anaesthesia. 46(7):519, 1974 Jul. Clarke IM. Ellis FR. Proceedings: Studies of the therapeutic value of procaine and lignocaine in malignant hyperpyrexia. British Journal of Anaesthesia. 46(4):315, 1974 Apr. McLellan I. Letter: Hyperpyrexia caused by trimeprazine. British Journal of Anaesthesia. 46(4):252, 1974 Apr. Sa:sinka M. Getl:ik A. Plenta I. Hru:skovi:c I. Strnov:a J. Sag:at T. P:alen:ikov:a O. Significance of genetic deviations for the adverse effects of various drugs [Slo] Journal Ceskoslovenska Pediatrie. 29(8):431-5, 1974 Aug. Havill JH. Malignant hyperthermia caused by salicylate overdose associated with phenelzine therapy-a case report. Anaesthesia & Intensive Care. 2(4):380-3, 1974 Nov. Schiller HH. Mair WG. Ultrastructural changes of muscle in malignant hyperthermia. Journal of the Neurological Sciences. 21(1):93-100, 1974 Jan. Schmitt J. Schmidt K. Ritter H. Hereditary malignant hyperpyrexia associated with muscle adenylate kinase deficiency. Humangenetik. 24(3):253-7, 1974. Raitt DG. Merrifield AJ. Letter: dexamethasone in malignant hyperpyrexia. British Medical Journal. 4(5945):656, 1974 Dec 14. Purschke R. Zindler M. Malignant hyperthermia: a dangerous anesthesia complication. (Diagnosis and therapy) [Ger] Journal Zentralblatt Fur Chirurgie. 99(36):1134-8, 1974 Sep 6. Ka:cinec J. Malatinsk:y J. Sadlo:n P. Klimasov:a A. Syndrome of malignant hyperthermia [Slo] Journal Rozhledy V Chirurgii. 53(11):734-9, 1974 Nov. Pollock RA. Turner JS Jr. Malignant hyperthermia in the otolaryngologic patient. Laryngoscope. 84(12):2113-8, 1974 Dec. Wingard DW. Letter: Malignant hyperthermia: a human stress syndrome?. Lancet. 2(7894):1450-1, 1974 Dec 14. Caseby NG. Letter: Anaesthesia during raised creatine phosphokinase activity. British Medical Journal. 4(5943):528, 1974 Nov 30. Anonymous. Editorial: New causes of malignant hyperpyrexia. British Medical Journal. 4(5943):488, 1974 Nov 30. de Jong RH. Heavner JE. Amory DW. Malignant hyperpyrexia in the cat. Anesthesiology. 41(6):608-9, 1974 Dec. Hartmann H. Malignant hyperthermia as an anesthesia incident [Ger] Journal Zeitschrift Fur Unfallmedizin Und Berufskrankheiten. 67(3):185 -9, 1974. G:orska E. Krawczy:nska R. Prawecka M. Roszkowski I. Anesthesia in cesarean section in a case of myotonia [Pol] Journal Ginekologia Polska. 45(11):1299-303, 1974 Nov. Ellis FR. Clarke IM. Appleyard TN. Dinsdale RC. Malignant hyperpyrexia induced by nitrous oxide and treated with dexamethasone. British Medical Journal. 4(5939):270-1, 1974 Nov 2. Moulds RF. Denborough MA. Letter: Myopathies and malignant hyperpyrexia. British Medical Journal. 3(5929):520, 1974 Aug 24. Denborough MA. Warne GL. Moulds RF. Martin FI. Insulin secretion in malignant hyperpyrexia. British Medical Journal. 3(5929):493-5, 1974 Aug 24. Owen G. Kerry RJ. Anaesthesia during raised creatine phosphokinase activity. British Medical Journal. 4(5936):75-6, 1974 Oct 12. Kaukinen S. Stenberg J. Kaukinen L. A fatal case of malignant hyperthermia during anaesthesia and a study of the patient's blood relatives. Annales Chirurgiae Et Gynaecologiae Fenniae. 63(3):212-6, 1974. Garstka J. Jagodzi:nska J. Celny A. Some aspects of the anesthesiological approach during surgical procedures in scoliosis [Pol] Journal Chirurgia Narzadow Ruchu I Ortopedia Polska. 39(4):457-61, 1974. Garstka J. Wierusz L. Malignant hyperthermia syndrome [Pol] Journal Chirurgia Narzadow Ruchu I Ortopedia Polska. 39(4):467-70, 1974. Johnstone RE. Letter: Malignant heating pad. Anesthesiology. 41(3):307, 1974 Sep. Clarke IM. Ellis FR. A pack for the emergency treatment of malignant hyperpyrexia. Anaesthesia. 29(4):452-5, 1974 Jul. P:ontinen PJ. Abele K. Autere T. Malignant hyperthermia [Fin] Journal Duodecim. 90(1):55-8, 1974. Stoyka WW. Garvey MB. Haematological and cardiorespiratory responses to induced hyperpyrexia. Canadian Anaesthetists Society Journal. 21(3):325-34, 1974 May. Britt BA. Webb GE. LeDuc C. Malignant hyperthermia induced by curare. Canadian Anaesthetists Society Journal. 21(4):371-5, 1974 Jul. Kelstrup J. Reske-Nielsen E. Haase J. Jorni J. Malignant hyperthermia in a family: a clinical and serological investigation of 139 members. Acta Anaesthesiologica Scandinavica. 18(1):58-64, 1974. Brown LL. Britt BA. Malignant hyperthermia. Southern Medical Journal. 67(7):799-804, 1974 Jul. Benumof J. Letter: Procaine for malignant hyperthermia. New England Journal of Medicine. 291(4):209-10, 1974 Jul 25. Bowers E. Letter: Biochemical basis of malignant hyperpyrexia. British Medical Journal. 2(919):614, 1974 Jun 15. Moulds RF. Denborough MA. Identification of susceptibility to malignant hyperpyrexia. British Medical Journal. 2(913):245-7, 1974 May 4. Moulds RF. Denborough MA. Biochemical basis of malignant hyperpyrexia. British Medical Journal. 2(913):241-4, 1974 May 4. Anido V. Conn RB. Mengoli HF. Anido G. Diagnostic efficacy of myocardial creatine phosphokinase using polyacrylamide disk gel electrophoresis. American Journal of Clinical Pathology. 61(5):599-605, 1974 May. Isaacs H. Barlow MB. Central core disease associated with elevated creatine phosphokinase levels. Two members of a family known to be susceptible to malignant hyperpyrexia. South African Medical Journal. 48(15):640-2, 1974 Mar 30. Britt BA. Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle. New England Journal of Medicine. 290(20):1140-2, 1974 May 16. Ryan JF. Donlon JV. Malt RA. Bland JH. Buckley MJ. Sreter FA. Lowenstein E. Cardiopulmonary bypass in the treatment of malignant hyperthermia. New England Journal of Medicine. 290(20):1121-2, 1974 May 16. Nelson TE. Jones EW. Henrickson RL. Falk SN. Kerr DD. Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs. American Journal of Veterinary Research. 35(3):347-50, 1974 Mar. Eikelenboom G. Sybesma W. A possible mechanism for induction of porcine malignant hyperthermia syndrome. Journal of Animal Science. 38(3):504-6, 1974 Mar. Mogensen JV. Misfeldt BB. Hanel HK. Letter: Preoperative excitement and malignant hyperthermia. Lancet. 1(855):461, 1974 Mar 16. MacLachlan D. Forrest AL. Letter: Procaine and malignant hyperthermia. Lancet. 1(853):355, 1974 Mar 2. Duboff GS. Letter: Expressing results of enzyme assays. Clinical Chemistry. 20(3):402-3, 1974 Mar. Wadhwa RK. Tantisira B. Parotidectomy in a patient with a family history of hyperthermia. Anesthesiology. 40(2):191-4, 1974 Feb. Hall GM. Lister D. Letter: Procaine and malignant hyperthermia. Lancet. 1(850):208, 1974 Feb 9. Brebner J. Jozefowicz JA. Procainamide therapy of malignant hyperthermia: case report. Canadian Anaesthetists Society Journal. 21(1):96-105, 1974 Jan. Harriman DG. Sumner DW. Ellis FR. Malignant hyperpyrexia myopathy. Quarterly Journal of Medicine. 42(168):639-64, 1973 Oct. Nesvetov AM. Dovgi:i GM. L'vova TN. Malignant hyperthermia during anesthesia [Rus] Journal Arkhiv Patologii. 35(11):73-7, 1973. Nelson TE. Jones EW. Bedell DM. Porcine malignant hyperthermia: a study on the triggering effects of succinylcholine. Anesthesia & Analgesia. 52(6):908-11, 1973 Nov-Dec. Moyes DG. Malignant hyperpyrexia caused by trimeprazine. Case report. British Journal of Anaesthesia. 45(11):1163-4, 1973 Nov. Spethman G. Horn H. Conradt K. Malignant hyperthermia: a case report. Nebraska Medical Journal. 58(10):369-71, 1973 Oct. Reske-Nielsen E. Ultrastructure of human muscle in malignant hyperthermia. Acta Pathologica Et Microbiologica Scandinavica - Section A, Pathology. 81(4):585-7, 1973 Jul. Kelstrup J. Haase J. Jorni J. Reske-Nielsen E. Hanel HK. Malignant hyperthermia in a family. Acta Anaesthesiologica Scandinavica. 17(4):283-4, 1973. Harrison GG. Althesin and malignant hyperpyrexia. British Journal of Anaesthesia. 45(10):1019-21, 1973 Oct. King JO. Denborough MA. Anesthetic-induced malignant hyperpyrexia in children. Journal of Pediatrics. 83(1):37-40, 1973 Jul. Althoff H. Limited resistance to anesthetics in patients with familial muscular diseases [Ger] Journal Beitrage Zur Gerichtlichen Medizin. 31:234-5, 1973. Short CE. Paddleford RR. Letter: Malignant hyperthermia in the dog. Anesthesiology. 39(4):462-3, 1973 Oct. Noble WH. McKee D. Gates B. Malignant hyperthermia with rigidity successfully treated with procainamide. Anesthesiology. 39(4):450-1, 1973 Oct. Isaacs H. Barlow MB. Malignant hyperpyrexia occurring in a second Johannesburg family. British Journal of Anaesthesia. 45(8):901-6, 1973 Aug. Isaacs H. Frere G. Mitchell J. Histological, histochemical and ultramicroscopic findings in muscle biopsies from carriers of the trait for malignant hyperpyrexia. British Journal of Anaesthesia. 45(8):860-8, 1973 Aug. Ehehalt V. Report on a early recognized case of "malignant hyperthermia" (author's transl) [Ger] Journal Anaesthesist. 22(8):377-8, 1973 Aug. Harrison GG. Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia. Anaesthesist. 22(8):373-6, 1973 Aug. Bernhardt D. Schiller H. Malignant hyperthermia under general anaesthesia. Abnormal histochemical and electron-microscopic muscle findings in combination with pathological serum-CPK-values evidencing the existence of primary myopathy (author's transl) [Ger] Journal Anaesthesist. 22(8):367-72, 1973 Aug. Hausman R. Muscle changes in malignant hyperthermia. Journal of Pathology. 110(3):Pv-vi, 1973 Jul. Maisel RH. Sessions DG. Miller RN. Malignant hyperpyrexia during general anesthesia. Successful management of a case. Annals of Otology, Rhinology & Laryngology. 82(5):729-33, 1973 Sep-Oct. Pinsky L. Levy EP. Denborough MA. Letter: Malignant hypersyrexia or the XX-XY Turner phenotype?. Journal of Pediatrics. 83(5):896-7, 1973 Nov. Anonymous. No negligence in malignant hyperpyrexia. Anesthesia & Analgesia. 52(5):746, 1973 Sep-Oct. Althoff H. Limited anesthetic possibilities in patients with hereditary muscular diseases [Ger] Journal Zeitschrift Fur Rechtsmedizin - Journal of Legal Medicine. 72(2):128-39, 1973 Apr 30. Berman MC. Role of preoperative management in development of malignant hyperthermia. Lancet. 2(831):743, 1973 Sep 29. Kalow W. Britt BA. Drugs causing rigidity in malignant hyperthermia. Lancet. 2(825):390-1, 1973 Aug 18. Britt BA. Kalow W. Gordon A. Humphrey JG. Rewcastle NB. Malignant hyperthermia: an investigation of five patients. Canadian Anaesthetists Society Journal. 20(4):431-67, 1973 Jul. Ellis FR. Harriman DG. A new screening test for susceptibility to malignant hyperpyrexia. British Journal of Anaesthesia. 45(6):638, 1973 Jun. Bull AB. Harrison GG. Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia. Acta Anaesthesiologica Belgica. 24(2):97-108, 1973 May. Ellis FR. Malignant hyperpyrexia. Anaesthesia. 28(3):245-52, 1973 May. Howat DD. Temperature regulation. A symposium on the use of induced hypothermia, the importance of normothermia in the surgical period and malignant hyperthermia. Chairman's introduction. Anaesthesia. 28(3):236, 1973 May. Harrison GG. A pharmacological in vitro model of malignant hyperpyrexia. South African Medical Journal. 47(18):774-6, 1973 May 12. Anonymous. Prevention of malignant hyperpyrexia. Lancet. 1(814):1225, 1973 Jun 2. Isaacs H. Barlow MB. Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening. Journal of Neurology, Neurosurgery & Psychiatry. 36(2):228-43, 1973 Apr. Bradley WG. Malignant hyperpyrexia. British Medical Journal. 2(862):366, 1973 May 12. Rizk SF. Malignant hyperpyrexia in a Negro. British Journal of Anaesthesia. 45(2):233, 1973 Feb. Takahashi T. Takasaki M. Namiki A. Dohi S. Rise in serum creatine phosphokinase associated with agents used in anaesthesia. British Journal of Anaesthesia. 45(2):185-90, 1973 Feb. Harrison GG. Verburg C. Erythrocyte osmotic fragility in hyperthermia-susceptible swine. British Journal of Anaesthesia. 45(2):131-3, 1973 Feb. King JO. Denborough MA. Malignant hyperpyrexia in Australia and New Zealand. Medical Journal of Australia. 1(11):525-8, 1973 Mar 17. Anonymous. Malignant hyperpyrexia. Medical Journal of Australia. 1(11):523-4, 1973 Mar 17. Ryan JF. Kerr WS Jr. Malignant hyperthermia: a catastrophic complication. Journal of Urology. 109(5):879-83, 1973 May. Ehehalt V. Burmeister G. Sauer H. Anesthesia incident: malignant hyperthermia (case report) [Ger] Journal Zeitschrift Fur Laryngologie, Rhinologie, Otologie Und Ihre Grenzgebiete. 52(3):167-9, 1973 Mar. Lister D. Thyroid status in malignant hyperpyrexia. British Journal of Anaesthesia. 45(1):115, 1973 Jan. Wedley JR. Jaffe EC. Malignant hyperpyrexia and the dental outpatient. Anaesthesia. 28(2):146-54, 1973 Mar. Anonymous. Malignant hyperpyrexia. British Medical Journal. 1(855):738-9, 1973 Mar 24. Harriman DG. Ellis FR. Central-core disease and malignant hyperpyrexia. British Medical Journal. 1(852):545-6, 1973 Mar 3. Schiller HH. Histochemical abnormalities of muscle in malignant hyperpyrexia (MH). Zeitschrift Fur Neurologie. 203(4):265-9, 1973 Feb 26. Pennington RJ. Worsfold M. Biochemical studies on malignant hyperpyrexia. Proceedings of the Royal Society of Medicine. 66(1):69-70, 1973 Jan. Bradley WG. Ward M. Murchison D. Hall L. Woolf N. Clinical, electrophysiological and pathological studies on malignant hyperpyrexia. Proceedings of the Royal Society of Medicine. 66(1):67-8, 1973 Jan. Ellis FR. Keaney NP. Harriman DG. Histopathological and neuropharmacological aspects of malignant hyperpyrexia. Proceedings of the Royal Society of Medicine. 66(1):66-7, 1973 Jan. Kyei-Mensah K. Tyrrell JH. Sumner DW. Clinical and genetic aspects of malignant hyperpyrexia. Proceedings of the Royal Society of Medicine. 66(1):63-6, 1973 Jan. Denborough MA. Dennett X. Anderson RM. Central-core disease and malignant hyperpyrexia. British Medical Journal. 1(848):272-3, 1973 Feb 3. Anonymous. Pathology of malignant hyperpyrexia. British Medical Journal. 1(848):249, 1973 Feb 3. Harrison GG. Pale, soft exudative pork, porcine stress syndrome and malignant hyperpyrexia--an identity?. Journal of the South African Veterinary Association. 43(1):57 -63, 1972 Mar. Hagelsten JO. Jessen K. Rosendal T. Clinical application of an outdoor-indoor thermometer. Anesthesia & Analgesia. 51(6):863-4, 1972 Nov-Dec. Iuchi Y. Madono K. Yamamoto T. Yoshizumi M. Ono T. 2 cases of malignant hyperpyrexia--with special reference to successful treatment by femoral VA bypass [Jpn] Journal Masui - Japanese Journal of Anesthesiology. 21(5):487-93, 1972 May. Ratzlaff EH. Jenkins LC. Malignant hyperthermia: a case report of successful management. Canadian Anaesthetists Society Journal. 19(5):549-56, 1972 Sep. Moulds RF. Denborough MA. Procaine in malignant hyperpyrexia. British Medical Journal. 4(839):526-8, 1972 Dec 2. Dugas M. Gu:eriot C. V:elin J. Porot D. Calvet S. Does the use of neuroleptics and drugs for mood disorders have any special risks in children? [Fre] Journal Annales De Medecine Interne. 123(8):801-4, 1972 Aug-Sep. Rawls GH. Malignant hyperthermia. Journal of the National Medical Association. 64(6):520-1, 1972 Nov. Isaacs H. Malignant hyperthermia in anaesthesia. South African Medical Journal. 46(37):1321, 1972 Sep 16. Rowland LP. Penn AS. Myoglobinuria. Medical Clinics of North America. 56(6):1233-56, 1972 Nov. Harriman DG. Ellis FR. Structural and neuropharmacological aspects of malignant hyperpyrexia. Journal of Pathology. 107(3):Pix, 1972 Jul. Harpman JA. Anesthetic malignant myopathy hyperthermia. Archives of Otolaryngology. 96(3):264-7, 1972 Sep. Bradley WG. Murchison D. Screening for malignant hyperpyrexia. British Medical Journal. 4(832):108-9, 1972 Oct 14. Zinganell K. Kreutz FH. Suchenwirth R. Enzyme changes, myoglobinuria and muscular necrosis following malignant hyperpyrexia [Ger] Journal Zeitschrift Fur Praktische Anasthesie, Wiederbelebung Und Intensivtherapie. 7(3):161-7, 1972 Jun. Ellis FR. Keaney NP. Harriman DG. Sumner DW. Kyei-Mensah K. Tyrrell JH. Hargreaves JB. Parikh RK. Mulrooney PL. Screening for malignant hyperpyrexia. British Medical Journal. 3(826):559-61, 1972 Sep 2. Parikh RK. Thomson WH. Malignant hyperthermia: a fatal case and his family. British Journal of Anaesthesia. 44(7):742-6, 1972 Jul. Rosalki SB. Enzyme assays in diseases of the heart and skeletal muscle. Journal of Clinical Pathology - Supplement (association of Clinical Pathologists). 4:60-70, 1970. Audet J. Rheault J. A case of malignant hyperthermia [Fre] Journal Union Medicale Du Canada. 100(12):2362-7, 1971